Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",A1BG,Alpha-1B-glycoprotein,7237,826,1.38 [0.92-2.06],0.1198489597150845
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AAMDC,Mth938 domain-containing protein,7030,808,0.94 [0.83-1.07],0.3714027811335066
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AARSD1,Alanyl-tRNA editing protein Aarsd1,8322,985,0.99 [0.89-1.10],0.8423863373588159
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ABCA2,ATP-binding cassette sub-family A member 2,6987,802,0.81 [0.66-0.98],0.0325280600107973
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ABHD14B,Protein ABHD14B,8243,968,0.95 [0.85-1.05],0.2901857011580215
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ABL1,Tyrosine-protein kinase ABL1,8322,985,0.97 [0.89-1.06],0.5080317203082922
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ABO,Histo-blood group ABO system transferase,7238,823,1.00 [0.95-1.04],0.8668447311826585
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ABRAXAS2,BRISC complex subunit Abraxas 2,6987,802,0.90 [0.81-1.00],0.0436002710186339
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",8180,948,1.01 [0.94-1.09],0.717855781533068
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",7092,819,0.93 [0.83-1.03],0.1502945664577734
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",7231,828,0.87 [0.80-0.94],0.0003862902268755
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACAN,Aggrecan core protein,8246,966,1.15 [0.93-1.42],0.1853767693021842
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACE,Angiotensin-converting enzyme,7238,823,0.93 [0.74-1.18],0.5456793485449072
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACE2,Angiotensin-converting enzyme 2,8206,953,0.94 [0.84-1.05],0.270957725598399
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACHE,Acetylcholinesterase,7068,806,0.87 [0.71-1.07],0.1979530402438707
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACOT13,Acyl-coenzyme A thioesterase 13,7204,827,0.92 [0.86-0.97],0.0031250404817642
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,8340,975,0.90 [0.80-1.01],0.0692409596849207
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACP1,Low molecular weight phosphotyrosine protein phosphatase,7008,809,1.05 [0.91-1.21],0.5024419793890518
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACP5,Tartrate-resistant acid phosphatase type 5,8391,975,0.98 [0.83-1.17],0.8400032570490774
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACP6,Lysophosphatidic acid phosphatase type 6,8425,985,1.07 [0.98-1.16],0.1308326163845095
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACRBP,Acrosin-binding protein,7208,827,0.83 [0.69-0.99],0.0367744737134421
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACRV1,Acrosomal protein SP-10,7008,809,0.96 [0.90-1.02],0.1704245244406198
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACSL1,Long-chain-fatty-acid--CoA ligase 1,6987,802,0.86 [0.70-1.05],0.1432588383691321
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACTA2,"Actin, aortic smooth muscle",8206,953,1.08 [0.95-1.23],0.2627950825044217
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACTN2,Alpha-actinin-2,6987,802,1.06 [0.95-1.18],0.2828029561998798
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACTN4,Alpha-actinin-4,8195,943,0.96 [0.80-1.15],0.6720501087198303
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACVRL1,Serine/threonine-protein kinase receptor R3,8252,970,1.32 [1.06-1.64],0.0120365618231978
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACY1,Aminoacylase-1,8340,975,1.02 [0.93-1.12],0.6908011760608701
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,6987,802,0.99 [0.87-1.12],0.8610869510884187
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACYP1,Acylphosphatase-1,7047,803,0.92 [0.83-1.03],0.1419882971029126
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADA,Adenosine deaminase,8443,992,0.91 [0.78-1.06],0.2302865610630224
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADA2,Adenosine deaminase 2,8321,970,0.91 [0.80-1.03],0.147596006060055
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,7008,809,1.14 [0.93-1.40],0.1949359220103436
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,8206,953,1.00 [0.83-1.20],0.9916384337760992
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,8266,970,1.24 [1.06-1.45],0.0082935897027153
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,8443,992,1.13 [0.96-1.33],0.1335556407814154
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,8400,980,1.12 [0.92-1.37],0.2473226301932539
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,7204,827,1.02 [0.81-1.27],0.8904581145710464
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,7008,809,1.13 [0.93-1.38],0.2287088026482837
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,8458,987,1.16 [0.92-1.48],0.2142094983115954
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,8322,985,0.91 [0.79-1.04],0.174849461185408
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,8206,953,0.99 [0.83-1.18],0.9019750822346704
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,7008,809,0.90 [0.74-1.10],0.3097474366162115
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,8384,984,1.00 [0.88-1.13],0.969700316960848
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAMTSL2,ADAMTS-like protein 2,7230,831,1.00 [0.82-1.22],0.9959108893266656
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAMTSL4,ADAMTS-like protein 4,7030,808,0.86 [0.65-1.14],0.2991926199935426
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAMTSL5,ADAMTS-like protein 5,7231,828,0.79 [0.67-0.94],0.0064837665135483
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,8180,948,0.93 [0.77-1.12],0.4525245569932935
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADD1,Alpha-adducin,7068,806,0.91 [0.83-1.00],0.050476723110894
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADGRB3,Adhesion G protein-coupled receptor B3,8252,970,1.01 [0.86-1.20],0.8762951164722703
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADGRD1,Adhesion G-protein coupled receptor D1,7068,806,1.05 [0.89-1.25],0.5579344687966029
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADGRE1,Adhesion G protein-coupled receptor E1,7204,827,0.99 [0.88-1.13],0.9267752899396348
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADGRE2,Adhesion G protein-coupled receptor E2,8377,979,1.18 [0.97-1.44],0.0884220099968368
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADGRE5,Adhesion G protein-coupled receptor E5,8422,982,1.16 [0.97-1.38],0.0968589406021749
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADGRF5,Adhesion G protein-coupled receptor F5,7231,828,0.89 [0.69-1.15],0.384257604582926
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADGRG1,Adhesion G-protein coupled receptor G1,8322,985,0.97 [0.91-1.03],0.3453161463699086
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADGRG2,Adhesion G-protein coupled receptor G2,8340,975,1.28 [1.04-1.59],0.0220402515613277
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADGRV1,Adhesion G-protein coupled receptor V1,7032,801,1.07 [0.98-1.17],0.139791226188336
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADH1B,All-trans-retinol dehydrogenase,7068,806,0.97 [0.88-1.06],0.4947822909531351
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,8206,953,0.99 [0.92-1.07],0.8802605371782021
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADIPOQ,Adiponectin,7237,826,1.04 [0.95-1.15],0.399867827860431
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADM,Pro-adrenomedullin,8438,986,0.95 [0.77-1.19],0.6797357917998845
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADRA2A,Alpha-2A adrenergic receptor,6987,802,0.96 [0.86-1.06],0.4000609756292429
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AFAP1,Actin filament-associated protein 1,7068,806,1.00 [0.92-1.09],0.9316717620424716
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AFM,Afamin,7237,826,0.85 [0.61-1.17],0.3204401772112375
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AFP,Alpha-fetoprotein,8237,967,1.04 [0.95-1.14],0.3894873291492607
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AGBL2,Cytosolic carboxypeptidase 2,7032,801,0.93 [0.87-1.00],0.0556027776247479
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AGER,Advanced glycosylation end product-specific receptor,8326,971,1.01 [0.88-1.16],0.8486706357933081
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AGR2,Anterior gradient protein 2 homolog,8100,935,1.02 [0.96-1.09],0.4242016133641898
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AGR3,Anterior gradient protein 3,8165,947,0.97 [0.88-1.07],0.5620476119062847
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AGRN,Agrin,8377,979,1.08 [0.92-1.27],0.3637762444821614
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AGRP,Agouti-related protein,8443,992,0.96 [0.86-1.07],0.4681973622508378
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AGT,Angiotensinogen,7238,823,1.23 [0.93-1.64],0.1483863529098189
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AGXT,Serine--pyruvate aminotransferase,8340,975,1.02 [0.95-1.11],0.5750043885032843
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AHCY,Adenosylhomocysteinase,8340,975,0.94 [0.87-1.03],0.1909123033610499
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AHNAK,Neuroblast differentiation-associated protein AHNAK,7030,808,1.37 [1.12-1.69],0.0024781859195232
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AHNAK2,Protein AHNAK2,7030,808,1.03 [0.82-1.27],0.8224443303980048
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,7208,827,0.97 [0.87-1.07],0.5157853234175209
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AHSG,Alpha-2-HS-glycoprotein,7238,823,1.01 [0.79-1.29],0.9259759150161668
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AHSP,Alpha-hemoglobin-stabilizing protein,8337,974,0.97 [0.91-1.04],0.453572555250831
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AIDA,"Axin interactor, dorsalization-associated protein",7040,799,0.89 [0.81-0.97],0.0083164806294441
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AIF1,Allograft inflammatory factor 1,8180,948,0.98 [0.87-1.09],0.6790848904231078
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AIF1L,Allograft inflammatory factor 1-like,7030,808,0.96 [0.84-1.09],0.5228665590977333
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",8312,984,0.94 [0.89-0.99],0.027545673100163
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AK1,Adenylate kinase isoenzyme 1,8340,975,1.01 [0.93-1.11],0.7745705611971332
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AK2,"Adenylate kinase 2, mitochondrial",7224,829,0.91 [0.85-0.97],0.002834663075037
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AKAP12,A-kinase anchor protein 12,7068,806,0.94 [0.67-1.31],0.6993847302326937
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AKR1B1,Aldo-keto reductase family 1 member B1,8180,948,1.01 [0.93-1.09],0.796910763707811
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AKR1B10,Aldo-keto reductase family 1 member B10,7040,799,0.97 [0.87-1.08],0.5578277651529322
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AKR1C4,Aldo-keto reductase family 1 member C4,8206,953,1.03 [0.92-1.15],0.6134754711762253
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AKR7L,Aflatoxin B1 aldehyde reductase member 4,7008,809,0.98 [0.89-1.09],0.7405451490660839
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AKT1S1,Proline-rich AKT1 substrate 1,8164,946,0.94 [0.86-1.03],0.1592502794662516
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AKT2,RAC-beta serine/threonine-protein kinase,7222,826,0.94 [0.90-1.00],0.0321718236349272
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AKT3,RAC-gamma serine/threonine-protein kinase,8149,943,0.97 [0.88-1.08],0.6129320832251548
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ALCAM,CD166 antigen,8458,987,1.50 [1.13-2.01],0.0053451290824961
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ALDH1A1,Retinal dehydrogenase 1,8360,976,1.03 [0.93-1.15],0.5614511462475031
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ALDH2,"Aldehyde dehydrogenase, mitochondrial",7208,827,0.91 [0.79-1.04],0.1732648327981648
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",8315,969,1.00 [0.92-1.08],0.9302527559493984
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",7222,826,0.88 [0.75-1.02],0.0831929338182339
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ALMS1,Alstrom syndrome protein 1,7092,819,1.01 [0.86-1.18],0.8848478020740254
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ALPI,Intestinal-type alkaline phosphatase,7008,809,1.00 [0.94-1.05],0.8664032632190191
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ALPP,"Alkaline phosphatase, placental type",8322,985,1.00 [0.95-1.06],0.9059624949772672
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMBN,Ameloblastin,8195,943,1.06 [0.86-1.29],0.590713759422664
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMBP,Protein AMBP,8427,986,1.44 [1.09-1.89],0.0102730790894382
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,7230,831,1.07 [0.83-1.39],0.6016581727847835
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMFR,E3 ubiquitin-protein ligase AMFR,8164,946,1.04 [0.95-1.14],0.3797103165802332
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMIGO1,Amphoterin-induced protein 1,7040,799,0.82 [0.70-0.96],0.0138620479666486
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMIGO2,Amphoterin-induced protein 2,8322,985,1.15 [0.91-1.46],0.2533068684622428
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMN,Protein amnionless,8195,943,1.07 [0.95-1.21],0.2527213625130132
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMOT,Angiomotin,7068,806,1.13 [0.94-1.36],0.1817188537967494
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMOTL2,Angiomotin-like protein 2,7175,820,0.89 [0.76-1.03],0.109110927728225
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMPD3,AMP deaminase 3,7224,829,1.03 [0.94-1.13],0.5182249224114821
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,6775,779,1.06 [0.92-1.21],0.4250406087432746
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMY2A,Pancreatic alpha-amylase,8044,940,1.06 [0.94-1.19],0.3415128750455972
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMY2B,Alpha-amylase 2B,7782,902,1.03 [0.91-1.16],0.6396321477466249
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANG,Angiogenin,8346,972,1.03 [0.87-1.23],0.7026367005572915
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANGPT1,Angiopoietin-1,8305,967,0.98 [0.91-1.05],0.5389569799912648
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANGPT2,Angiopoietin-2,8438,986,1.02 [0.88-1.19],0.7932811929340017
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANGPTL1,Angiopoietin-related protein 1,8221,959,1.17 [0.96-1.42],0.1293461827929675
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANGPTL2,Angiopoietin-related protein 2,8348,975,1.03 [0.89-1.19],0.7090921975804209
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANGPTL3,Angiopoietin-related protein 3,8370,976,1.06 [0.90-1.25],0.487237976037758
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANGPTL4,Angiopoietin-related protein 4,8365,974,1.00 [0.88-1.14],0.9936504453973336
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANGPTL7,Angiopoietin-related protein 7,8438,986,0.97 [0.82-1.14],0.6846199587661188
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANK2,Ankyrin-2,6987,802,0.90 [0.81-1.00],0.0612078056986906
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,7008,809,0.93 [0.85-1.01],0.0812348709930391
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANKRA2,Ankyrin repeat family A protein 2,6987,805,0.98 [0.87-1.11],0.7463431476699691
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANKRD54,Ankyrin repeat domain-containing protein 54,8180,948,1.08 [0.98-1.19],0.1153307518851885
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,7030,808,0.78 [0.64-0.95],0.0148627001762606
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANPEP,Aminopeptidase N,8384,979,1.07 [0.87-1.31],0.545177032103997
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANXA1,Annexin A1,7035,802,1.06 [0.91-1.24],0.4443478453086086
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANXA10,Annexin A10,8164,946,0.97 [0.90-1.04],0.4052320430701244
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANXA11,Annexin A11,8322,971,0.93 [0.85-1.01],0.0898071956017689
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANXA2,Annexin A2,6918,796,1.02 [0.93-1.13],0.6619446118828134
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANXA3,Annexin A3,8400,980,0.98 [0.90-1.06],0.5817698291892011
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANXA4,Annexin A4,8307,970,0.95 [0.88-1.03],0.2499172403669203
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANXA5,Annexin A5,8133,943,1.15 [0.96-1.39],0.1330319856885691
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AOC1,Amiloride-sensitive amine oxidase [copper-containing],8195,943,0.87 [0.77-0.97],0.0164308386080006
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AOC3,Membrane primary amine oxidase,8395,979,0.78 [0.64-0.94],0.009888192165328
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AP1G2,AP-1 complex subunit gamma-like 2,7208,827,0.92 [0.85-1.00],0.0628862179192098
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AP2B1,AP-2 complex subunit beta,7040,799,0.83 [0.71-0.96],0.0141193680627127
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AP3B1,AP-3 complex subunit beta-1,7204,827,0.91 [0.83-0.99],0.0354285874896347
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AP3S2,AP-3 complex subunit sigma-2,7224,829,0.93 [0.81-1.07],0.3322561266957067
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,8322,985,1.11 [0.98-1.25],0.1030050948366406
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APCS,Serum amyloid P-component,7162,819,1.16 [0.94-1.44],0.1612273492895092
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,8407,981,1.04 [0.95-1.15],0.3746901469749774
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APLP1,Amyloid-like protein 1,8340,975,1.08 [0.96-1.20],0.2055343906243684
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APOA1,Apolipoprotein A-I,7237,826,1.08 [0.85-1.38],0.5364328762855257
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APOA2,Apolipoprotein A-II,7238,823,0.93 [0.82-1.07],0.3252225552015767
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APOA4,Apolipoprotein A-IV,7237,826,1.10 [0.91-1.34],0.3154292414729105
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APOB,Apolipoprotein B-100,7238,823,0.93 [0.70-1.25],0.6402153707826468
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APOBR,Apolipoprotein B receptor,7030,808,1.07 [0.91-1.26],0.4180264143475113
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APOC1,Apolipoprotein C-I,7227,826,1.05 [0.88-1.25],0.6072266178908696
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APOD,Apolipoprotein D,6935,797,1.00 [0.85-1.19],0.9757543847543216
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APOE,Apolipoprotein E,7237,826,1.08 [0.99-1.18],0.0750846855066898
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APOF,Apolipoprotein F,7238,823,0.93 [0.71-1.21],0.5879058848441854
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APOH,Beta-2-glycoprotein 1,8360,976,1.06 [0.91-1.24],0.4588881562964919
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APOL1,Apolipoprotein L1,7238,823,1.19 [1.05-1.34],0.0057164508440206
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APOM,Apolipoprotein M,8382,977,1.02 [0.84-1.24],0.8213698220898447
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APP,Amyloid-beta precursor protein,8348,972,0.94 [0.86-1.03],0.167500919658395
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APPL2,DCC-interacting protein 13-beta,7068,806,0.93 [0.87-0.98],0.0116945983328141
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APRT,Adenine phosphoribosyltransferase,8242,967,0.97 [0.86-1.09],0.5985522682813338
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARAF,Serine/threonine-protein kinase A-Raf,7092,819,0.89 [0.80-0.99],0.0282090488002351
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AREG,Amphiregulin,8322,985,0.95 [0.82-1.10],0.5178165338809596
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARF6,ADP-ribosylation factor 6,7204,827,0.96 [0.90-1.02],0.199077442181752
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARFIP1,Arfaptin-1,7222,826,0.86 [0.78-0.95],0.003718581240439
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARG1,Arginase-1,8301,967,1.05 [0.94-1.17],0.4050652671428244
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARG2,"Arginase-2, mitochondrial",7208,827,0.89 [0.75-1.05],0.1704891621633868
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARHGAP1,Rho GTPase-activating protein 1,8180,948,0.90 [0.80-1.02],0.1140210052580372
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARHGAP25,Rho GTPase-activating protein 25,8180,948,0.94 [0.85-1.03],0.2025857346821934
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARHGAP30,Rho GTPase-activating protein 30,7092,819,0.83 [0.69-1.00],0.0512667733006683
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARHGAP45,Rho GTPase-activating protein 45,7068,806,0.90 [0.83-0.98],0.0182161287096721
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARHGAP5,Rho GTPase-activating protein 5,6987,805,0.90 [0.82-0.98],0.0224855163733842
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARHGEF1,Rho guanine nucleotide exchange factor 1,7224,829,0.91 [0.84-0.98],0.0098210628422612
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARHGEF10,Rho guanine nucleotide exchange factor 10,7222,826,0.92 [0.86-0.99],0.0284623220528383
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARHGEF12,Rho guanine nucleotide exchange factor 12,8335,971,0.95 [0.90-1.01],0.0800530080028124
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARHGEF5,Rho guanine nucleotide exchange factor 5,7032,801,0.95 [0.87-1.05],0.3482791849351927
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARID3A,AT-rich interactive domain-containing protein 3A,7032,801,0.90 [0.75-1.07],0.2190113122791127
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARID4B,AT-rich interactive domain-containing protein 4B,8164,946,1.07 [0.93-1.22],0.345275020664342
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARL13B,ADP-ribosylation factor-like protein 13B,6987,802,0.93 [0.84-1.03],0.1619895190788237
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,6987,802,0.81 [0.68-0.96],0.0178040212644108
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARMCX2,Armadillo repeat-containing X-linked protein 2,7032,801,1.04 [0.93-1.16],0.5052912096488851
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARNT,Aryl hydrocarbon receptor nuclear translocator,8195,943,0.95 [0.81-1.12],0.5469519588328544
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,6987,802,0.91 [0.79-1.05],0.1992012866883944
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARSA,Arylsulfatase A,8360,976,1.06 [0.94-1.20],0.3354638845629518
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARSB,Arylsulfatase B,8322,985,0.95 [0.86-1.06],0.3771332942364096
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ART3,Ecto-ADP-ribosyltransferase 3,8395,979,0.97 [0.83-1.13],0.6800877964978556
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ART5,Ecto-ADP-ribosyltransferase 5,7032,801,1.01 [0.91-1.13],0.8232668020860338
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARTN,Artemin,8195,943,1.05 [0.93-1.19],0.4315261105916973
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ASAH1,Acid ceramidase,7163,823,0.90 [0.77-1.05],0.1729894136417412
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ASAH2,Neutral ceramidase,8266,970,0.98 [0.88-1.09],0.7673974277945984
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ASGR1,Asialoglycoprotein receptor 1,8266,970,1.11 [0.92-1.34],0.2868928549183326
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ASGR2,Asialoglycoprotein receptor 2,7238,823,1.28 [1.00-1.63],0.0495427241204087
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ASPN,Asporin,7231,828,0.86 [0.67-1.10],0.2339432984426169
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ASPSCR1,Tether containing UBX domain for GLUT4,7222,826,0.90 [0.81-0.99],0.0393848696684591
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ASRGL1,Isoaspartyl peptidase/L-asparaginase,7030,808,0.99 [0.92-1.06],0.6998283073516116
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ASS1,Argininosuccinate synthase,6987,802,0.95 [0.87-1.05],0.3166695287055318
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATF2,Cyclic AMP-dependent transcription factor ATF-2,8164,946,0.97 [0.88-1.06],0.4959272408070511
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATF4,Cyclic AMP-dependent transcription factor ATF-4,6987,805,0.89 [0.73-1.10],0.2802468070926025
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATG16L1,Autophagy-related protein 16-1,7204,827,0.91 [0.84-0.99],0.0247814448546848
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATG4A,Cysteine protease ATG4A,8180,948,0.97 [0.88-1.07],0.5528699198664413
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATOX1,Copper transport protein ATOX1,8384,984,0.98 [0.90-1.06],0.5492937333344898
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,6987,802,1.00 [0.86-1.16],0.9886206460380492
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,6987,802,0.93 [0.75-1.15],0.4977701224291161
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,6987,802,0.83 [0.68-1.00],0.0524578391514766
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP1B4,Protein ATP1B4,6987,805,1.02 [0.87-1.19],0.8509213851073146
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP2B4,Plasma membrane calcium-transporting ATPase 4,6987,802,0.87 [0.77-0.99],0.0322326887498339
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP5F1D,"ATP synthase subunit delta, mitochondrial",6987,802,0.92 [0.80-1.06],0.224970736246654
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP5IF1,"ATPase inhibitor, mitochondrial",8377,979,0.96 [0.91-1.01],0.1040111412479036
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP5PO,"ATP synthase subunit O, mitochondrial",8164,946,1.04 [0.91-1.19],0.5463010459898023
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP6AP2,Renin receptor,8180,948,1.04 [0.90-1.20],0.5532229848444605
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP6V1D,V-type proton ATPase subunit D,8322,985,0.96 [0.76-1.20],0.7015707696773237
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP6V1F,V-type proton ATPase subunit F,8152,944,0.94 [0.86-1.03],0.2108220815289353
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP6V1G1,V-type proton ATPase subunit G 1,7030,808,0.90 [0.82-0.99],0.0309115894957813
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP6V1G2,V-type proton ATPase subunit G 2,6987,802,0.99 [0.92-1.07],0.8033511359401149
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATRAID,All-trans retinoic acid-induced differentiation factor,7204,827,1.10 [0.89-1.36],0.3908810731464948
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATRN,"Attractin, Isoform 2",7237,826,1.18 [0.79-1.76],0.4298885018422278
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATXN10,Ataxin-10,8164,946,0.93 [0.86-1.01],0.0904928675812104
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATXN2,Ataxin-2,7032,801,0.95 [0.89-1.02],0.1609349688912691
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATXN2L,Ataxin-2-like protein,7222,826,0.84 [0.72-0.97],0.0202669809596629
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATXN3,Ataxin-3,7224,829,0.95 [0.85-1.05],0.3134486306259967
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AXIN1,Axin-1,8335,971,0.97 [0.91-1.03],0.328514449194963
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AXL,Tyrosine-protein kinase receptor UFO,8395,979,1.23 [1.00-1.51],0.0501106396712847
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AZI2,5-azacytidine-induced protein 2,7222,826,0.91 [0.81-1.03],0.1465600338150221
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AZU1,Azurocidin,8095,943,1.05 [0.97-1.13],0.2196977451384265
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",B2M,Beta-2-microglobulin,7237,826,1.11 [0.91-1.36],0.3049316120561845
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,6987,802,0.71 [0.50-1.00],0.0499469043841472
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",7030,808,0.99 [0.82-1.18],0.8869081562796332
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",B4GALT1,"Beta-1,4-galactosyltransferase 1",8377,979,1.18 [0.96-1.44],0.1176372928893696
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",B4GAT1,"Beta-1,4-glucuronyltransferase 1",8360,976,0.99 [0.78-1.25],0.9098082620651348
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BABAM1,BRISC and BRCA1-A complex member 1,7008,809,0.81 [0.63-1.03],0.088427738170637
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BACH1,Transcription regulator protein BACH1,8335,971,0.96 [0.89-1.04],0.2951377905776897
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BAG3,BAG family molecular chaperone regulator 3,8252,970,1.01 [0.88-1.16],0.8956356783511259
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BAG4,BAG family molecular chaperone regulator 4,7008,809,0.99 [0.86-1.14],0.905361886197671
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BAG6,Large proline-rich protein BAG6,8206,953,1.00 [0.85-1.17],0.9818357120010552
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,8180,948,1.04 [0.95-1.14],0.365978472567237
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BAMBI,BMP and activin membrane-bound inhibitor homolog,8180,948,1.20 [0.99-1.47],0.0646621514681822
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BANK1,B-cell scaffold protein with ankyrin repeats,8335,971,0.97 [0.92-1.03],0.317925001280827
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BAP18,Chromatin complexes subunit BAP18,7224,829,1.02 [0.93-1.12],0.7043983068588491
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BATF,Basic leucine zipper transcriptional factor ATF-like,7040,799,0.98 [0.91-1.07],0.7042425806431403
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BAX,Apoptosis regulator BAX,8150,944,0.94 [0.88-1.00],0.065884416123867
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BCAM,Basal cell adhesion molecule,8360,976,1.11 [0.88-1.40],0.3803161613479635
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BCAN,Brevican core protein,8266,970,1.15 [0.98-1.36],0.0948647273183603
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",7231,828,0.94 [0.75-1.18],0.6046146555502345
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",7032,801,0.96 [0.84-1.09],0.5406796626029532
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BCHE,Cholinesterase,7101,812,0.95 [0.74-1.23],0.7194227374005934
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BCL2,Apoptosis regulator Bcl-2,7204,827,1.03 [0.91-1.16],0.6575777286170217
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BCL2L1,Bcl-2-like protein 1,7224,829,0.91 [0.85-0.97],0.0063350609495996
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",8335,971,0.85 [0.75-0.97],0.0155630498181267
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BCL2L15,Bcl-2-like protein 15,7008,809,1.07 [0.96-1.20],0.242482924853073
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BCL7A,B-cell CLL/lymphoma 7 protein family member A,6987,805,0.97 [0.87-1.08],0.5991886640618858
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BCL7B,B-cell CLL/lymphoma 7 protein family member B,7208,827,0.87 [0.75-1.02],0.080754416453691
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BCR,Breakpoint cluster region protein,8335,971,0.95 [0.89-1.01],0.0889977328454162
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BDNF,Brain-derived neurotrophic factor,7230,831,0.94 [0.87-1.01],0.0955512716288053
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BECN1,Beclin-1,7030,808,0.95 [0.85-1.07],0.4397527209930352
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BEX3,Protein BEX3,6987,805,0.96 [0.82-1.12],0.5948904872849345
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BGLAP,Osteocalcin,7230,831,1.04 [0.96-1.13],0.3345132667562148
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BGN,Biglycan,8169,948,1.01 [0.96-1.06],0.646500694532953
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BHLHE40,Class E basic helix-loop-helix protein 40,7032,801,0.97 [0.88-1.08],0.6103022938452258
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,6987,802,0.82 [0.63-1.06],0.1241487567001717
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BID,BH3-interacting domain death agonist,8335,971,1.02 [0.93-1.11],0.7146349563620628
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BIN2,Bridging integrator 2,8360,976,0.93 [0.87-0.99],0.0269259261653684
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BIRC2,Baculoviral IAP repeat-containing protein 2,8180,948,0.92 [0.84-1.01],0.0760877360265588
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BLMH,Bleomycin hydrolase,8458,987,0.93 [0.77-1.12],0.451696974141852
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BLNK,B-cell linker protein,7008,809,1.21 [1.03-1.43],0.0211934671085022
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,7032,801,0.83 [0.75-0.92],0.0004195467428309
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,7224,829,0.85 [0.71-1.01],0.0591362144776021
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BLVRB,Flavin reductase,8360,976,1.05 [0.96-1.14],0.2856941502065704
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BMP10,Bone morphogenetic protein 10,7068,806,0.86 [0.68-1.09],0.2193335469252213
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BMP4,Bone morphogenetic protein 4,8252,970,1.00 [0.89-1.13],0.995113380583858
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BMP6,Bone morphogenetic protein 6,8196,953,0.83 [0.72-0.96],0.0129641382321627
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BMPER,BMP-binding endothelial regulator protein,7068,806,1.10 [0.82-1.49],0.5219328561012817
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,7231,828,0.77 [0.63-0.95],0.01243454401139
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,7008,809,0.96 [0.81-1.13],0.5981566303484362
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BOC,Brother of CDO,8206,953,1.14 [0.89-1.46],0.3102405361823963
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BOLA1,BolA-like protein 1,7032,801,0.94 [0.83-1.08],0.383101804802083
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BOLA2_BOLA2B,BolA-like protein 2,7030,808,0.93 [0.82-1.06],0.2610270029605061
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BPIFA2,BPI fold-containing family A member 2,6791,779,1.02 [0.95-1.08],0.6263060212581711
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BPIFB1,BPI fold-containing family B member 1,8347,972,0.93 [0.85-1.01],0.0999617823956465
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BPIFB2,BPI fold-containing family B member 2,7213,824,1.02 [0.92-1.13],0.7186477866788893
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BRAP,BRCA1-associated protein,7139,819,0.91 [0.86-0.97],0.0025262972425294
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BRD1,Bromodomain-containing protein 1,7092,819,0.75 [0.59-0.96],0.0205417236492309
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BRD2,Bromodomain-containing protein 2,7032,801,0.78 [0.63-0.97],0.0237728481148388
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BRD3,Bromodomain-containing protein 3,6987,802,0.84 [0.72-0.98],0.0272448319136226
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BRDT,Bromodomain testis-specific protein,6987,802,0.74 [0.61-0.89],0.0014580276343472
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BRK1,Protein BRICK1,8164,946,0.99 [0.87-1.12],0.8640614768586776
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BRME1,Break repair meiotic recombinase recruitment factor 1,7032,801,0.87 [0.72-1.05],0.1561524134423123
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BRSK2,Serine/threonine-protein kinase BRSK2,7222,826,0.87 [0.72-1.06],0.1581149792043551
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BSG,Basigin,8430,991,1.43 [1.09-1.88],0.0107501166636634
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BSND,Barttin,6987,805,0.96 [0.79-1.17],0.692090726899731
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,8412,980,1.09 [0.96-1.24],0.1741411312970563
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BST2,Bone marrow stromal antigen 2,8412,980,1.09 [0.97-1.22],0.1596548281020989
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BTC,Probetacellulin,8180,948,0.95 [0.87-1.02],0.1719340411953772
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BTD,Biotinidase,7237,826,0.91 [0.66-1.25],0.5550070716500246
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BTLA,B- and T-lymphocyte attenuator,6987,805,0.95 [0.87-1.03],0.1864235910925357
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BTN1A1,Butyrophilin subfamily 1 member A1,7190,824,1.02 [0.86-1.21],0.819179668961743
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BTN2A1,Butyrophilin subfamily 2 member A1,8377,979,1.30 [1.06-1.60],0.0112641289189922
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BTN3A2,Butyrophilin subfamily 3 member A2,8335,971,0.94 [0.80-1.09],0.3964908760487065
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BTNL10,Butyrophilin-like protein 10,6987,805,0.92 [0.77-1.10],0.3526194739881731
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C19orf12,Protein C19orf12,8164,946,0.96 [0.87-1.05],0.359076803519009
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C1GALT1C1,C1GALT1-specific chaperone 1,6987,802,0.73 [0.58-0.91],0.0057706906712291
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C1QA,Complement C1q subcomponent subunit A,8401,985,1.18 [0.91-1.51],0.2066206201797236
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",7222,826,0.93 [0.84-1.03],0.1634927261960111
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C1QL2,Complement C1q-like protein 2,7008,809,1.00 [0.85-1.18],0.9987328545291674
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,8395,979,1.00 [0.87-1.14],0.9577893120381368
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,7068,806,1.10 [0.91-1.33],0.343877683079307
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,7222,826,0.87 [0.71-1.08],0.2218725929866469
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,7058,806,0.99 [0.86-1.14],0.8825213302977124
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C1R,Complement C1r subcomponent,7237,826,1.18 [0.82-1.70],0.3770305837472395
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C1RL,Complement C1r subcomponent-like protein,7217,825,1.27 [0.90-1.79],0.1686827079511477
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C1S,Complement C1s subcomponent,7237,826,1.09 [0.79-1.50],0.5980246798736469
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C2,Complement C2,8382,977,0.84 [0.65-1.09],0.1859794291895464
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C2CD2L,Phospholipid transfer protein C2CD2L,8152,944,1.02 [0.89-1.17],0.7997897888965106
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C2orf69,UPF0565 protein C2orf69,7040,799,0.90 [0.79-1.03],0.1177065652828172
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C3,Complement C3,6854,791,0.99 [0.85-1.15],0.8978545311614334
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C4BPB,C4b-binding protein beta chain,8384,984,1.14 [0.98-1.32],0.088981441728488
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C5,Complement C5,7237,826,1.09 [0.69-1.71],0.7185666760137417
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C7,Complement component C7,7060,813,0.87 [0.70-1.08],0.2046876634569106
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C7orf50,Uncharacterized protein C7orf50,7224,829,1.14 [0.88-1.48],0.3318102279728394
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C8B,Complement component C8 beta chain,7237,826,0.90 [0.72-1.13],0.3603266462160617
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C9,Complement component C9,7238,823,1.03 [0.91-1.16],0.625584273088286
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C9orf40,Uncharacterized protein C9orf40,7204,827,1.08 [0.99-1.17],0.0769028372243483
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA1,Carbonic anhydrase 1,8194,954,1.04 [0.94-1.15],0.4541026606020937
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA11,Carbonic anhydrase-related protein 11,8180,948,1.05 [0.87-1.27],0.5997117454489598
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA12,Carbonic anhydrase 12,8322,985,1.18 [1.00-1.41],0.0539466668060561
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA13,Carbonic anhydrase 13,8238,963,0.95 [0.90-1.00],0.0561798038339631
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA14,Carbonic anhydrase 14,8438,986,1.19 [1.02-1.38],0.031553385352286
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA2,Carbonic anhydrase 2,8326,971,1.01 [0.93-1.10],0.7982438215778518
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA3,Carbonic anhydrase 3,8449,986,1.13 [1.03-1.23],0.0126606785771207
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA4,Carbonic anhydrase 4,8458,987,0.97 [0.77-1.22],0.8108642640005029
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA5A,"Carbonic anhydrase 5A, mitochondrial",8206,953,1.01 [0.94-1.07],0.8750001713465265
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA6,Carbonic anhydrase 6,8338,974,1.02 [0.93-1.12],0.7093998916218894
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA7,Carbonic anhydrase 7,7092,819,1.08 [0.90-1.30],0.4201741972054758
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA8,Carbonic anhydrase-related protein,7008,809,1.07 [0.83-1.39],0.5817055222916165
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA9,Carbonic anhydrase 9,8438,986,0.97 [0.86-1.09],0.5730493434828674
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CABP2,Calcium-binding protein 2,7040,799,0.80 [0.71-0.90],0.0002153918135467
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,7032,801,0.94 [0.76-1.17],0.6054581670219839
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,6987,802,0.91 [0.80-1.04],0.1750528448844081
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,7032,801,0.93 [0.83-1.05],0.220643181839269
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,7222,826,0.89 [0.82-0.97],0.0060268001347521
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CACYBP,Calcyclin-binding protein,7058,806,0.93 [0.87-1.00],0.0437711010973333
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CADPS,Calcium-dependent secretion activator 1,7040,799,1.00 [0.84-1.18],0.9646536206673172
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CALB1,Calbindin,8322,985,1.13 [1.00-1.28],0.051148547175008
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CALB2,Calretinin,8164,946,0.95 [0.78-1.17],0.6494444664121557
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CALCA,Calcitonin,8254,968,0.97 [0.89-1.06],0.5259385857173648
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CALCB,Calcitonin gene-related peptide 2,7224,829,0.99 [0.83-1.17],0.8748547045950463
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,8410,983,0.97 [0.92-1.02],0.2693602924351341
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,7030,808,0.91 [0.83-1.00],0.0406540654051701
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CALY,Neuron-specific vesicular protein calcyon,6987,802,0.94 [0.78-1.13],0.508046894998598
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,8180,948,0.94 [0.82-1.08],0.3947765751029637
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CAMLG,Guided entry of tail-anchored proteins factor CAMLG,7040,799,0.92 [0.81-1.05],0.2226544973006048
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,7222,826,0.95 [0.89-1.01],0.1083511520100231
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CANT1,Soluble calcium-activated nucleotidase 1,8311,972,1.20 [0.91-1.59],0.2048996175111782
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CAPG,Macrophage-capping protein,8305,975,1.08 [0.98-1.19],0.1122429605721307
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CAPN3,Calpain-3,7208,827,1.14 [0.95-1.35],0.1514976536709291
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CAPS,Calcyphosin,7224,829,0.93 [0.87-1.00],0.0644736390953274
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CARHSP1,Calcium-regulated heat-stable protein 1,8164,946,1.03 [0.92-1.15],0.5774507201844765
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CASC3,Protein CASC3,7040,799,0.84 [0.71-1.00],0.0473505403200119
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CASP1,Caspase-1,8164,946,1.04 [0.96-1.13],0.3192889157253883
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CASP10,Caspase-10,8164,946,1.00 [0.92-1.09],0.963848063338204
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CASP2,Caspase-2,8335,971,0.97 [0.89-1.05],0.4512375815631019
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CASP3,Caspase-3,8458,987,0.94 [0.89-1.01],0.0818295011617775
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CASP4,Caspase-4,7092,819,0.96 [0.92-1.00],0.0764575309846568
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CASP7,Caspase-7,7224,829,0.91 [0.84-0.98],0.0168010748587867
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CASP8,Caspase-8,8414,985,1.02 [0.93-1.12],0.685509486477484
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CASP9,Caspase-9,7008,809,0.97 [0.87-1.09],0.6035574119413235
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CASQ2,Calsequestrin-2,6987,802,0.87 [0.74-1.02],0.0828851753588431
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CAT,Catalase,7136,814,1.08 [0.95-1.22],0.2368002671056078
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CBLIF,Cobalamin binding intrinsic factor,8328,973,0.99 [0.92-1.06],0.7384432980671725
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CBLN1,Cerebellin-1,7032,801,1.01 [0.93-1.09],0.8479408731512444
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CBLN4,Cerebellin-4,8438,986,1.01 [0.86-1.20],0.8743074462305281
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CBS,Cystathionine beta-synthase,7030,808,1.10 [0.97-1.26],0.1491545044158932
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CBX2,Chromobox protein homolog 2,6987,802,0.90 [0.75-1.08],0.2599235512789237
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CC2D1A,Coiled-coil and C2 domain-containing protein 1A,8266,970,0.97 [0.89-1.05],0.4390788558790236
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCAR2,Cell cycle and apoptosis regulator protein 2,7224,829,1.03 [0.91-1.16],0.6596765229482415
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCDC134,Coiled-coil domain-containing protein 134,7208,827,0.93 [0.81-1.07],0.3081275758511702
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCDC28A,Coiled-coil domain-containing protein 28A,7040,799,0.74 [0.59-0.93],0.0100501418719858
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCDC50,Coiled-coil domain-containing protein 50,7222,826,0.96 [0.88-1.06],0.4292295504935619
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCDC80,Coiled-coil domain-containing protein 80,8340,975,1.12 [0.96-1.31],0.1466230257941174
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCER2,Coiled-coil domain-containing glutamate-rich protein 2,7030,808,1.05 [0.94-1.17],0.3933505408637383
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL11,Eotaxin,8443,992,0.85 [0.73-0.98],0.0259047963641545
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL13,C-C motif chemokine 13,8433,990,0.94 [0.87-1.03],0.1745484117373894
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL14,C-C motif chemokine 14,8346,972,0.98 [0.85-1.13],0.7387662186173046
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL15,C-C motif chemokine 15,8458,987,1.01 [0.89-1.15],0.9119803072791828
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL16,C-C motif chemokine 16,8458,987,1.03 [0.92-1.15],0.6098760698964059
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL17,C-C motif chemokine 17,8327,970,0.95 [0.89-1.01],0.0803907738510912
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL18,C-C motif chemokine 18,8246,959,0.95 [0.87-1.03],0.2064696737555522
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL19,C-C motif chemokine 19,8412,980,0.98 [0.93-1.02],0.3148143775704879
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL2,C-C motif chemokine 2,8252,970,0.93 [0.84-1.04],0.2137668947040762
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL20,C-C motif chemokine 20,8443,992,0.93 [0.87-0.99],0.0278673748961539
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL21,C-C motif chemokine 21,8377,979,0.89 [0.77-1.04],0.1453344456941133
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL22,C-C motif chemokine 22,8266,967,0.97 [0.86-1.08],0.525478879443778
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL23,C-C motif chemokine 23,8377,979,1.05 [0.92-1.21],0.4526699510961069
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL24,C-C motif chemokine 24,8365,974,0.99 [0.93-1.06],0.8504117394201057
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL25,C-C motif chemokine 25,8443,992,0.95 [0.84-1.06],0.3428068431591115
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL26,C-C motif chemokine 26,8335,971,0.98 [0.92-1.04],0.5384218722820993
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL27,C-C motif chemokine 27,8340,975,0.95 [0.87-1.05],0.3170952589002453
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL28,C-C motif chemokine 28,8303,969,0.95 [0.86-1.05],0.2869662723580806
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL3,C-C motif chemokine 3,8335,971,1.10 [1.01-1.21],0.0385783995996759
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL4,C-C motif chemokine 4,8353,975,1.08 [0.99-1.17],0.0859608105361453
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL5,C-C motif chemokine 5,8395,979,0.94 [0.88-0.99],0.0181443822327936
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL7,C-C motif chemokine 7,8335,971,1.00 [0.91-1.11],0.93302271683318
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL8,C-C motif chemokine 8,8427,986,0.99 [0.90-1.08],0.7566512931289329
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCN1,CCN family member 1,8311,985,0.94 [0.87-1.02],0.1335358604902017
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCN2,CCN family member 2,8337,968,0.96 [0.87-1.07],0.4952459299914054
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCN3,CCN family member 3,8445,987,1.30 [1.11-1.53],0.0015592488847072
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCN4,CCN family member 4,8438,986,1.07 [0.93-1.24],0.3497208549615859
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCN5,CCN family member 5,8360,976,1.01 [0.87-1.17],0.9261658728651128
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCND2,G1/S-specific cyclin-D2,7092,819,1.08 [0.90-1.30],0.411587316553076
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCNE1,G1/S-specific cyclin-E1,7008,809,0.99 [0.92-1.07],0.7605917102617687
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCS,Copper chaperone for superoxide dismutase,8266,970,1.03 [0.91-1.17],0.6152386275154542
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCT5,T-complex protein 1 subunit epsilon,8180,948,0.90 [0.79-1.03],0.1260581666981566
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD101,Immunoglobulin superfamily member 2,7204,827,1.04 [0.90-1.22],0.5806118881650079
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD109,CD109 antigen,8360,976,0.82 [0.69-0.97],0.0190418907911611
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD14,Monocyte differentiation antigen CD14,8208,958,0.97 [0.85-1.12],0.7144816489577495
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD160,CD160 antigen,8443,992,1.10 [0.98-1.24],0.1102102674612594
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD163,Scavenger receptor cysteine-rich type 1 protein M130,8395,979,0.94 [0.82-1.07],0.3452969927878124
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD164,Sialomucin core protein 24,8360,976,0.93 [0.74-1.16],0.5170580138316838
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD164L2,CD164 sialomucin-like 2 protein,7040,799,0.90 [0.75-1.09],0.3020647354405997
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD177,CD177 antigen,8341,974,1.05 [1.00-1.10],0.0293896760505254
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD1C,T-cell surface glycoprotein CD1c,8384,984,1.28 [1.01-1.62],0.0371608891253488
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD2,T-cell surface antigen CD2,6987,802,0.86 [0.71-1.04],0.1164469641081003
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD200,OX-2 membrane glycoprotein,8335,971,0.87 [0.70-1.08],0.2028183488125412
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD200R1,Cell surface glycoprotein CD200 receptor 1,8311,969,1.13 [0.96-1.32],0.1339939731574721
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD207,C-type lectin domain family 4 member K,8172,972,0.96 [0.83-1.11],0.5719237459825055
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD209,CD209 antigen,8384,980,1.17 [1.01-1.35],0.0368487061740764
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD22,B-cell receptor CD22,8443,992,1.13 [0.99-1.29],0.0693480383937673
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD226,CD226 antigen,7008,809,0.85 [0.72-1.00],0.0454836725267835
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD244,Natural killer cell receptor 2B4,8443,992,1.14 [0.94-1.40],0.1914689037551559
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD248,Endosialin,7230,831,1.10 [0.94-1.30],0.2411417295443002
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD27,CD27 antigen,8384,984,1.05 [0.92-1.21],0.4733160821687439
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD274,Programmed cell death 1 ligand 1,8266,970,1.04 [0.87-1.23],0.6720965724576842
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD276,CD276 antigen,8340,974,1.03 [0.88-1.20],0.7572603205023691
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD28,T-cell-specific surface glycoprotein CD28,8180,948,1.03 [0.88-1.20],0.7347793729570165
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD2AP,CD2-associated protein,8340,975,0.93 [0.85-1.02],0.1159862080944291
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD300A,CMRF35-like molecule 8,7068,806,1.13 [0.91-1.41],0.2606741063832388
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD300C,CMRF35-like molecule 6,8412,980,1.17 [1.00-1.38],0.0464970838669607
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD300E,CMRF35-like molecule 2,8414,985,1.16 [1.01-1.33],0.029745563366998
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD300LF,CMRF35-like molecule 1,8438,986,1.05 [0.95-1.15],0.3418615769112035
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD300LG,CMRF35-like molecule 9,8360,976,1.18 [1.01-1.37],0.0311476823603875
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD302,CD302 antigen,8322,985,1.19 [0.99-1.42],0.0623222888945817
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD33,Myeloid cell surface antigen CD33,8384,984,0.98 [0.92-1.05],0.6407110633300754
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD34,Hematopoietic progenitor cell antigen CD34,8385,976,1.24 [0.98-1.57],0.0674584720174252
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD36,Platelet glycoprotein 4,7008,809,0.79 [0.67-0.92],0.0027117847403752
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,8322,985,0.94 [0.80-1.12],0.5138648472830504
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD3D,T-cell surface glycoprotein CD3 delta chain,7032,801,0.91 [0.74-1.12],0.3863512530873004
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD3E,T-cell surface glycoprotein CD3 epsilon chain,7092,819,0.96 [0.79-1.16],0.6538715567886295
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD3G,T-cell surface glycoprotein CD3 gamma chain,7008,809,0.99 [0.91-1.07],0.8052676871813047
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD4,T-cell surface glycoprotein CD4,8323,971,0.95 [0.78-1.15],0.6010514229379775
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD40,Tumor necrosis factor receptor superfamily member 5,8341,970,0.92 [0.82-1.04],0.1918634802960348
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD40LG,CD40 ligand,8443,992,0.94 [0.88-1.01],0.107306902055056
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD46,Membrane cofactor protein,8322,971,0.89 [0.73-1.09],0.257837518924893
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD48,CD48 antigen,8365,974,1.21 [1.00-1.46],0.0517910778721538
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD5,T-cell surface glycoprotein CD5,8427,986,1.26 [1.07-1.48],0.0061093226058071
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD55,Complement decay-accelerating factor,8074,950,1.03 [0.83-1.27],0.8168338396944455
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD58,Lymphocyte function-associated antigen 3,8327,972,1.00 [0.73-1.38],0.9804086157046232
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD59,CD59 glycoprotein,8075,941,1.26 [0.99-1.61],0.0568003410281517
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD5L,CD5 antigen-like,7207,821,1.02 [0.89-1.18],0.7726950800231355
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD6,T-cell differentiation antigen CD6,8430,991,1.06 [0.95-1.18],0.2861224385831346
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD63,CD63 antigen,8252,970,0.91 [0.81-1.02],0.1130311220653901
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD69,Early activation antigen CD69,8304,969,0.92 [0.86-0.98],0.0133604187294997
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD7,T-cell antigen CD7,6995,809,0.99 [0.85-1.16],0.9302681226131644
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD70,CD70 antigen,8335,971,0.97 [0.85-1.10],0.6196963801772959
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD72,B-cell differentiation antigen CD72,7068,806,1.22 [1.04-1.43],0.0174512153546522
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD74,HLA class II histocompatibility antigen gamma chain,8412,980,1.16 [0.98-1.37],0.0794119491618785
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD79B,B-cell antigen receptor complex-associated protein beta chain,8443,992,1.12 [0.98-1.27],0.0871648091370555
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD80,T-lymphocyte activation antigen CD80,7231,828,0.95 [0.78-1.17],0.6418698016206839
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD82,CD82 antigen,7092,819,0.92 [0.77-1.10],0.3422351905223135
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD83,CD83 antigen,8335,971,1.00 [0.85-1.19],0.9762223506919748
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD84,SLAM family member 5,8335,971,0.94 [0.78-1.12],0.4785911022109917
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD86,T-lymphocyte activation antigen CD86,7204,827,1.20 [0.96-1.50],0.1053751381942842
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD8A,T-cell surface glycoprotein CD8 alpha chain,8412,980,1.04 [0.93-1.16],0.502495864019181
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD93,Complement component C1q receptor,8071,944,1.14 [0.95-1.38],0.1573573300329996
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD99,CD99 antigen,8360,976,1.05 [0.79-1.39],0.7544722487737969
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD99L2,CD99 antigen-like protein 2,8360,976,1.05 [0.84-1.33],0.6531105532961747
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDA,Cytidine deaminase,7220,825,1.09 [0.95-1.25],0.2364229586564829
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDAN1,Codanin-1,7224,829,0.93 [0.69-1.25],0.6249481415565306
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDC123,Cell division cycle protein 123 homolog,6987,805,0.96 [0.86-1.08],0.4823758789900781
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDC25A,M-phase inducer phosphatase 1,6987,805,0.87 [0.72-1.05],0.1483990218239481
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDC26,Anaphase-promoting complex subunit CDC26,7187,826,0.89 [0.80-0.98],0.0194389437054155
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDC27,Cell division cycle protein 27 homolog,8180,948,0.96 [0.87-1.06],0.3921598139884139
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDC37,Hsp90 co-chaperone Cdc37,8384,984,0.93 [0.87-1.00],0.0431168140533396
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDC42BPB,Serine/threonine-protein kinase MRCK beta,7204,827,0.93 [0.87-1.00],0.0403742318532979
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDCP1,CUB domain-containing protein 1,8266,970,1.00 [0.90-1.11],0.992254470333936
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDH1,Cadherin-1,8084,950,0.97 [0.83-1.12],0.6497253090100743
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDH15,Cadherin-15,8400,978,1.00 [0.93-1.08],0.9956612183786592
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDH17,Cadherin-17,8340,975,1.03 [0.95-1.11],0.5473231912542413
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDH2,Cadherin-2,8340,975,0.96 [0.82-1.13],0.6272963891667012
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDH22,Cadherin-22,7092,819,0.72 [0.56-0.93],0.013095303369199
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDH23,Cadherin-23,7224,829,0.79 [0.61-1.02],0.0657710840445261
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDH3,Cadherin-3,8412,980,1.21 [1.04-1.41],0.0128645735268298
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDH4,Cadherin-4,7032,801,1.04 [0.90-1.20],0.6026688501189801
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDH5,Cadherin-5,8458,987,1.01 [0.84-1.21],0.925351041810736
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDH6,Cadherin-6,8340,975,1.04 [0.89-1.21],0.6177545856735027
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDHR1,Cadherin-related family member 1,8164,946,0.99 [0.86-1.14],0.9051250610898484
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDHR2,Cadherin-related family member 2,8322,985,1.00 [0.92-1.10],0.9426639071287286
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDHR5,Cadherin-related family member 5,8340,975,1.23 [1.06-1.43],0.0072119228081745
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDK1,Cyclin-dependent kinase 1,6987,805,1.01 [0.83-1.21],0.9573644110294413
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDK5RAP3,CDK5 regulatory subunit-associated protein 3,7222,826,0.98 [0.87-1.10],0.6941100344438749
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDKL5,Cyclin-dependent kinase-like 5,7032,801,0.99 [0.87-1.13],0.8874219405033787
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDKN1A,Cyclin-dependent kinase inhibitor 1,8322,985,0.95 [0.90-1.00],0.0441612469026035
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDKN2D,Cyclin-dependent kinase 4 inhibitor D,8322,985,0.96 [0.90-1.02],0.159991434379335
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDNF,Cerebral dopamine neurotrophic factor,8322,985,1.06 [0.89-1.26],0.4949765098910962
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,8351,974,1.00 [0.80-1.25],0.9775428524851528
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDSN,Corneodesmosin,8422,985,1.03 [0.90-1.17],0.6612220644935585
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,8369,980,0.97 [0.74-1.27],0.8033563991516602
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,7204,827,0.99 [0.91-1.08],0.8488064143271217
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,7092,819,0.93 [0.84-1.03],0.1828933898734129
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,7204,827,0.96 [0.81-1.13],0.6055297033021709
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,7092,819,1.12 [0.97-1.30],0.1165985923394949
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,8335,971,1.00 [0.94-1.07],0.9088611578652894
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,8180,948,1.00 [0.88-1.13],0.9787193237282972
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,8085,939,1.03 [0.94-1.14],0.4866991997440317
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,7230,831,0.90 [0.76-1.07],0.2341516780310991
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,8206,953,1.08 [0.97-1.22],0.174297362034038
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEBPA,CCAAT/enhancer-binding protein alpha,7008,809,1.10 [0.92-1.33],0.2907564741602377
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEBPB,CCAAT/enhancer-binding protein beta,8206,953,1.03 [0.89-1.20],0.7039885154664323
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CELA2A,Chymotrypsin-like elastase family member 2A,7230,831,1.00 [0.90-1.11],0.934592014841591
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CELA3A,Chymotrypsin-like elastase family member 3A,8448,985,1.05 [0.96-1.16],0.2762274534235674
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,7068,806,0.79 [0.63-1.00],0.0532730277036235
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEMIP2,Cell surface hyaluronidase,7008,809,1.08 [0.87-1.34],0.4929853799657628
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEND1,Cell cycle exit and neuronal differentiation protein 1,7032,801,1.06 [0.96-1.18],0.2476864751687975
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CENPF,Centromere protein F,7092,819,1.05 [0.93-1.19],0.3861533252033211
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CENPJ,Centromere protein J,7092,819,0.88 [0.80-0.98],0.0200223673797801
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEP112,Centrosomal protein of 112 kDa,6987,802,0.93 [0.80-1.09],0.373491894270598
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEP152,Centrosomal protein of 152 kDa,6987,805,0.96 [0.81-1.13],0.6016629171991366
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEP164,Centrosomal protein of 164 kDa,8195,943,1.00 [0.92-1.10],0.9167260558296336
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEP170,Centrosomal protein of 170 kDa,7030,808,0.96 [0.87-1.05],0.3314530175835025
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEP20,Centrosomal protein 20,8180,948,0.95 [0.88-1.03],0.2410304102190365
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEP290,Centrosomal protein of 290 kDa,7092,819,0.86 [0.75-0.99],0.0342033313387685
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEP350,Centrosome-associated protein 350,6987,805,0.99 [0.82-1.19],0.9022244077021596
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEP43,Centrosomal protein 43,8142,944,0.96 [0.88-1.04],0.3053564681838728
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEP85,Centrosomal protein of 85 kDa,8180,948,0.99 [0.91-1.09],0.8772400273419374
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CERT,Ceramide transfer protein,8164,946,0.91 [0.83-1.01],0.0680384903240932
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CES1,Liver carboxylesterase 1,8380,977,0.97 [0.91-1.04],0.4583326531448226
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CES2,Cocaine esterase,8322,985,0.88 [0.80-0.98],0.0208804278166592
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CES3,Carboxylesterase 3,8322,985,0.97 [0.90-1.05],0.5085493384264264
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CETN2,Centrin-2,8164,946,0.95 [0.87-1.04],0.2713982172085587
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CETN3,Centrin-3,7204,827,0.93 [0.85-1.01],0.0891581685872551
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CFB,Complement factor B,7115,812,1.06 [0.86-1.30],0.6030086859463382
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CFC1,Cryptic protein,8180,948,0.99 [0.87-1.12],0.8396808417915422
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CFD,Complement factor D,7237,826,0.99 [0.72-1.37],0.9615176115896308
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CFH,Complement factor H,6832,784,1.17 [0.86-1.58],0.3107754499022551
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CFHR2,Complement factor H-related protein 2,7190,822,1.00 [0.89-1.12],0.9702191313427146
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CFHR4,Complement factor H-related protein 4,7224,825,0.98 [0.89-1.07],0.5929148205606438
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CFHR5,Complement factor H-related protein 5,7151,815,1.11 [0.94-1.31],0.2090629364747712
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CFI,Complement factor I,7237,826,1.00 [0.70-1.41],0.9856577308808612
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CFP,Properdin,7237,826,1.15 [0.88-1.51],0.3069899354018178
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CGA,Glycoprotein hormones alpha chain,8360,976,0.97 [0.89-1.06],0.514215751057165
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,7238,823,0.91 [0.76-1.08],0.2826992742694588
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CGN,Cingulin,7040,799,0.99 [0.82-1.19],0.903670695878998
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CGREF1,Cell growth regulator with EF hand domain protein 1,8340,975,1.20 [1.05-1.36],0.0066258973068906
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,8180,948,0.91 [0.83-1.01],0.0870343383434736
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHAD,Chondroadherin,7068,806,1.02 [0.88-1.17],0.8261182536744733
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",7224,829,1.12 [0.95-1.31],0.1706709308301138
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHCHD6,MICOS complex subunit MIC25,7208,827,0.93 [0.73-1.19],0.5693738335586818
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHEK2,Serine/threonine-protein kinase Chk2,8206,953,1.04 [0.87-1.25],0.6412716304384296
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHGA,Chromogranin-A,7230,831,0.98 [0.91-1.05],0.5514751511266768
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHGB,Secretogranin-1,8389,976,1.01 [0.88-1.15],0.9306725845538364
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHI3L1,Chitinase-3-like protein 1,8191,956,0.96 [0.90-1.03],0.2471743303412079
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHIT1,Chitotriosidase-1,8396,976,0.98 [0.95-1.01],0.2603960095067454
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHL1,Neural cell adhesion molecule L1-like protein,8383,976,0.94 [0.78-1.14],0.5298673447858148
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHM,Rab proteins geranylgeranyltransferase component A 1,7040,799,0.85 [0.76-0.96],0.0071858413106513
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHMP1A,Charged multivesicular body protein 1a,8266,970,0.92 [0.86-0.99],0.0298255195424012
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHMP6,Charged multivesicular body protein 6,7231,828,0.88 [0.78-0.99],0.0326105037073891
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHP1,Calcineurin B homologous protein 1,7032,801,0.96 [0.87-1.06],0.4327975739375864
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHRDL1,Chordin-like protein 1,8365,974,0.99 [0.83-1.19],0.9481182769569512
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHRDL2,Chordin-like protein 2,8340,975,0.97 [0.85-1.09],0.5795100319817825
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHRM1,Muscarinic acetylcholine receptor M1,7040,799,0.97 [0.80-1.18],0.7943398520971625
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CIAPIN1,Anamorsin,8384,984,0.95 [0.86-1.04],0.264198233555686
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CILP,Cartilage intermediate layer protein 1,7230,831,1.03 [0.91-1.16],0.6591927227149412
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CINP,Cyclin-dependent kinase 2-interacting protein,7092,819,0.99 [0.85-1.16],0.926860027210337
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CIRBP,Cold-inducible RNA-binding protein,7204,827,0.91 [0.85-0.98],0.0078869887411712
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CIT,Citron Rho-interacting kinase,7040,799,0.97 [0.83-1.13],0.6833321367327487
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CKAP4,Cytoskeleton-associated protein 4,8406,987,1.20 [0.99-1.44],0.064923088901473
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CKB,Creatine kinase B-type,7230,831,1.01 [0.90-1.13],0.902972661231842
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",8317,968,1.00 [0.91-1.09],0.970954910817412
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLASP1,CLIP-associating protein 1,6987,805,0.91 [0.83-1.00],0.0625613383406076
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLC,Galectin-10,8327,974,1.05 [0.97-1.14],0.2448010182913586
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC10A,C-type lectin domain family 10 member A,8266,970,1.01 [0.86-1.19],0.8955630450772091
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC11A,C-type lectin domain family 11 member A,8348,974,1.03 [0.92-1.16],0.6099384134706456
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC12A,C-type lectin domain family 12 member A,7008,809,1.37 [0.99-1.91],0.0603599476879171
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC14A,C-type lectin domain family 14 member A,8360,976,1.13 [0.95-1.34],0.1768063966454852
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC1A,C-type lectin domain family 1 member A,8206,953,1.19 [1.01-1.41],0.0423274913808263
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC1B,C-type lectin domain family 1 member B,8412,980,0.95 [0.90-1.01],0.1176366661764408
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC2L,C-type lectin domain family 2 member L,7040,799,0.79 [0.67-0.93],0.0036807934530986
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC3B,Tetranectin,7070,809,1.16 [0.84-1.59],0.3703436104498466
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC4A,C-type lectin domain family 4 member A,8335,971,1.15 [0.98-1.36],0.0819169943550531
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC4C,C-type lectin domain family 4 member C,8335,971,0.96 [0.85-1.08],0.4792597041370999
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC4D,C-type lectin domain family 4 member D,8335,971,1.02 [0.93-1.12],0.6114462490227494
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC4G,C-type lectin domain family 4 member G,8335,971,1.22 [1.03-1.45],0.019556359264959
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC4M,C-type lectin domain family 4 member M,7217,831,1.13 [0.99-1.30],0.0723253535832275
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC5A,C-type lectin domain family 5 member A,8317,972,1.23 [1.02-1.48],0.0278727824976104
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC6A,C-type lectin domain family 6 member A,8180,948,1.02 [0.90-1.15],0.7586436130113223
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC7A,C-type lectin domain family 7 member A,8443,992,1.15 [1.04-1.28],0.0083839002599322
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLGN,Calmegin,7040,799,0.95 [0.81-1.10],0.4953539785298912
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLIC5,Chloride intracellular channel protein 5,7040,799,0.95 [0.76-1.18],0.6343998180702266
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLINT1,Clathrin interactor 1,6987,805,0.91 [0.78-1.07],0.237292911681465
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLIP2,CAP-Gly domain-containing linker protein 2,8335,971,0.98 [0.93-1.03],0.4620756297423177
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLMP,CXADR-like membrane protein,8438,986,1.24 [0.96-1.60],0.0927507296520841
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLNS1A,Methylosome subunit pICln,7040,799,0.99 [0.81-1.21],0.9163866687004808
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",8254,968,0.92 [0.87-0.98],0.0076589844273021
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLPS,Colipase,8337,974,1.01 [0.93-1.09],0.8471447133841971
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLSPN,Claspin,8152,944,0.94 [0.79-1.11],0.454022330499793
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLSTN1,Calsyntenin-1,8164,946,1.04 [0.93-1.16],0.480617667688577
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLSTN2,Calsyntenin-2,8443,992,0.98 [0.85-1.13],0.7900427729097137
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLSTN3,Calsyntenin-3,7224,829,0.96 [0.77-1.20],0.7241600326687503
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLTA,Clathrin light chain A,8206,953,0.90 [0.79-1.03],0.1191321660370506
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLU,Clusterin,7237,826,1.20 [0.99-1.47],0.0647305374673403
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLUL1,Clusterin-like protein 1,8326,972,1.00 [0.88-1.13],0.9583911493747792
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CMC1,COX assembly mitochondrial protein homolog,7231,828,0.89 [0.83-0.96],0.0023860928196744
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CMIP,C-Maf-inducing protein,7208,827,0.90 [0.83-0.98],0.0163213504212175
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNDP1,Beta-Ala-His dipeptidase,8395,979,0.99 [0.87-1.11],0.8294956886546134
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNGB3,Cyclic nucleotide-gated cation channel beta-3,7032,801,0.98 [0.86-1.12],0.800384577902196
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",7015,807,0.95 [0.87-1.03],0.2306191991563322
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNPY2,Protein canopy homolog 2,8206,953,0.92 [0.83-1.02],0.0992648222508789
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNPY4,Protein canopy homolog 4,8322,985,0.92 [0.86-1.00],0.0384784163989332
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNST,Consortin,8340,975,0.94 [0.89-0.99],0.0227480553734482
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNTF,Ciliary neurotrophic factor,7032,801,0.89 [0.73-1.08],0.2395797394924056
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNTN1,Contactin-1,8458,987,1.10 [0.89-1.35],0.3829627419729207
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNTN2,Contactin-2,8438,986,0.90 [0.79-1.02],0.1073937675876277
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNTN3,Contactin-3,8360,976,1.04 [0.85-1.28],0.7046224031552493
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNTN4,Contactin-4,8360,976,1.06 [0.83-1.34],0.655377217551609
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNTN5,Contactin-5,8359,971,1.11 [0.95-1.29],0.186594768044416
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNTNAP2,Contactin-associated protein-like 2,8335,971,1.21 [1.06-1.38],0.004341731256998
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNTNAP4,Contactin-associated protein-like 4,7040,799,0.90 [0.83-0.97],0.0051518058720317
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COCH,Cochlin,7231,828,0.87 [0.75-1.01],0.0632369198193371
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL15A1,Collagen alpha-1(XV) chain,7230,831,1.03 [0.80-1.32],0.8391900554448031
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL18A1,Collagen alpha-1(XVIII) chain,8399,979,1.28 [1.01-1.63],0.0402225725946366
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL1A1,Collagen alpha-1(I) chain,8458,987,1.34 [1.06-1.69],0.0149886631854837
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL24A1,Collagen alpha-1(XXIV) chain,7204,827,1.06 [0.94-1.19],0.3652237181690966
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL28A1,Collagen alpha-1(XXVIII) chain,7040,799,1.02 [0.94-1.11],0.6663972837554424
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL2A1,Collagen alpha-1(II) chain,7030,808,0.96 [0.88-1.05],0.3751229773151185
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL3A1,Collagen alpha-1(III) chain,7230,831,1.07 [0.81-1.42],0.6281774875029753
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL4A1,Collagen alpha-1(IV) chain,8340,975,1.07 [0.93-1.24],0.3581454358536294
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL4A4,Collagen alpha-4(IV) chain,7081,819,0.98 [0.87-1.11],0.7551306787096798
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL5A1,Collagen alpha-1(V) chain,7068,806,0.88 [0.73-1.05],0.1490086219919656
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL6A3,Collagen alpha-3(VI) chain,8458,987,1.18 [1.01-1.38],0.0333500109845949
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL9A1,Collagen alpha-1(IX) chain,8335,971,1.04 [0.92-1.18],0.4945444065068082
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL9A2,Collagen alpha-2(IX) chain,7092,819,0.98 [0.84-1.14],0.7848088784278318
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COLEC12,Collectin-12,8340,974,1.14 [0.93-1.41],0.2101840100953986
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COMMD1,COMM domain-containing protein 1,7030,808,0.93 [0.83-1.05],0.2393251020583685
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COMMD9,COMM domain-containing protein 9,7208,827,0.88 [0.74-1.05],0.1708911574135209
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COMP,Cartilage oligomeric matrix protein,8275,965,0.93 [0.78-1.11],0.4146090488381415
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COMT,Catechol O-methyltransferase,8125,944,0.96 [0.89-1.03],0.208202797403803
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COPB2,Coatomer subunit beta',6987,802,0.78 [0.66-0.92],0.0025163625892519
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COPE,Coatomer subunit epsilon,8164,946,0.93 [0.82-1.05],0.2312448539275923
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",7030,808,1.02 [0.87-1.20],0.7932560696254609
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CORO1A,Coronin-1A,8182,952,0.96 [0.90-1.03],0.2340742174906634
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CORO6,Coronin-6,7032,801,0.95 [0.79-1.15],0.6094584163344053
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",8322,985,0.94 [0.86-1.02],0.1470817835007659
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COX6B1,Cytochrome c oxidase subunit 6B1,7231,828,0.74 [0.60-0.91],0.0052064262900001
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPA1,Carboxypeptidase A1,8458,987,1.07 [0.98-1.17],0.1097876453917355
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPA2,Carboxypeptidase A2,8392,977,1.00 [0.92-1.09],0.97262756827526
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPA4,Carboxypeptidase A4,6926,790,1.08 [0.92-1.27],0.3529055108657987
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPB1,Carboxypeptidase B,8458,987,1.09 [0.99-1.19],0.0703260770653861
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPB2,Carboxypeptidase B2,7227,826,0.79 [0.59-1.07],0.1238523553198042
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPE,Carboxypeptidase E,8362,980,0.99 [0.86-1.15],0.9395590329783358
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPLX2,Complexin-2,6987,805,1.12 [0.92-1.37],0.2462960641104604
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPM,Carboxypeptidase M,8366,975,0.88 [0.74-1.04],0.1281190833732111
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",7008,809,1.03 [0.81-1.32],0.7949457726246103
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPPED1,Serine/threonine-protein phosphatase CPPED1,8412,980,1.02 [0.94-1.12],0.5805622627287473
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPQ,Carboxypeptidase Q,7218,830,0.99 [0.82-1.19],0.913888801592608
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPTP,Ceramide-1-phosphate transfer protein,6987,802,0.93 [0.78-1.12],0.4599701612085345
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPVL,Probable serine carboxypeptidase CPVL,8425,985,1.03 [0.90-1.19],0.6597743164361174
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPXM1,Probable carboxypeptidase X1,8384,984,0.94 [0.86-1.02],0.1282011147290992
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPXM2,Inactive carboxypeptidase-like protein X2,7231,828,0.99 [0.76-1.30],0.96982109440109
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CR1,Complement receptor type 1,7213,820,1.08 [0.89-1.31],0.4443984070125367
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CR2,Complement receptor type 2,8395,979,1.05 [0.93-1.18],0.4482369910075745
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRACR2A,EF-hand calcium-binding domain-containing protein 4B,8180,948,0.99 [0.92-1.06],0.748858839954641
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRADD,Death domain-containing protein CRADD,8254,968,0.93 [0.86-1.01],0.0737018742894372
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CREB3,Cyclic AMP-responsive element-binding protein 3,6987,805,0.90 [0.79-1.02],0.1046848079436838
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CREBZF,CREB/ATF bZIP transcription factor,6987,805,0.75 [0.57-0.99],0.0393671454136969
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CREG1,Protein CREG1,8262,970,1.02 [0.89-1.18],0.7385585279783132
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRELD1,Protein disulfide isomerase CRELD1,7068,806,1.11 [0.92-1.34],0.2697165403057635
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRELD2,Protein disulfide isomerase CRELD2,8365,974,1.01 [0.90-1.12],0.8941592574903338
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRH,Corticoliberin,8168,945,0.93 [0.87-1.00],0.0530400829985096
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRHBP,Corticotropin-releasing factor-binding protein,8340,974,1.09 [0.88-1.34],0.4258264764208912
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRHR1,Corticotropin-releasing factor receptor 1,8206,953,1.07 [0.98-1.18],0.1215485549547013
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRIM1,Cysteine-rich motor neuron 1 protein,8377,979,1.23 [0.93-1.62],0.1440073667818553
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRIP2,Cysteine-rich protein 2,8266,970,0.96 [0.82-1.12],0.6090157919395879
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRISP2,Cysteine-rich secretory protein 2,8438,986,1.05 [0.94-1.16],0.3894745883782536
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRISP3,Cysteine-rich secretory protein 3,7171,818,1.12 [0.88-1.44],0.3616710108872508
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRKL,Crk-like protein,8352,972,0.97 [0.92-1.02],0.2205565230735179
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRLF1,Cytokine receptor-like factor 1,8377,979,1.21 [0.96-1.52],0.1066611487081712
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRNN,Cornulin,8124,949,0.97 [0.89-1.06],0.4801531390211996
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRTAC1,Cartilage acidic protein 1,8458,987,1.00 [0.83-1.20],0.974010079668946
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRTAM,Cytotoxic and regulatory T-cell molecule,8266,970,1.13 [1.01-1.27],0.0294384566352856
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRTAP,Cartilage-associated protein,7040,799,0.96 [0.83-1.10],0.5309132539499434
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRX,Cone-rod homeobox protein,8206,953,0.98 [0.92-1.03],0.4279716581980313
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRYBB1,Beta-crystallin B1,7231,828,0.92 [0.83-1.02],0.129484685596956
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRYBB2,Beta-crystallin B2,7224,829,0.94 [0.86-1.03],0.202205849494955
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRYGD,Gamma-crystallin D,7224,829,0.97 [0.91-1.04],0.4546602446121988
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRYM,Ketimine reductase mu-crystallin,7032,801,0.97 [0.88-1.07],0.5802938027007005
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRYZL1,Quinone oxidoreductase-like protein 1,7030,808,0.92 [0.86-1.00],0.0437124981121759
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSDE1,Cold shock domain-containing protein E1,6987,802,0.91 [0.86-0.97],0.0059988504796116
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSF1,Macrophage colony-stimulating factor 1,8377,979,1.35 [1.09-1.66],0.0051716921011139
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSF1R,Macrophage colony-stimulating factor 1 receptor,7238,823,0.93 [0.79-1.10],0.4080518929104383
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSF2,Granulocyte-macrophage colony-stimulating factor,6987,802,0.89 [0.73-1.08],0.2229820602769838
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,8266,970,1.01 [0.92-1.11],0.8315427611099632
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSF2RB,Cytokine receptor common subunit beta,7008,809,1.01 [0.86-1.19],0.9024491788574798
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSF3,Granulocyte colony-stimulating factor,8195,943,1.00 [0.89-1.13],0.957119713344419
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSF3R,Granulocyte colony-stimulating factor receptor,7008,809,1.09 [0.86-1.38],0.4611770125619829
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSH1,Chorionic somatomammotropin hormone 1,7238,823,1.10 [0.88-1.38],0.4031255047916089
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSNK1D,Casein kinase I isoform delta,7008,809,0.99 [0.89-1.11],0.9237582700581228
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSNK2A1,Casein kinase II subunit alpha,7222,826,0.88 [0.75-1.02],0.090977198041875
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSPG4,Chondroitin sulfate proteoglycan 4,7230,831,1.06 [0.86-1.29],0.5993987633740618
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSPG5,Chondroitin sulfate proteoglycan 5,7032,801,0.91 [0.79-1.05],0.1964669547897326
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSRP3,Cysteine and glycine-rich protein 3,6987,802,1.03 [0.96-1.10],0.4593247657410791
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CST1,Cystatin-SN,6285,715,0.96 [0.90-1.04],0.3086145205855752
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CST3,Cystatin-C,8382,979,1.11 [0.91-1.34],0.3125230017607783
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CST5,Cystatin-D,8176,962,1.05 [0.95-1.17],0.3072320813183333
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CST6,Cystatin-M,8131,952,1.07 [0.95-1.20],0.2522652771925907
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CST7,Cystatin-F,8353,975,1.03 [0.98-1.10],0.2635500857251627
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSTB,Cystatin-B,8230,957,1.15 [1.01-1.31],0.0386550362842572
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTAG1A_CTAG1B,Cancer/testis antigen 1,7084,818,1.04 [0.91-1.19],0.596076825138429
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTBS,Di-N-acetylchitobiase,7125,808,0.93 [0.72-1.21],0.6045625834506765
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTF1,Cardiotrophin-1,8206,953,0.96 [0.90-1.03],0.2965183596365567
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTHRC1,Collagen triple helix repeat-containing protein 1,7230,831,1.33 [1.06-1.67],0.0151874231153675
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTLA4,Cytotoxic T-lymphocyte protein 4,7230,831,0.94 [0.75-1.17],0.5635396462450999
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTNNA1,Catenin alpha-1,7032,801,0.76 [0.60-0.97],0.0289769669966657
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTRB1,Chymotrypsinogen B,8360,976,1.05 [0.95-1.15],0.3426369523500855
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTRC,Chymotrypsin-C,8336,971,1.03 [0.95-1.13],0.4689765449362715
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTRL,Chymotrypsin-like protease CTRL-1,7224,829,0.98 [0.89-1.08],0.7180548624787316
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTSB,Cathepsin B,8367,979,1.02 [0.92-1.13],0.7357544821921256
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTSC,Dipeptidyl peptidase 1,8324,968,0.94 [0.83-1.07],0.3861577295388354
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTSD,Cathepsin D,7822,921,0.95 [0.82-1.10],0.5024626234398857
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTSE,Cathepsin E,7068,806,0.94 [0.82-1.07],0.3164200925703285
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTSF,Cathepsin F,8384,984,1.06 [0.92-1.22],0.4473889137684945
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTSH,Pro-cathepsin H,8167,948,0.97 [0.90-1.05],0.47808755957474
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTSL,Cathepsin L1,8340,975,1.32 [1.05-1.66],0.0161707514239182
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTSO,Cathepsin O,8443,992,1.07 [0.89-1.28],0.497957714717177
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTSS,Cathepsin S,6571,763,1.03 [0.77-1.39],0.8247672864706852
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTSV,Cathepsin L2,8409,985,0.93 [0.81-1.07],0.293114292691942
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTSZ,Cathepsin Z,8370,978,0.98 [0.82-1.17],0.817707793450506
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CUZD1,CUB and zona pellucida-like domain-containing protein 1,7040,799,0.95 [0.79-1.13],0.5475504063324959
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CWC15,Spliceosome-associated protein CWC15 homolog,7160,821,0.93 [0.83-1.05],0.2452893045001394
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CX3CL1,Fractalkine,8266,970,1.10 [0.92-1.30],0.298625254652905
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXADR,Coxsackievirus and adenovirus receptor,8335,971,1.13 [1.01-1.27],0.0397369875099264
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL1,Growth-regulated alpha protein,8328,970,0.97 [0.92-1.03],0.379916402925823
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL10,C-X-C motif chemokine 10,8377,979,1.03 [0.94-1.12],0.4991665822266159
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL11,C-X-C motif chemokine 11,8412,980,0.98 [0.91-1.05],0.5432424201039767
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL12,Stromal cell-derived factor 1,8195,943,0.91 [0.79-1.06],0.2435958374742489
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL13,C-X-C motif chemokine 13,8412,980,1.06 [0.97-1.16],0.2292458012681156
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL14,C-X-C motif chemokine 14,8195,943,0.99 [0.89-1.10],0.8267185104079635
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL16,C-X-C motif chemokine 16,8447,987,0.85 [0.67-1.09],0.1987292512675164
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL17,C-X-C motif chemokine 17,8443,992,0.87 [0.75-1.00],0.0440514935410639
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL3,C-X-C motif chemokine 3,8341,970,0.99 [0.93-1.05],0.7087597993538695
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL5,C-X-C motif chemokine 5,8315,974,1.01 [0.96-1.06],0.8061811550327347
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL6,C-X-C motif chemokine 6,8443,992,0.99 [0.92-1.07],0.8526472632887804
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL8,Interleukin-8,8322,973,0.96 [0.88-1.05],0.3860563936722673
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL9,C-X-C motif chemokine 9,8377,979,1.00 [0.92-1.10],0.945451925103377
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CYB5A,Cytochrome b5,6987,805,1.03 [0.94-1.13],0.5702993010873476
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CYB5R2,NADH-cytochrome b5 reductase 2,7139,821,0.93 [0.83-1.06],0.2810524757410743
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",6987,802,0.88 [0.80-0.96],0.0046886293476714
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CYTH3,Cytohesin-3,6987,805,1.01 [0.92-1.11],0.7721240822860067
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CYTL1,Cytokine-like protein 1,7230,831,1.03 [0.80-1.34],0.801984154364125
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DAAM1,Disheveled-associated activator of morphogenesis 1,7068,806,0.86 [0.79-0.94],0.0004919073365918
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DAB2,Disabled homolog 2,8438,986,0.95 [0.90-1.00],0.0468685713385279
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DAG1,Dystroglycan,8377,979,0.93 [0.82-1.05],0.2157968451828395
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DAND5,DAN domain family member 5,7008,809,1.03 [0.92-1.16],0.581235421440875
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DAPK2,Death-associated protein kinase 2,7008,809,0.96 [0.85-1.09],0.5489565957147657
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,8335,971,0.98 [0.94-1.02],0.3612952165532264
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DARS1,"Aspartate--tRNA ligase, cytoplasmic",8254,968,0.97 [0.90-1.05],0.5215189952446669
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DBH,Dopamine beta-hydroxylase,7227,820,0.98 [0.92-1.04],0.4661627447235479
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DBI,Acyl-CoA-binding protein,8323,972,0.95 [0.88-1.02],0.1596092424673297
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DBN1,Drebrin,7008,809,0.89 [0.77-1.02],0.1054621954076483
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DBNL,Drebrin-like protein,8377,979,0.95 [0.90-1.01],0.1376550803438279
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",8384,984,0.89 [0.76-1.05],0.1636896869491718
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCC,Netrin receptor DCC,7040,799,0.74 [0.52-1.03],0.0740515907994223
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCDC2C,Doublecortin domain-containing protein 2C,6987,805,0.97 [0.86-1.08],0.5335266436070911
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCLRE1C,Protein artemis,6987,805,0.97 [0.78-1.21],0.8102894887809204
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCN,Decorin,8206,953,0.99 [0.78-1.27],0.9404472528702594
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCTD,Deoxycytidylate deaminase,7068,806,0.91 [0.85-0.98],0.013192299272336
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCTN1,Dynactin subunit 1,8438,986,0.91 [0.84-1.00],0.0483990364695212
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCTN2,Dynactin subunit 2,8322,985,0.97 [0.91-1.03],0.3484594548608868
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCTN6,Dynactin subunit 6,8164,946,0.90 [0.82-0.98],0.0132282682886121
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCTPP1,dCTP pyrophosphatase 1,8340,975,1.07 [0.89-1.28],0.4931832836868866
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCUN1D1,DCN1-like protein 1,7032,801,0.89 [0.81-0.99],0.0266607358159236
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCUN1D2,DCN1-like protein 2,6987,805,0.96 [0.88-1.05],0.3723103968120625
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCXR,L-xylulose reductase,8384,984,1.03 [0.92-1.14],0.6508827152024781
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDA1,DET1- and DDB1-associated protein 1,6987,802,0.95 [0.79-1.14],0.581254836408387
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",8322,985,1.01 [0.88-1.15],0.9142735336827688
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDC,Aromatic-L-amino-acid decarboxylase,8328,973,1.07 [0.95-1.21],0.2833650073901645
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDHD2,Phospholipase DDHD2,7222,826,0.90 [0.81-1.00],0.04257698062639
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDI2,Protein DDI1 homolog 2,7068,806,1.03 [0.95-1.13],0.4463690182074972
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDR1,Epithelial discoidin domain-containing receptor 1,8412,980,1.23 [0.97-1.57],0.0891363882309615
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDT,D-dopachrome decarboxylase,7230,831,1.04 [0.89-1.22],0.6289744878741215
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDX1,ATP-dependent RNA helicase DDX1,7204,827,0.94 [0.81-1.08],0.364465099021229
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDX25,ATP-dependent RNA helicase DDX25,7040,799,0.85 [0.69-1.04],0.1134434095892152
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDX39A,ATP-dependent RNA helicase DDX39A,7008,809,1.04 [0.80-1.35],0.7835024646726434
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDX4,Probable ATP-dependent RNA helicase DDX4,7008,809,1.05 [0.92-1.19],0.4711630451436266
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDX53,Probable ATP-dependent RNA helicase DDX53,7040,799,0.98 [0.81-1.19],0.8349510340843133
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDX58,Antiviral innate immune response receptor RIG-I,8180,948,1.01 [0.91-1.12],0.8055076572610168
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",8335,971,0.94 [0.89-1.00],0.0473935983920335
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DEFA1_DEFA1B,Neutrophil defensin 1,8191,952,1.06 [0.96-1.18],0.2559743073027504
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DEFB103A_DEFB103B,Beta-defensin 103,6955,802,0.87 [0.73-1.03],0.1099477517737871
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DEFB104A_DEFB104B,Beta-defensin 104,7032,801,0.93 [0.81-1.05],0.2454223082616247
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DEFB116,Beta-defensin 116,7032,801,0.99 [0.90-1.09],0.8117538580449464
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DEFB118,Beta-defensin 118,7032,801,0.95 [0.83-1.08],0.4478149192524162
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DEFB4A_DEFB4B,Beta-defensin 4A,8252,982,0.96 [0.92-1.00],0.0306817219168203
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DENND2B,DENN domain-containing protein 2B,6987,802,0.82 [0.69-0.96],0.0166875293070661
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DENR,Density-regulated protein,7008,809,0.89 [0.79-1.01],0.0744124964108077
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DFFA,DNA fragmentation factor subunit alpha,8443,992,0.95 [0.88-1.04],0.2867200219517559
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DGCR6,Protein DGCR6,7032,801,0.99 [0.84-1.17],0.9388770548237776
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DGKA,Diacylglycerol kinase alpha,7008,809,0.90 [0.79-1.03],0.1136251594947257
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DGKZ,Diacylglycerol kinase zeta,8195,943,1.02 [0.87-1.20],0.7811031123500409
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DHODH,Dihydroorotate dehydrogenase,6987,802,1.08 [0.94-1.23],0.2883847640021696
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DHPS,Deoxyhypusine synthase,7208,827,1.01 [0.85-1.19],0.9420584577364066
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,7224,829,0.76 [0.65-0.89],0.000726739171464
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DIABLO,"Diablo homolog, mitochondrial",8317,972,0.94 [0.89-0.99],0.0226376209247908
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DIPK1C,Divergent protein kinase domain 1C,7040,799,1.05 [0.89-1.23],0.5612720344367297
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DIPK2B,Divergent protein kinase domain 2B,7068,806,0.86 [0.67-1.10],0.2248281181684224
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DKK1,Dickkopf-related protein 1,8412,980,0.96 [0.87-1.05],0.3755779644355818
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DKK3,Dickkopf-related protein 3,8458,987,1.10 [0.91-1.33],0.3360621525072654
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DKK4,Dickkopf-related protein 4,8253,970,1.01 [0.89-1.14],0.8799836433291988
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DKKL1,Dickkopf-like protein 1,8322,985,1.02 [0.96-1.09],0.5024468547947012
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DLG4,Disks large homolog 4,7224,829,0.86 [0.78-0.94],0.0016340967603687
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DLGAP5,Disks large-associated protein 5,7222,826,0.99 [0.86-1.13],0.835734168326927
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DLK1,Protein delta homolog 1,8458,987,1.02 [0.93-1.13],0.6336110637100365
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DLL1,Delta-like protein 1,8384,984,1.29 [1.08-1.55],0.0062111376899285
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DLL4,Delta-like protein 4,7030,808,0.97 [0.90-1.05],0.4600559097263458
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DMD,Dystrophin,7030,808,1.13 [0.99-1.29],0.0742341918969927
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DMP1,Dentin matrix acidic phosphoprotein 1,7030,808,0.97 [0.86-1.09],0.589166835243912
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNAJA1,DnaJ homolog subfamily A member 1,6987,805,1.06 [0.92-1.23],0.3873915161004134
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNAJA2,DnaJ homolog subfamily A member 2,8419,988,0.95 [0.89-1.02],0.1501912860145036
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNAJA4,DnaJ homolog subfamily A member 4,7224,829,1.04 [0.95-1.14],0.3633676750876685
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNAJB1,DnaJ homolog subfamily B member 1,8322,985,0.93 [0.87-0.99],0.024062595082468
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNAJB14,DnaJ homolog subfamily B member 14,7204,827,0.92 [0.83-1.03],0.152497077798425
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNAJB2,DnaJ homolog subfamily B member 2,7068,806,0.97 [0.85-1.10],0.6055298168267643
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNAJB6,DnaJ homolog subfamily B member 6,7000,799,0.91 [0.83-0.98],0.0200302093627695
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNAJB8,DnaJ homolog subfamily B member 8,8206,953,0.94 [0.85-1.05],0.3018018505436645
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNAJC21,DnaJ homolog subfamily C member 21,7224,829,0.94 [0.79-1.11],0.4528495051201296
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNAJC6,Putative tyrosine-protein phosphatase auxilin,7030,808,0.92 [0.85-1.00],0.0538713449841355
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNAJC9,DnaJ homolog subfamily C member 9,7204,827,0.94 [0.86-1.02],0.1594151615489487
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNER,Delta and Notch-like epidermal growth factor-related receptor,8320,968,1.00 [0.80-1.24],0.9793961097708094
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNLZ,DNL-type zinc finger protein,7032,801,1.01 [0.93-1.09],0.8283265974336252
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNM1,Dynamin-1,7204,827,0.90 [0.85-0.96],0.0004088722596028
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNM3,Dynamin-3,7222,826,0.91 [0.80-1.03],0.1515865898720761
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNMBP,Dynamin-binding protein,8266,970,0.99 [0.90-1.09],0.8584733013435193
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNPEP,Aspartyl aminopeptidase,7224,829,1.06 [0.94-1.20],0.3339925244711481
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,8364,977,1.00 [0.89-1.12],0.9890316828250484
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DOC2B,Double C2-like domain-containing protein beta,7040,799,0.89 [0.72-1.09],0.2680397857339707
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DOCK9,Dedicator of cytokinesis protein 9,7032,801,1.02 [0.97-1.08],0.4033282869361494
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DOK1,Docking protein 1,7224,829,0.94 [0.89-0.98],0.0060902029090424
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DOK2,Docking protein 2,8340,975,0.96 [0.92-1.01],0.1170998155041524
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DPEP1,Dipeptidase 1,8254,968,1.12 [0.99-1.27],0.069090454802596
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DPEP2,Dipeptidase 2,8322,985,1.13 [0.94-1.36],0.2081638367602779
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DPP10,Inactive dipeptidyl peptidase 10,8335,971,0.92 [0.78-1.08],0.3107591188572721
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DPP4,Dipeptidyl peptidase 4,8216,958,0.87 [0.71-1.08],0.2159634562982301
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DPP6,Dipeptidyl aminopeptidase-like protein 6,8322,985,0.92 [0.78-1.08],0.3145423468243703
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DPP7,Dipeptidyl peptidase 2,8282,967,0.97 [0.88-1.06],0.5015604871500259
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DPT,Dermatopontin,8458,987,1.06 [0.84-1.32],0.6392974238592831
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DPY30,Protein dpy-30 homolog,8407,981,1.05 [0.95-1.15],0.3490806984145762
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DRAXIN,Draxin,8266,970,1.12 [0.98-1.28],0.0940139981565258
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DRG2,Developmentally-regulated GTP-binding protein 2,8322,985,0.92 [0.83-1.02],0.1008016348387093
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DSC2,Desmocollin-2,8268,965,1.18 [1.00-1.39],0.0456594587135732
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DSCAM,Down syndrome cell adhesion molecule,7222,826,0.88 [0.73-1.07],0.1977763340001521
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DSG2,Desmoglein-2,8360,976,1.12 [0.91-1.37],0.288389055578141
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DSG3,Desmoglein-3,8405,980,1.08 [0.92-1.27],0.3726046537318442
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DSG4,Desmoglein-4,8292,984,1.10 [0.98-1.23],0.1102714346665748
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DTD1,D-aminoacyl-tRNA deacylase 1,7068,806,0.88 [0.82-0.96],0.0020394048370152
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DTNB,Dystrobrevin beta,7191,826,1.10 [0.94-1.28],0.2466186509999309
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DTX2,Probable E3 ubiquitin-protein ligase DTX2,7040,799,1.03 [0.92-1.15],0.6314907746629317
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DTX3,Probable E3 ubiquitin-protein ligase DTX3,8322,985,1.26 [1.00-1.59],0.0463737715750494
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DTYMK,Thymidylate kinase,7231,828,0.93 [0.84-1.03],0.1428587704257398
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DUOX2,Dual oxidase 2,8206,953,0.94 [0.87-1.03],0.1792463478207859
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DUSP13,Dual specificity protein phosphatase 13 isoform A,7208,827,0.93 [0.79-1.10],0.4092079617612875
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DUSP29,Dual specificity phosphatase 29,7040,799,1.08 [0.98-1.19],0.1278558253877729
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DUSP3,Dual specificity protein phosphatase 3,8164,946,0.91 [0.84-0.97],0.0075634950179669
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",7204,827,0.92 [0.86-0.98],0.0125228746782619
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DXO,Decapping and exoribonuclease protein,7224,829,0.89 [0.77-1.04],0.1411397673769517
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,7208,827,0.91 [0.78-1.07],0.2619895253051383
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DYNLT1,Dynein light chain Tctex-type 1,7040,799,0.93 [0.85-1.02],0.139248607775843
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DYNLT3,Dynein light chain Tctex-type 3,7208,827,0.92 [0.79-1.07],0.2616764146073314
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,8266,970,0.95 [0.90-1.01],0.1250687200926376
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EBI3_IL27,Interleukin-27,8425,985,1.08 [0.90-1.30],0.4217313890656071
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ECE1,Endothelin-converting enzyme 1,8164,946,0.97 [0.82-1.14],0.6971491722685075
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",7231,828,1.00 [0.91-1.10],0.9715814777468672
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ECHS1,"Enoyl-CoA hydratase, mitochondrial",7030,808,0.92 [0.86-0.99],0.0337501493040742
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ECI2,Enoyl-CoA delta isomerase 2,6987,802,0.94 [0.84-1.05],0.2758050892570785
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ECM1,Extracellular matrix protein 1,7055,809,1.02 [0.85-1.23],0.8220744832040052
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ECSCR,Endothelial cell-specific chemotaxis regulator,7032,801,0.81 [0.70-0.95],0.010438361908414
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EDA2R,Tumor necrosis factor receptor superfamily member 27,8438,986,1.09 [0.94-1.25],0.2449444613631274
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EDAR,Tumor necrosis factor receptor superfamily member EDAR,8335,971,0.96 [0.90-1.03],0.2326610921835901
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EDDM3B,Epididymal secretory protein E3-beta,7208,827,1.04 [0.93-1.17],0.4752773605708028
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,6987,802,0.79 [0.64-0.97],0.0257648029927752
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EDF1,Endothelial differentiation-related factor 1,7222,826,0.90 [0.81-1.01],0.063157802046336
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,8206,953,0.92 [0.77-1.10],0.3445869720129828
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EDN1,Endothelin-1,7030,808,0.90 [0.71-1.13],0.357321852378805
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EDNRB,Endothelin receptor type B,7008,809,1.01 [0.86-1.18],0.8808886611507389
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EEF1D,Elongation factor 1-delta,7231,828,0.93 [0.87-1.00],0.0665802454247704
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EFCAB14,EF-hand calcium-binding domain-containing protein 14,7204,827,1.08 [0.87-1.34],0.4692053297742042
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EFCAB2,Dynein regulatory complex protein 8,7092,819,0.78 [0.64-0.95],0.0159782860192309
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,8384,979,0.99 [0.83-1.18],0.9114648716181886
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EFHD1,EF-hand domain-containing protein D1,7222,826,1.24 [1.04-1.48],0.0162382645510264
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EFNA1,Ephrin-A1,8349,975,1.35 [1.12-1.62],0.0017547075975302
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EFNA4,Ephrin-A4,8252,970,1.13 [0.94-1.35],0.1840895671063831
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EFNB2,Ephrin-B2,7040,799,0.94 [0.83-1.07],0.379916147780578
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EGF,Pro-epidermal growth factor,8326,965,0.94 [0.89-0.99],0.0208894343709952
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EGFL7,Epidermal growth factor-like protein 7,8180,948,1.07 [0.92-1.24],0.4008629596987865
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EGFLAM,Pikachurin,7204,827,1.00 [0.80-1.25],0.9959680158780424
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EGFR,Epidermal growth factor receptor,8458,987,1.35 [0.95-1.92],0.0906034701567288
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EGLN1,Egl nine homolog 1,8335,971,1.07 [0.97-1.18],0.1848395225139178
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EHBP1,EH domain-binding protein 1,7231,828,0.94 [0.86-1.03],0.2155511055010887
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EHD3,EH domain-containing protein 3,7030,808,0.94 [0.89-0.99],0.029823171820304
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",7224,829,0.86 [0.76-0.98],0.0257643166943572
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",7172,820,0.94 [0.88-1.00],0.049624512758314
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,6987,802,0.97 [0.87-1.08],0.5884315824819926
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,7030,808,0.86 [0.72-1.01],0.0702390481466455
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EIF4B,Eukaryotic translation initiation factor 4B,8266,970,0.92 [0.83-1.01],0.0882231732889892
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EIF4E,Eukaryotic translation initiation factor 4E,7008,809,0.91 [0.84-0.99],0.0225688019370635
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,8340,975,0.96 [0.88-1.05],0.3763434256396153
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,8443,992,0.97 [0.91-1.02],0.2610352128613404
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,7222,826,0.94 [0.84-1.04],0.2319006134422058
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EIF5,Eukaryotic translation initiation factor 5,6987,802,0.82 [0.69-0.97],0.0228779827532658
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EIF5A,Eukaryotic translation initiation factor 5A-1,8195,943,0.94 [0.78-1.15],0.557149210695105
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ELAC1,Zinc phosphodiesterase ELAC protein 1,7222,826,0.90 [0.84-0.98],0.0121761802520119
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ELAVL4,ELAV-like protein 4,7032,801,0.91 [0.83-0.99],0.0263907401405343
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ELN,Elastin,7231,828,1.07 [0.88-1.31],0.4740714720590612
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ELOA,Elongin-A,8322,985,1.12 [1.02-1.23],0.016966110197009
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ELOB,Elongin-B,6987,802,0.87 [0.72-1.05],0.1448773234854868
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENAH,Protein enabled homolog,8195,943,1.03 [0.91-1.16],0.658450827803398
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENDOU,Poly(U)-specific endoribonuclease,6662,761,1.08 [0.96-1.23],0.2054565961819023
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENG,Endoglin,8458,987,1.18 [0.85-1.63],0.3178438771711991
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENO1,Alpha-enolase,8329,973,0.95 [0.88-1.02],0.1407852627428643
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENO2,Gamma-enolase,8412,980,0.94 [0.86-1.03],0.1819193285401059
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENO3,Beta-enolase,7030,808,0.94 [0.84-1.05],0.2874394330538409
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENOPH1,Enolase-phosphatase E1,7208,827,0.90 [0.78-1.03],0.1301904939197666
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENOX2,Ecto-NOX disulfide-thiol exchanger 2,6987,802,0.82 [0.63-1.05],0.119456289910491
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENPEP,Glutamyl aminopeptidase,6987,802,0.97 [0.82-1.14],0.6919769455274133
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,8458,987,1.01 [0.80-1.27],0.9369036303510172
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,8377,979,0.93 [0.82-1.05],0.2292218166844832
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,7030,808,1.16 [0.96-1.40],0.1340648671894786
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,8064,942,0.96 [0.90-1.03],0.3045577077977477
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENSA,Alpha-endosulfine,7208,827,0.92 [0.81-1.05],0.2126155459175615
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,8180,948,1.21 [1.06-1.39],0.0058201223310602
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,8206,953,0.88 [0.68-1.14],0.3488910569888089
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,8206,953,0.97 [0.79-1.19],0.7747771877176184
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENTR1,Endosome-associated-trafficking regulator 1,7030,808,0.92 [0.82-1.04],0.1843601996040514
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EP300,Histone acetyltransferase p300,7008,809,1.00 [0.80-1.24],0.9685436820785718
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPB41L5,Band 4.1-like protein 5,7040,799,1.03 [0.93-1.15],0.5719234401378988
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPCAM,Epithelial cell adhesion molecule,8332,972,1.05 [0.99-1.11],0.1213503659708531
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPGN,Epigen,7208,827,0.86 [0.72-1.02],0.0800348403738133
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPHA1,Ephrin type-A receptor 1,8364,977,1.22 [1.02-1.47],0.0322635317375457
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPHA10,Ephrin type-A receptor 10,8164,946,1.01 [0.93-1.10],0.8360143520377483
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPHA2,Ephrin type-A receptor 2,8079,952,1.19 [1.00-1.43],0.0539359825677371
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPHA4,Ephrin type-A receptor 4,7068,806,0.91 [0.72-1.14],0.4095390558324555
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPHB4,Ephrin type-B receptor 4,8458,987,1.32 [1.07-1.64],0.0112211983310657
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPHB6,Ephrin type-B receptor 6,8254,968,1.20 [1.01-1.43],0.0368353688329464
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPHX2,Bifunctional epoxide hydrolase 2,8206,953,0.98 [0.89-1.08],0.7117055072929298
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPN1,Epsin-1,7092,819,0.84 [0.71-1.00],0.0456560400179108
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPO,Erythropoietin,8335,971,0.96 [0.89-1.05],0.3800795728259384
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPPK1,Epiplakin,7030,808,0.97 [0.88-1.06],0.4862117246661043
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,8420,982,1.35 [1.12-1.62],0.0016413565297575
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ERBB2,Receptor tyrosine-protein kinase erbB-2,8384,984,0.96 [0.76-1.22],0.7491426042823793
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ERBB3,Receptor tyrosine-protein kinase erbB-3,8314,968,1.11 [0.84-1.47],0.4676398674170612
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ERBB4,Receptor tyrosine-protein kinase erbB-4,8384,984,0.97 [0.76-1.23],0.8049880440960058
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ERBIN,Erbin,8322,985,0.95 [0.90-1.01],0.0809918504915592
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ERC2,ERC protein 2,7040,799,0.89 [0.80-0.98],0.0219730576048359
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ERCC1,DNA excision repair protein ERCC-1,6987,805,0.95 [0.78-1.16],0.623838295075349
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EREG,Proepiregulin,8254,968,0.94 [0.88-1.02],0.1196423540919383
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ERI1,3'-5' exoribonuclease 1,7092,819,0.97 [0.79-1.18],0.7390420484841583
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ERMAP,Erythroid membrane-associated protein,7008,809,0.93 [0.79-1.08],0.3221101328477879
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,7208,827,1.05 [0.87-1.27],0.6256522317085025
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ERP29,Endoplasmic reticulum resident protein 29,7068,806,0.93 [0.88-0.98],0.013016375063083
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ERP44,Endoplasmic reticulum resident protein 44,8311,985,0.92 [0.74-1.15],0.4532328220005522
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,6987,802,0.92 [0.78-1.09],0.3302704877984076
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ESAM,Endothelial cell-selective adhesion molecule,8458,987,1.06 [0.89-1.27],0.48228312441902
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ESM1,Endothelial cell-specific molecule 1,8340,974,1.03 [0.87-1.21],0.7654509278701054
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ESPL1,Separin,6987,805,0.93 [0.82-1.06],0.2632833654491666
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ESR1,Estrogen receptor,7008,809,0.98 [0.86-1.11],0.7253248835943219
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ESYT2,Extended synaptotagmin-2,7224,829,0.90 [0.83-0.97],0.0104647242101584
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EVI2B,Protein EVI2B,6987,805,1.10 [0.94-1.28],0.2513988206521869
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EVI5,Ecotropic viral integration site 5 protein homolog,7008,809,0.93 [0.86-1.00],0.0610472984810061
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EVPL,Envoplakin,7092,819,0.98 [0.79-1.20],0.8122825832016207
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EXOSC10,Exosome component 10,6987,802,1.08 [0.96-1.21],0.2059132140286935
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EXTL1,Exostosin-like 1,6987,802,0.94 [0.81-1.08],0.3711140425692005
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EZR,Ezrin,8412,980,1.31 [1.04-1.65],0.0207828255677269
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",F10,Coagulation factor X,7238,823,1.13 [0.91-1.40],0.2687859341496421
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",F11,Coagulation factor XI,7142,818,1.10 [0.89-1.36],0.3859833065180875
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",F11R,Junctional adhesion molecule A,8360,976,0.91 [0.82-1.01],0.0711202512337849
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",F12,Coagulation factor XII,7237,826,1.14 [0.97-1.35],0.1138657543464675
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",F13B,Coagulation factor XIII B chain,7207,821,1.20 [0.92-1.57],0.1777591468400537
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",F2,Prothrombin,7237,826,1.04 [0.67-1.62],0.8511920082802793
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",F2R,Proteinase-activated receptor 1,8365,974,0.96 [0.87-1.07],0.4873363227168809
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",F3,Tissue factor,8384,982,1.29 [1.04-1.61],0.0206224529135761
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",F7,Coagulation factor VII,8382,975,1.03 [0.86-1.23],0.7704114196873438
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",F9,Coagulation factor IX,8382,977,0.80 [0.59-1.09],0.1626202489630276
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FABP1,"Fatty acid-binding protein, liver",8340,974,1.01 [0.95-1.07],0.7464029426272223
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FABP2,"Fatty acid-binding protein, intestinal",8340,975,1.01 [0.95-1.09],0.6767910599411753
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FABP3,"Fatty acid-binding protein, heart",7231,828,1.17 [1.03-1.32],0.0127362030463175
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FABP4,"Fatty acid-binding protein, adipocyte",8458,987,1.07 [0.96-1.20],0.2201286591621861
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FABP5,Fatty acid-binding protein 5,8381,978,0.99 [0.91-1.07],0.7560881334605939
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FABP6,Gastrotropin,8189,950,1.11 [1.01-1.22],0.0360660135166576
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FABP9,Fatty acid-binding protein 9,8335,971,1.04 [0.95-1.15],0.4009134148442587
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FADD,FAS-associated death domain protein,8340,975,0.93 [0.86-1.00],0.0665215202082309
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FAM13A,Protein FAM13A,7204,827,0.93 [0.84-1.03],0.1454770368632606
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FAM171A2,Protein FAM171A2,7222,826,1.00 [0.96-1.04],0.9418440088740856
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FAM171B,Protein FAM171B,7208,827,0.92 [0.71-1.18],0.5039068199073824
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FAM172A,Cotranscriptional regulator FAM172A,7030,808,0.91 [0.81-1.02],0.1124943681765859
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FAM20A,Pseudokinase FAM20A,7231,828,1.06 [0.84-1.35],0.6002770377050002
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FAM3B,Protein FAM3B,8322,985,1.05 [0.89-1.24],0.5383730472445833
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FAM3C,Protein FAM3C,8328,973,1.13 [0.94-1.36],0.1994006172398474
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FAM3D,Protein FAM3D,7204,827,1.01 [0.93-1.09],0.8626694700749251
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FAP,Prolyl endopeptidase FAP,8458,987,1.11 [0.90-1.37],0.3233028465025452
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FARSA,Phenylalanine--tRNA ligase alpha subunit,7040,799,0.87 [0.79-0.97],0.0116838137668263
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FAS,Tumor necrosis factor receptor superfamily member 6,8434,983,1.15 [0.99-1.33],0.0692815920645418
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FASLG,Tumor necrosis factor ligand superfamily member 6,8443,992,1.14 [0.98-1.33],0.0927752809994294
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FBLN2,Fibulin-2,7230,831,1.08 [0.87-1.34],0.4749267002197775
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FBN2,Fibrillin-2,7040,799,1.06 [0.94-1.19],0.3264558724648916
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FBP1,"Fructose-1,6-bisphosphatase 1",8340,975,0.99 [0.91-1.07],0.7842864239665
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,7231,828,1.06 [0.97-1.17],0.1959149041312647
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCAR,Immunoglobulin alpha Fc receptor,8335,971,0.96 [0.85-1.08],0.4821768519445527
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,7222,826,1.19 [0.90-1.58],0.2325744001863951
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCER2,Low affinity immunoglobulin epsilon Fc receptor,8360,976,1.12 [1.00-1.25],0.0474997965974055
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,8329,969,0.89 [0.81-0.97],0.0071877523488052
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,8180,948,1.03 [0.93-1.14],0.6042843718831707
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,8369,973,1.03 [0.91-1.15],0.6673930429712254
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCN1,Ficolin-1,7227,820,1.04 [0.92-1.17],0.5752837549030296
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCN2,Ficolin-2,8333,973,1.00 [0.87-1.15],0.982929227957714
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCRL1,Fc receptor-like protein 1,8340,975,1.21 [1.06-1.37],0.0035742407820168
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCRL2,Fc receptor-like protein 2,8397,986,1.14 [1.02-1.28],0.0197694768393594
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCRL3,Fc receptor-like protein 3,8195,943,1.10 [0.99-1.23],0.0733765477505263
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCRL5,Fc receptor-like protein 5,8360,976,0.93 [0.84-1.03],0.142902435399342
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCRL6,Fc receptor-like protein 6,8335,971,1.00 [0.92-1.08],0.9723122658690356
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCRLB,Fc receptor-like B,8180,948,0.95 [0.86-1.04],0.2485355611669605
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FDX1,"Adrenodoxin, mitochondrial",6987,802,0.94 [0.84-1.06],0.3354381573031646
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FDX2,"Ferredoxin-2, mitochondrial",6987,802,0.85 [0.74-0.96],0.0113333098058462
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FEN1,Flap endonuclease 1,8180,948,1.07 [0.99-1.16],0.1065017000553086
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FES,Tyrosine-protein kinase Fes/Fps,8180,948,0.97 [0.85-1.09],0.5876417654403506
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FETUB,Fetuin-B,8382,977,1.07 [0.89-1.28],0.4794897457826794
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGA,Fibrinogen alpha chain,7071,811,1.22 [0.98-1.53],0.0746362837267952
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",7222,826,0.92 [0.85-1.00],0.0591190320082468
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGF12,Fibroblast growth factor 12,7008,809,1.03 [0.90-1.18],0.7007137901668002
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGF16,Fibroblast growth factor 16,7008,809,1.00 [0.86-1.16],0.952305650267639
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGF19,Fibroblast growth factor 19,8377,979,1.01 [0.94-1.08],0.8799620922842863
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGF2,Fibroblast growth factor 2,8335,971,0.91 [0.83-0.99],0.0221565407626292
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGF20,Fibroblast growth factor 20,7008,809,0.93 [0.79-1.10],0.3937760658715313
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGF21,Fibroblast growth factor 21,8425,985,0.99 [0.95-1.04],0.7858489305675095
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGF23,Fibroblast growth factor 23,8425,984,1.08 [0.98-1.20],0.1336013953803209
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGF3,Fibroblast growth factor 3,7008,809,1.02 [0.82-1.27],0.8708031821702927
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGF5,Fibroblast growth factor 5,8195,943,0.97 [0.82-1.16],0.7507419049651727
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGF6,Fibroblast growth factor 6,7008,809,1.02 [0.86-1.21],0.7979881021582796
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGF7,Fibroblast growth factor 7,6987,805,1.02 [0.93-1.11],0.7207233783195447
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGF9,Fibroblast growth factor 9,6979,804,0.82 [0.69-0.96],0.0145314986524059
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGFBP1,Fibroblast growth factor-binding protein 1,8384,984,1.01 [0.85-1.20],0.9303336527891471
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGFBP2,Fibroblast growth factor-binding protein 2,7230,831,0.92 [0.81-1.05],0.2198806493792248
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGFBP3,Fibroblast growth factor-binding protein 3,7224,829,0.92 [0.76-1.10],0.3547881199385153
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGFR2,Fibroblast growth factor receptor 2,8384,984,1.18 [0.91-1.52],0.2150000217165976
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGFR4,Fibroblast growth factor receptor 4,7068,806,1.11 [0.97-1.26],0.1312952131599978
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGL1,Fibrinogen-like protein 1,7238,823,1.02 [0.92-1.13],0.6934015139397598
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGR,Tyrosine-protein kinase Fgr,8164,946,1.06 [0.97-1.16],0.1737034885608751
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FH,"Fumarate hydratase, mitochondrial",7032,801,1.00 [0.92-1.09],0.9557781903082416
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FHIP2A,FHF complex subunit HOOK interacting protein 2A,6987,802,1.03 [0.90-1.18],0.6705867279774314
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FHIT,Bis(5'-adenosyl)-triphosphatase,8164,946,0.95 [0.88-1.03],0.2369792987321821
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FIS1,Mitochondrial fission 1 protein,8340,973,0.95 [0.88-1.03],0.1980828665977433
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,7222,826,0.92 [0.86-0.99],0.0179147889984397
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,8366,980,0.94 [0.89-0.99],0.0185785097648197
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,8266,970,0.92 [0.80-1.05],0.2156332270271405
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,8266,970,0.96 [0.91-1.02],0.2428767331355531
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,8152,944,0.99 [0.88-1.12],0.9075047539026578
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FKBPL,FK506-binding protein-like,7204,827,0.87 [0.78-0.98],0.0202231609457565
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FLI1,Friend leukemia integration 1 transcription factor,8180,948,0.94 [0.89-0.99],0.016619289060032
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,8266,970,1.10 [0.90-1.34],0.3419462231496165
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FLT1,Vascular endothelial growth factor receptor 1,8298,985,1.08 [0.84-1.39],0.5444982347176935
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FLT3,Receptor-type tyrosine-protein kinase FLT3,8180,948,0.92 [0.75-1.11],0.3751985836798371
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FLT3LG,Fms-related tyrosine kinase 3 ligand,8443,992,0.82 [0.69-0.96],0.0134119379902169
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FLT4,Vascular endothelial growth factor receptor 3,8384,984,1.16 [0.98-1.37],0.0899720012232179
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FMNL1,Formin-like protein 1,8164,946,1.07 [0.99-1.16],0.0988105531281805
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FMR1,Synaptic functional regulator FMR1,8180,948,0.96 [0.82-1.14],0.6541432705688972
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FN1,Fibronectin,7237,826,0.95 [0.74-1.22],0.6821240421990227
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FNDC1,Fibronectin type III domain-containing protein 1,7224,829,1.04 [0.90-1.20],0.5673427412034624
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,7208,827,0.95 [0.77-1.16],0.589218306915902
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FOLH1,Glutamate carboxypeptidase 2,7008,809,1.01 [0.95-1.08],0.7331079021717043
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FOLR1,Folate receptor alpha,8343,976,1.00 [0.82-1.21],0.9622206162282152
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FOLR2,Folate receptor beta,8412,980,1.12 [0.92-1.36],0.2485698935196843
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FOLR3,Folate receptor gamma,8357,980,1.01 [0.98-1.04],0.4954416268954001
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FOS,Proto-oncogene c-Fos,6979,804,0.89 [0.73-1.08],0.2393727489235279
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FOSB,Protein fosB,8164,946,0.98 [0.84-1.14],0.772127247630659
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FOXJ3,Forkhead box protein J3,7008,809,0.97 [0.83-1.14],0.7350458424400057
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FOXO1,Forkhead box protein O1,8335,971,0.95 [0.89-1.02],0.1329855823545976
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FOXO3,Forkhead box protein O3,8180,948,0.93 [0.88-1.00],0.0356837316759127
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FRMD4B,FERM domain-containing protein 4B,6987,802,0.94 [0.85-1.03],0.1923864597270695
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FRMD7,FERM domain-containing protein 7,7040,799,0.94 [0.77-1.14],0.5360824346416462
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FRZB,Secreted frizzled-related protein 3,8238,967,0.88 [0.70-1.12],0.3028535667307467
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FSHB,Follitropin subunit beta,7030,808,0.90 [0.77-1.07],0.232819337992182
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FST,Follistatin,8365,974,1.05 [0.93-1.18],0.4186861339412182
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FSTL1,Follistatin-related protein 1,7030,808,1.25 [0.92-1.70],0.1553658010148059
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FSTL3,Follistatin-related protein 3,8320,970,1.26 [1.06-1.50],0.0084942957165014
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FTCD,Formimidoyltransferase-cyclodeaminase,7207,828,0.99 [0.91-1.07],0.8238035952044197
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FUCA1,Tissue alpha-L-fucosidase,8402,977,0.99 [0.93-1.06],0.7571708983896079
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FUOM,Fucose mutarotase,7068,806,0.93 [0.83-1.04],0.222678251416836
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FURIN,Furin,8384,984,0.89 [0.75-1.07],0.2134412226053973
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FUS,RNA-binding protein FUS,8167,946,1.11 [0.96-1.29],0.1568284966048726
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",7078,819,1.02 [0.92-1.14],0.7029302785225047
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,8412,980,1.01 [0.90-1.14],0.8364484567109137
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FUT8,"Alpha-(1,6)-fucosyltransferase",8266,970,0.95 [0.86-1.05],0.3211852901959345
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FXN,"Frataxin, mitochondrial",8438,986,0.90 [0.84-0.98],0.0121316682880304
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FXYD5,FXYD domain-containing ion transport regulator 5,8195,943,0.92 [0.84-1.01],0.0798588770450469
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FYB1,FYN-binding protein 1,8337,974,0.94 [0.88-1.00],0.0490858915938293
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FZD10,Frizzled-10,7040,799,0.94 [0.83-1.06],0.3130429727426889
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FZD8,Frizzled-8,7032,801,0.98 [0.84-1.15],0.7949549291915758
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GABARAP,Gamma-aminobutyric acid receptor-associated protein,7208,827,1.00 [0.87-1.16],0.9552677387980666
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,7092,819,0.97 [0.87-1.07],0.5087303871215854
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,7032,801,0.93 [0.83-1.05],0.2543232813087381
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GAD1,Glutamate decarboxylase 1,6987,805,1.02 [0.79-1.32],0.8811718736323468
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GAD2,Glutamate decarboxylase 2,7008,809,1.10 [0.96-1.25],0.1655954584030933
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,7092,819,0.89 [0.76-1.04],0.1419355062537139
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,7030,808,0.82 [0.72-0.94],0.0046400189312865
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GAGE2A,G antigen 2A,6987,805,0.95 [0.85-1.05],0.3037615012802205
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GAL,Galanin peptides,8377,979,0.96 [0.88-1.05],0.3836708445404264
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,8322,985,0.83 [0.67-1.01],0.0652954780752906
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,8438,986,0.98 [0.80-1.21],0.8709271861416803
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,8195,943,0.99 [0.87-1.13],0.9110139564302612
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,7231,828,0.88 [0.69-1.11],0.2887231517343523
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GALNT7,N-acetylgalactosaminyltransferase 7,8322,985,0.95 [0.72-1.24],0.697606927215719
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GAMT,Guanidinoacetate N-methyltransferase,6987,802,0.75 [0.59-0.95],0.0154098381050789
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,6894,783,0.71 [0.57-0.87],0.0010193912062164
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GART,Trifunctional purine biosynthetic protein adenosine-3,7222,826,0.96 [0.74-1.24],0.7523822850325965
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GAS2,Growth arrest-specific protein 2,7092,819,0.96 [0.84-1.10],0.5578690599353063
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GAS6,Growth arrest-specific protein 6,8412,982,1.03 [0.82-1.29],0.8208673785082223
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GASK1A,Golgi-associated kinase 1A,6987,802,0.99 [0.84-1.16],0.859756280950053
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GAST,Gastrin,7224,829,0.99 [0.94-1.04],0.5870285466810667
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GATA3,Trans-acting T-cell-specific transcription factor GATA-3,6987,805,1.09 [0.84-1.41],0.5313259898706786
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",7030,808,0.90 [0.82-0.98],0.021218023335921
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GBA,Lysosomal acid glucosylceramidase,7040,799,0.97 [0.85-1.10],0.6042841092312392
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GBP1,Guanylate-binding protein 1,7211,828,1.06 [0.95-1.17],0.2852439345805763
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GBP2,Guanylate-binding protein 2,8195,943,1.06 [0.96-1.17],0.2313564931723007
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GBP4,Guanylate-binding protein 4,8164,946,1.00 [0.89-1.13],0.9804446223020192
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GBP6,Guanylate-binding protein 6,6987,802,1.03 [0.89-1.21],0.678333043045866
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GC,Vitamin D-binding protein,7237,826,1.13 [0.87-1.46],0.3469079193950151
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GCC1,GRIP and coiled-coil domain-containing protein 1,7224,829,0.93 [0.88-0.99],0.027290110421728
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GCG,Pro-glucagon,8180,948,0.96 [0.92-1.00],0.0730739203796046
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,6894,785,1.06 [0.93-1.22],0.3894754998589183
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GCLM,Glutamate--cysteine ligase regulatory subunit,6987,802,0.80 [0.67-0.95],0.0096879620271068
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",8322,985,1.06 [0.90-1.25],0.4685537919117263
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GDF15,Growth/differentiation factor 15,8458,987,1.08 [0.95-1.22],0.2390947913691048
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GDF2,Growth/differentiation factor 2,8340,975,0.93 [0.79-1.09],0.3683233050333726
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GDNF,Glial cell line-derived neurotrophic factor,8164,946,1.07 [0.92-1.24],0.3979326888484618
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GET3,ATPase GET3,7231,828,1.00 [0.88-1.13],0.9621117592508944
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GFAP,Glial fibrillary acidic protein,8167,947,0.92 [0.82-1.05],0.2123753972545182
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GFER,FAD-linked sulfhydryl oxidase ALR,8180,948,0.98 [0.90-1.08],0.7277277534380472
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,8180,948,1.01 [0.96-1.06],0.6692090082176918
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GFRA1,GDNF family receptor alpha-1,8425,985,1.18 [0.97-1.44],0.0955444324483522
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GFRA2,GDNF family receptor alpha-2,8322,985,1.05 [0.80-1.38],0.7091660174910603
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GFRA3,GDNF family receptor alpha-3,8246,967,0.94 [0.76-1.15],0.5480536804525403
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GFRAL,GDNF family receptor alpha-like,6998,805,0.98 [0.88-1.10],0.784073218563913
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GGA1,ADP-ribosylation factor-binding protein GGA1,8164,946,1.05 [0.97-1.15],0.2156982395105706
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GGACT,Gamma-glutamylaminecyclotransferase,7231,828,0.91 [0.83-1.01],0.0659249623255011
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GGCT,Gamma-glutamylcyclotransferase,7219,827,0.88 [0.76-1.02],0.0789150146129041
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GGH,Gamma-glutamyl hydrolase,8223,961,0.97 [0.81-1.14],0.6872624251176619
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GGT1,Glutathione hydrolase 1 proenzyme,8349,975,1.02 [0.90-1.14],0.7861774469690479
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GGT5,Glutathione hydrolase 5 proenzyme,8266,970,0.95 [0.74-1.22],0.6916477827733123
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GH1,Somatotropin,8328,973,0.98 [0.95-1.02],0.3078286385499006
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GH2,Growth hormone variant,8180,948,1.03 [0.99-1.06],0.1523052810632318
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GHR,Growth hormone receptor,7068,806,0.95 [0.74-1.21],0.6537485124086577
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GHRHR,Growth hormone-releasing hormone receptor,8164,946,1.02 [0.92-1.13],0.7476994799042472
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GHRL,Appetite-regulating hormone,8340,975,1.01 [0.94-1.07],0.8633355737634004
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GID8,Glucose-induced degradation protein 8 homolog,7222,826,0.73 [0.58-0.92],0.0086342427365585
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GIGYF2,GRB10-interacting GYF protein 2,7222,826,0.90 [0.82-0.98],0.0207692069515027
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GIMAP7,GTPase IMAP family member 7,7068,806,1.22 [1.00-1.49],0.0447100602295822
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GIMAP8,GTPase IMAP family member 8,6987,805,1.02 [0.88-1.17],0.8258896564721054
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GIP,Gastric inhibitory polypeptide,7030,808,1.00 [0.89-1.13],0.9884551142211158
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GIPC2,PDZ domain-containing protein GIPC2,7224,829,1.22 [0.99-1.50],0.0586115328529554
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GIPC3,PDZ domain-containing protein GIPC3,7204,827,0.90 [0.84-0.96],0.0025845708613173
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GIPR,Gastric inhibitory polypeptide receptor,7008,809,0.93 [0.79-1.09],0.377847950487204
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GIT1,ARF GTPase-activating protein GIT1,7008,809,0.95 [0.88-1.02],0.1464843132016088
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GJA8,Gap junction alpha-8 protein,6987,805,0.91 [0.81-1.02],0.1001379654648127
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GKN1,Gastrokine-1,8010,927,1.03 [0.83-1.28],0.7651414353772655
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GLA,Alpha-galactosidase A,7058,806,0.80 [0.67-0.95],0.0131853892372077
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GLB1,Beta-galactosidase,8266,970,0.93 [0.81-1.07],0.2922752284238689
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GLI2,Zinc finger protein GLI2,7008,809,1.00 [0.81-1.25],0.965590355088804
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GLO1,Lactoylglutathione lyase,8206,953,0.97 [0.88-1.08],0.5841355019915053
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GLOD4,Glyoxalase domain-containing protein 4,8328,968,0.97 [0.82-1.14],0.7090965961095617
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GLP1R,Glucagon-like peptide 1 receptor,7032,801,0.96 [0.80-1.16],0.6979640793270622
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GLRX,Glutaredoxin-1,8289,969,1.03 [0.93-1.13],0.6199040132764535
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GLRX5,"Glutaredoxin-related protein 5, mitochondrial",7068,806,0.89 [0.82-0.97],0.0049253956818753
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GLT8D2,Glycosyltransferase 8 domain-containing protein 2,8164,946,0.94 [0.82-1.08],0.3691478403363295
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GLYR1,Putative oxidoreductase GLYR1,7208,827,1.08 [0.96-1.20],0.1947966095518396
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GM2A,Ganglioside GM2 activator,7063,812,1.16 [0.98-1.38],0.0842711868800992
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GMFG,Glia maturation factor gamma,7231,828,0.90 [0.82-0.99],0.0364118912013347
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GMPR,GMP reductase 1,8443,992,0.95 [0.84-1.06],0.3375487774311301
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GMPR2,GMP reductase 2,7068,806,0.90 [0.81-1.00],0.0410048997498947
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GNAS,Neuroendocrine secretory protein 55,7222,826,0.94 [0.87-1.03],0.1726707696851195
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,8180,948,0.96 [0.87-1.05],0.325105030029309
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,7040,799,0.98 [0.85-1.13],0.8039931019086538
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GNLY,Granulysin,8360,976,1.09 [0.98-1.21],0.1007091287382971
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GNPDA1,Glucosamine-6-phosphate isomerase 1,7030,808,1.04 [0.87-1.25],0.6726214415668201
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GNPDA2,Glucosamine-6-phosphate isomerase 2,7068,806,0.86 [0.72-1.04],0.1317615259488986
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GOLGA3,Golgin subfamily A member 3,7222,826,0.90 [0.83-0.99],0.0253298414550046
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GOLM2,Protein GOLM2,8412,980,1.17 [0.93-1.48],0.1809766055989953
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,8335,971,0.97 [0.91-1.02],0.244481463129632
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GORASP2,Golgi reassembly-stacking protein 2,7204,827,0.84 [0.72-0.97],0.0155444951478271
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GOT1,"Aspartate aminotransferase, cytoplasmic",7230,831,1.07 [0.91-1.25],0.4266190615279496
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GP1BA,Platelet glycoprotein Ib alpha chain,8338,972,0.97 [0.82-1.15],0.7402874211278194
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GP1BB,Platelet glycoprotein Ib beta chain,6987,802,0.87 [0.79-0.96],0.0076928500641597
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GP2,Pancreatic secretory granule membrane major glycoprotein GP2,8103,940,1.20 [1.13-1.28],2.4576576950692144e-08
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GP5,Platelet glycoprotein V,7068,806,0.83 [0.69-1.00],0.0471907833893953
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GP6,Platelet glycoprotein VI,8337,974,0.95 [0.89-1.01],0.1015069406438484
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPA33,Cell surface A33 antigen,8322,985,1.03 [0.99-1.08],0.1050691325372677
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPC1,Glypican-1,8438,986,1.01 [0.83-1.22],0.934104536484785
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPC5,Glypican-5,8266,970,0.92 [0.83-1.02],0.1136490362671022
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPD1,Glycerol-3-phosphate dehydrogenase,7208,827,0.92 [0.80-1.05],0.1974384400424241
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPHA2,Glycoprotein hormone alpha-2,7204,827,0.95 [0.81-1.12],0.5263024700661669
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPI,Glucose-6-phosphate isomerase,7238,823,0.84 [0.73-0.98],0.022152474224858
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,7204,827,0.97 [0.88-1.06],0.456552459808808
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPKOW,G-patch domain and KOW motifs-containing protein,8164,946,1.10 [0.92-1.32],0.2789063656009821
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPNMB,Transmembrane glycoprotein NMB,8120,945,1.13 [0.93-1.38],0.2201082759924013
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPR101,Probable G-protein coupled receptor 101,7032,801,0.90 [0.79-1.04],0.1476942315048556
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPR158,Probable G-protein coupled receptor 158,7222,826,0.92 [0.75-1.12],0.3964924404605876
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPR15L,Protein GPR15L,7204,827,0.95 [0.85-1.06],0.3642455159728424
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPR37,Prosaposin receptor GPR37,8206,953,1.07 [0.98-1.17],0.1188487868940659
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPRC5C,G-protein coupled receptor family C group 5 member C,7208,827,1.18 [1.05-1.32],0.0041900709909444
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GRAP2,GRB2-related adapter protein 2,8340,975,0.96 [0.92-1.01],0.0891754681248345
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,7231,828,0.92 [0.83-1.03],0.1314963629391081
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GRIK2,"Glutamate receptor ionotropic, kainate 2",7222,826,0.77 [0.65-0.91],0.0022322856966284
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",7032,801,0.79 [0.67-0.91],0.0018741290666902
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GRK5,G protein-coupled receptor kinase 5,8206,953,1.02 [0.91-1.14],0.7665884008194045
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GRN,Progranulin,8312,971,1.00 [0.79-1.27],0.9897529623225136
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GRP,Gastrin-releasing peptide,7030,808,0.92 [0.81-1.04],0.1854379669403377
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GRPEL1,"GrpE protein homolog 1, mitochondrial",8322,985,1.04 [0.94-1.15],0.4503368615999829
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GRSF1,G-rich sequence factor 1,6951,799,0.86 [0.79-0.94],0.0011327637093151
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GSAP,Gamma-secretase-activating protein,8180,948,0.98 [0.91-1.05],0.5959132243858283
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GSN,Gelsolin,7210,821,0.97 [0.68-1.39],0.8638429383795456
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GSR,"Glutathione reductase, mitochondrial",7197,819,1.06 [0.78-1.43],0.7100267348899654
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GSTA1,Glutathione S-transferase A1,8327,974,1.00 [0.93-1.08],0.9369302647104194
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GSTA3,Glutathione S-transferase A3,8180,948,1.04 [0.96-1.12],0.3040956163810177
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GSTM4,Glutathione S-transferase Mu 4,6987,802,0.94 [0.85-1.03],0.1905319097985846
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GSTP1,Glutathione S-transferase P,8114,938,0.94 [0.86-1.02],0.1346801409751683
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GSTT2B,Glutathione S-transferase theta-2B,7224,829,0.97 [0.95-1.00],0.0632034177638324
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,7092,819,1.00 [0.90-1.10],0.9592962230641072
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GTPBP2,GTP-binding protein 2,7040,799,0.90 [0.83-0.98],0.0172284115098356
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GUCA2A,Guanylin,8309,971,1.21 [1.03-1.42],0.0198118620869126
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GUCY2C,Heat-stable enterotoxin receptor,7092,819,0.93 [0.85-1.02],0.1222300325238963
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GUK1,Guanylate kinase,6987,802,0.93 [0.78-1.12],0.457423025756305
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GUSB,Beta-glucuronidase,8391,975,0.93 [0.85-1.02],0.1151628160158442
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GYS1,"Glycogen [starch] synthase, muscle",8206,953,0.93 [0.87-0.99],0.0224287176747052
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GZMA,Granzyme A,8443,992,0.92 [0.78-1.09],0.3174009051047662
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GZMB,Granzyme B,8335,971,1.04 [0.96-1.13],0.317750490497721
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GZMH,Granzyme H,8206,953,1.05 [0.98-1.13],0.1727857608968848
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",H2AP,Huntingtin-interacting protein M,6987,805,0.93 [0.81-1.08],0.3487461784298677
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",6987,802,0.99 [0.89-1.09],0.8164462301715871
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",8414,985,1.04 [0.96-1.12],0.3406323342076346
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HAO1,Hydroxyacid oxidase 1,8438,986,0.99 [0.95-1.04],0.7272432161959634
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HARS1,"Histidine--tRNA ligase, cytoplasmic",8360,976,0.91 [0.85-0.98],0.0168230768809025
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HAVCR1,Hepatitis A virus cellular receptor 1,8427,986,1.04 [0.95-1.14],0.3499826336600456
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HAVCR2,Hepatitis A virus cellular receptor 2,8360,976,1.17 [1.00-1.37],0.0564333785580046
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HBEGF,Proheparin-binding EGF-like growth factor,8414,985,0.96 [0.89-1.04],0.3133091266484429
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HBQ1,Hemoglobin subunit theta-1,8438,986,1.06 [0.97-1.15],0.2230362278639168
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HBZ,Hemoglobin subunit zeta,7231,828,1.03 [0.97-1.09],0.3720971928703998
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HCG22,Protein PBMUCL2,6987,802,0.88 [0.77-1.02],0.0871130470611547
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HCLS1,Hematopoietic lineage cell-specific protein,8443,992,0.96 [0.87-1.07],0.4547415182151775
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HDAC8,Histone deacetylase 8,7008,809,1.00 [0.89-1.12],0.9893338167341288
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HDAC9,Histone deacetylase 9,7032,801,1.06 [0.97-1.16],0.2177338994542117
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HDDC2,5'-deoxynucleotidase HDDC2,7204,827,0.94 [0.81-1.10],0.4435033655171194
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HDGF,Hepatoma-derived growth factor,8415,984,0.98 [0.93-1.05],0.6186858719414605
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HDGFL2,Hepatoma-derived growth factor-related protein 2,7224,829,1.03 [0.93-1.14],0.617576063322254
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HEBP1,Heme-binding protein 1,8206,953,0.99 [0.89-1.11],0.9015391194063824
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HEG1,Protein HEG homolog 1,7068,806,0.91 [0.71-1.18],0.4789591913835
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HEPACAM2,HEPACAM family member 2,7224,829,0.95 [0.81-1.10],0.4742118306377453
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HEPH,Hephaestin,7231,828,1.01 [0.80-1.28],0.9235539841778296
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HEXIM1,Protein HEXIM1,8335,971,0.96 [0.89-1.03],0.2399316402808963
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HGF,Hepatocyte growth factor,8443,992,1.00 [0.85-1.18],0.9761020514224475
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HGFAC,Hepatocyte growth factor activator,7177,817,0.80 [0.62-1.02],0.0724599706302203
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,8180,948,0.95 [0.88-1.03],0.223829850465654
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HHEX,Hematopoietically-expressed homeobox protein HHEX,7224,829,0.89 [0.82-0.98],0.0126373431392311
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HIF1A,Hypoxia-inducible factor 1-alpha,7008,809,1.04 [0.94-1.16],0.4432858193853611
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HIP1,Huntingtin-interacting protein 1,6987,802,0.89 [0.72-1.10],0.2687021207023746
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HIP1R,Huntingtin-interacting protein 1-related protein,7206,828,1.04 [0.91-1.20],0.5485126474181206
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HJV,Hemojuvelin,7222,826,0.97 [0.82-1.14],0.6843349536231831
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HK2,Hexokinase-2,8206,953,0.89 [0.72-1.09],0.2596726250417525
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HLA-A,"HLA class I histocompatibility antigen, A alpha chain",7222,826,1.02 [0.83-1.25],0.8546681296945424
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",8310,968,1.08 [0.93-1.26],0.3114816238846343
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",8335,971,1.03 [0.85-1.24],0.7989873107733163
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HMBS,Porphobilinogen deaminase,8438,986,1.07 [0.93-1.23],0.3186338530326881
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HMCN2,Hemicentin-2,7056,805,1.05 [0.93-1.18],0.4236588233851808
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",7030,808,0.83 [0.72-0.96],0.0142994849356915
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",6987,802,0.91 [0.77-1.07],0.2585766213784451
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HMMR,Hyaluronan mediated motility receptor,6970,804,1.01 [0.88-1.16],0.8771370047869079
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HMOX1,Heme oxygenase 1,8258,964,1.05 [0.94-1.18],0.3709660023562713
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HMOX2,Heme oxygenase 2,8164,946,1.07 [0.94-1.21],0.3030255971789688
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HNF1A,Hepatocyte nuclear factor 1-alpha,7040,799,0.94 [0.84-1.04],0.2249919118507629
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HNMT,Histamine N-methyltransferase,8228,966,1.16 [1.03-1.31],0.01584251576724
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HNRNPK,Heterogeneous nuclear ribonucleoprotein K,8181,951,0.98 [0.90-1.05],0.5335987773622074
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,7222,826,0.92 [0.80-1.06],0.2283816212760169
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HPCAL1,Hippocalcin-like protein 1,8443,992,0.93 [0.86-1.00],0.0481547431028647
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HPGDS,Hematopoietic prostaglandin D synthase,8180,948,1.14 [0.98-1.32],0.0920202167210013
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HPSE,Heparanase,7138,821,0.91 [0.85-0.98],0.0140453197986528
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HRAS,GTPase Hras,7075,818,0.95 [0.88-1.03],0.1905145811123928
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,7030,808,0.90 [0.71-1.12],0.3365584941227208
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HRG,Histidine-rich glycoprotein,7207,821,0.96 [0.78-1.18],0.6761321909254544
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HS1BP3,HCLS1-binding protein 3,7030,808,0.92 [0.85-1.00],0.0399892324195198
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,8322,985,0.90 [0.77-1.05],0.1657236853935176
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,8438,986,1.08 [0.92-1.26],0.3442544624329173
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,7008,809,1.05 [0.88-1.26],0.5901275641503927
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HSBP1,Heat shock factor-binding protein 1,7030,808,0.95 [0.89-1.02],0.1896389009476024
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,8335,971,0.96 [0.83-1.11],0.5886657551310196
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,7224,829,1.04 [0.93-1.16],0.4849098153076312
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HSD17B3,Testosterone 17-beta-dehydrogenase 3,6987,802,0.84 [0.72-0.97],0.0213395517251684
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HSDL2,Hydroxysteroid dehydrogenase-like protein 2,7030,808,0.87 [0.75-1.00],0.0546088464090468
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HSP90B1,Endoplasmin,8119,941,0.97 [0.89-1.07],0.5945865487415256
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HSPA1A,Heat shock 70 kDa protein 1A,8364,977,1.00 [0.93-1.09],0.9144539634215944
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HSPA2,Heat shock-related 70 kDa protein 2,7208,827,1.01 [0.83-1.23],0.8949439484815752
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HSPB1,Heat shock protein beta-1,8225,964,0.91 [0.84-0.98],0.0190451697738827
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HSPB6,Heat shock protein beta-6,8438,986,1.19 [1.04-1.37],0.0127622689334854
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,8300,968,1.10 [0.89-1.35],0.3923975326258079
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HTR1A,5-hydroxytryptamine receptor 1A,7032,801,0.97 [0.88-1.08],0.6111533653307071
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HTR1B,5-hydroxytryptamine receptor 1B,7032,801,0.80 [0.67-0.95],0.0090525576697921
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HTRA2,"Serine protease HTRA2, mitochondrial",8384,984,0.94 [0.86-1.03],0.2110958743755606
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HYAL1,Hyaluronidase-1,8320,966,0.80 [0.62-1.03],0.0814241552485942
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HYOU1,Hypoxia up-regulated protein 1,8458,987,1.31 [1.03-1.67],0.0253515790652764
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ICA1,Islet cell autoantigen 1,8195,943,0.98 [0.91-1.06],0.6546841233530882
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ICAM1,Intercellular adhesion molecule 1,8332,970,0.93 [0.76-1.13],0.457617072382419
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ICAM2,Intercellular adhesion molecule 2,8458,987,1.22 [1.03-1.45],0.0238909456868529
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ICAM3,Intercellular adhesion molecule 3,8458,987,1.10 [0.88-1.36],0.4024285041726577
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ICAM4,Intercellular adhesion molecule 4,8335,971,1.04 [0.93-1.16],0.4735151088459364
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ICAM5,Intercellular adhesion molecule 5,8340,975,0.93 [0.82-1.05],0.2322205541590323
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ICOSLG,ICOS ligand,8322,985,1.25 [0.93-1.68],0.13665674770109
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ID4,DNA-binding protein inhibitor ID-4,7092,819,0.84 [0.70-1.00],0.0476401641834522
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IDI2,Isopentenyl-diphosphate delta-isomerase 2,8164,946,1.00 [0.89-1.13],0.9626645250361602
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IDO1,"Indoleamine 2,3-dioxygenase 1",7030,808,0.97 [0.87-1.09],0.650802043793515
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IDS,Iduronate 2-sulfatase,8443,992,1.01 [0.55-1.88],0.9674619846508808
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IDUA,Alpha-L-iduronidase,8438,986,0.87 [0.77-0.98],0.0202779416738843
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,7025,805,1.21 [1.02-1.44],0.0306630219220317
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,7092,819,0.86 [0.75-0.98],0.0261397022081259
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,7092,819,0.88 [0.73-1.06],0.1846693944214594
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IFNAR1,Interferon alpha/beta receptor 1,7204,827,0.87 [0.67-1.14],0.3187221145078114
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IFNG,Interferon gamma,8195,943,0.95 [0.91-1.00],0.0765623893379604
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IFNGR1,Interferon gamma receptor 1,8377,979,1.38 [1.07-1.78],0.0132235229178065
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IFNGR2,Interferon gamma receptor 2,8266,970,0.84 [0.75-0.94],0.0021419730702387
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IFNL1,Interferon lambda-1,8164,946,0.93 [0.82-1.06],0.2958266326971907
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IFNL2,Interferon lambda-2,7032,801,0.97 [0.86-1.09],0.6024755909856092
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IFNLR1,Interferon lambda receptor 1,8335,971,0.99 [0.84-1.17],0.9318439500665588
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IFNW1,Interferon omega-1,6987,802,0.76 [0.61-0.95],0.0153363078466928
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IFT20,Intraflagellar transport protein 20 homolog,7040,799,0.87 [0.74-1.03],0.1059856976618033
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGBP1,Immunoglobulin-binding protein 1,7222,826,0.90 [0.80-1.01],0.0632924800666289
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGDCC3,Immunoglobulin superfamily DCC subclass member 3,7032,801,0.96 [0.83-1.11],0.5485719007980742
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,7230,831,1.10 [0.86-1.41],0.4370810858898856
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGF1R,Insulin-like growth factor 1 receptor,8322,985,1.17 [0.91-1.51],0.2269188806485157
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,6987,802,0.99 [0.85-1.16],0.9442552126050292
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGF2R,Cation-independent mannose-6-phosphate receptor,8360,976,1.08 [0.85-1.38],0.5083777224836832
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGFBP1,Insulin-like growth factor-binding protein 1,8449,986,1.02 [0.97-1.07],0.4501957618803409
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGFBP2,Insulin-like growth factor-binding protein 2,8446,986,1.03 [0.93-1.13],0.5978660402488001
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGFBP3,Insulin-like growth factor-binding protein 3,8395,979,1.15 [0.97-1.36],0.11825040485889
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGFBP4,Insulin-like growth factor-binding protein 4,8254,962,1.13 [1.00-1.28],0.0530573089823909
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGFBP6,Insulin-like growth factor-binding protein 6,8323,972,1.05 [0.88-1.25],0.6133211632011956
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGFBP7,Insulin-like growth factor-binding protein 7,8458,987,1.13 [0.94-1.35],0.1829570350956181
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGFBPL1,Insulin-like growth factor-binding protein-like 1,8340,975,1.23 [1.04-1.45],0.0143520566066765
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGFL4,Insulin growth factor-like family member 4,7008,809,1.03 [0.94-1.13],0.5309901630852352
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGHMBP2,DNA-binding protein SMUBP-2,6987,802,0.90 [0.80-1.03],0.1222147601143261
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGLC2,Immunoglobulin lambda constant 2,7227,826,0.83 [0.61-1.11],0.2110189534741963
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGLON5,IgLON family member 5,6987,805,0.94 [0.87-1.02],0.1383246522325355
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGSF21,Immunoglobulin superfamily member 21,7030,808,0.90 [0.75-1.08],0.2551998911577173
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGSF3,Immunoglobulin superfamily member 3,8322,985,1.05 [0.89-1.24],0.5769320509815676
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGSF8,Immunoglobulin superfamily member 8,8340,975,1.07 [0.89-1.29],0.4537126607045443
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGSF9,Protein turtle homolog A,7231,828,1.00 [0.92-1.08],0.999137738753386
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IKBKG,NF-kappa-B essential modulator,8335,971,0.97 [0.91-1.03],0.3482724037862718
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IKZF2,Zinc finger protein Helios,8180,948,1.00 [0.93-1.07],0.9714414793125938
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL10,Interleukin-10,8195,943,1.04 [0.96-1.12],0.339118786442685
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL10RA,Interleukin-10 receptor subunit alpha,8195,943,0.88 [0.78-0.98],0.0252751467917041
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL10RB,Interleukin-10 receptor subunit beta,8377,979,1.22 [1.01-1.47],0.0344090807838184
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL11,Interleukin-11,8195,943,1.02 [0.93-1.11],0.7322555163698596
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL12A_IL12B,Interleukin-12,8322,985,1.03 [0.96-1.11],0.4059377703394731
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL12B,Interleukin-12 subunit beta,8443,992,1.03 [0.93-1.14],0.6055424759517831
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL12RB1,Interleukin-12 receptor subunit beta-1,8195,943,1.07 [0.91-1.25],0.4227191670937728
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL12RB2,Interleukin-12 receptor subunit beta-2,7008,809,0.98 [0.83-1.16],0.8252898833563542
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL13,Interleukin-13,8195,943,1.01 [0.90-1.14],0.8341899142750125
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL13RA1,Interleukin-13 receptor subunit alpha-1,8259,966,1.50 [1.19-1.91],0.0007900247200041
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL13RA2,Interleukin-13 receptor subunit alpha-2,7032,801,0.71 [0.56-0.90],0.0042146232092606
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL15,Interleukin-15,8335,971,0.89 [0.75-1.06],0.1924090113794163
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL15RA,Interleukin-15 receptor subunit alpha,8195,943,1.08 [0.92-1.28],0.3567779966259298
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL16,Pro-interleukin-16,8443,992,1.18 [1.04-1.33],0.0106154680092679
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL17A,Interleukin-17A,8181,941,0.73 [0.63-0.86],8.272562292293988e-05
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL17C,Interleukin-17C,8195,943,1.02 [0.94-1.10],0.6037837741174201
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL17D,Interleukin-17D,8195,943,0.92 [0.77-1.10],0.3633129644181737
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL17F,Interleukin-17F,8195,943,1.00 [0.92-1.08],0.9472325152087564
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL17RA,Interleukin-17 receptor A,8360,976,1.02 [0.90-1.16],0.772231153232057
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL17RB,Interleukin-17 receptor B,8242,964,0.95 [0.85-1.06],0.3339902660088774
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL18,Interleukin-18,8316,971,1.05 [0.92-1.19],0.4977514529684509
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL18BP,Interleukin-18-binding protein,8395,979,1.11 [0.93-1.33],0.2505915101108336
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL18R1,Interleukin-18 receptor 1,8443,992,0.99 [0.84-1.18],0.9307037057588976
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL18RAP,Interleukin-18 receptor accessory protein,8215,963,0.96 [0.92-0.99],0.0130028349716159
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL19,Interleukin-19,8124,951,0.93 [0.86-1.01],0.1073993514962294
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL1A,Interleukin-1 alpha,8195,943,0.97 [0.88-1.07],0.5325764228793317
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL1B,Interleukin-1 beta,8161,939,1.02 [0.93-1.13],0.6554208525554317
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL1R1,Interleukin-1 receptor type 1,8349,975,1.13 [0.88-1.44],0.3304500998719135
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL1R2,Interleukin-1 receptor type 2,8327,970,0.78 [0.59-1.04],0.0853987116789648
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL1RAP,Interleukin-1 receptor accessory protein,8360,976,0.99 [0.88-1.12],0.8913984024060229
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL1RL1,Interleukin-1 receptor-like 1,8434,983,0.94 [0.83-1.06],0.2905140170597667
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL1RL2,Interleukin-1 receptor-like 2,8195,943,0.98 [0.84-1.15],0.82568067575154
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL1RN,Interleukin-1 receptor antagonist protein,8324,970,1.08 [0.97-1.20],0.1872350916436038
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL2,Interleukin-2,8195,943,0.99 [0.82-1.19],0.9245232342350967
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL20,Interleukin-20,8195,943,0.95 [0.84-1.08],0.4266618175415219
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL20RA,Interleukin-20 receptor subunit alpha,8195,943,1.07 [0.95-1.21],0.2445318042862259
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL20RB,Interleukin-20 receptor subunit beta,7008,809,1.02 [0.87-1.20],0.8199975960915351
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL21R,Interleukin-21 receptor,7008,809,1.00 [0.89-1.12],0.9594524291448032
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL22,Interleukin-22,7208,827,0.95 [0.86-1.05],0.3422003425578506
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL22RA1,Interleukin-22 receptor subunit alpha-1,8195,943,1.04 [0.92-1.18],0.5172246419470741
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL24,Interleukin-24,8195,943,0.94 [0.84-1.07],0.3569315994984797
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL25,Interleukin-25,6960,801,0.90 [0.74-1.10],0.322099214410539
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL2RA,Interleukin-2 receptor subunit alpha,8289,968,1.17 [1.02-1.34],0.0288732863423645
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL2RB,Interleukin-2 receptor subunit beta,8195,943,0.86 [0.73-1.02],0.0848740752980243
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL2RG,Cytokine receptor common subunit gamma,7208,827,0.89 [0.73-1.09],0.2495423432730546
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL3,Interleukin-3,6987,805,0.97 [0.88-1.08],0.5774806548672231
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL31,Interleukin-31,7008,809,0.91 [0.80-1.04],0.1754907054688997
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL31RA,Interleukin-31 receptor subunit alpha,6981,809,1.12 [0.93-1.34],0.2425860294918974
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL32,Interleukin-32,8335,971,0.94 [0.82-1.08],0.39469629960447
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL33,Interleukin-33,8195,943,1.04 [0.90-1.20],0.5976504557145701
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL34,Interleukin-34,8150,944,0.97 [0.83-1.14],0.7016046087943073
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL36A,Interleukin-36 alpha,7008,809,0.88 [0.77-1.01],0.0638540876542563
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL36G,Interleukin-36 gamma,6980,803,1.00 [0.91-1.11],0.9534870251021956
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL3RA,Interleukin-3 receptor subunit alpha,8195,943,1.11 [0.93-1.34],0.2440836038048294
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL4,Interleukin-4,8195,943,0.95 [0.89-1.00],0.0581734231955096
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL4R,Interleukin-4 receptor subunit alpha,8335,971,1.15 [0.98-1.34],0.0829399614347586
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL5,Interleukin-5,8195,943,1.02 [0.98-1.07],0.264412149590452
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL5RA,Interleukin-5 receptor subunit alpha,8335,971,0.89 [0.81-0.99],0.0273514488732109
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL6,Interleukin-6,8322,985,0.95 [0.88-1.03],0.1993560219135491
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL6R,Interleukin-6 receptor subunit alpha,8324,969,1.11 [0.94-1.31],0.2184305207725417
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL6ST,Interleukin-6 receptor subunit beta,8340,975,1.18 [0.85-1.64],0.3130650218296852
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL7,Interleukin-7,8335,971,0.96 [0.87-1.05],0.3295219744286221
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL7R,Interleukin-7 receptor subunit alpha,8360,976,1.11 [0.99-1.24],0.0656957862923364
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL9,Interleukin-9,7092,819,0.87 [0.76-1.00],0.0427160973163696
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,8150,943,1.00 [0.91-1.11],0.9262843409772428
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IMMT,MICOS complex subunit MIC60,7208,827,1.03 [0.88-1.19],0.7237508709081286
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IMPA1,Inositol monophosphatase 1,8266,970,0.91 [0.83-1.00],0.0527147916835847
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IMPACT,Protein IMPACT,7224,829,0.93 [0.82-1.05],0.2475346716889294
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IMPG1,Interphotoreceptor matrix proteoglycan 1,7032,801,0.97 [0.78-1.21],0.8020269041858719
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ING1,Inhibitor of growth protein 1,8152,944,1.01 [0.90-1.14],0.8620113555039866
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",INHBB,Inhibin beta B chain,7068,806,1.02 [0.90-1.16],0.7438404839119463
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",INHBC,Inhibin beta C chain,8360,976,0.97 [0.84-1.13],0.7019527740882915
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",INPP1,Inositol polyphosphate 1-phosphatase,8322,985,0.96 [0.87-1.07],0.5095627104094376
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",7030,808,0.95 [0.84-1.08],0.4326793628187363
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",7222,826,0.93 [0.79-1.10],0.417963130123459
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",8322,985,0.95 [0.90-1.01],0.1221687980899343
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",INSL3,Insulin-like 3,7224,829,1.01 [0.94-1.09],0.6997962593187261
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",INSL4,Early placenta insulin-like peptide,7208,827,1.02 [0.89-1.17],0.7980233678696138
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",INSL5,Insulin-like peptide INSL5,7204,827,0.97 [0.91-1.04],0.4387760829174383
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",INSR,Insulin receptor,7008,809,1.02 [0.68-1.52],0.9186141422982596
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IPCEF1,Interactor protein for cytohesin exchange factors 1,8252,970,0.97 [0.91-1.03],0.3171429443869733
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IQGAP2,Ras GTPase-activating-like protein IQGAP2,8322,985,0.97 [0.88-1.08],0.6230762022226828
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",8206,953,1.03 [0.96-1.09],0.4431481686138607
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IRAK1,Interleukin-1 receptor-associated kinase 1,8195,943,0.96 [0.88-1.04],0.2968450058685742
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IRAK4,Interleukin-1 receptor-associated kinase 4,8335,971,0.96 [0.91-1.02],0.1822228583036547
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,8049,931,0.99 [0.85-1.16],0.9305863247583424
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ISM1,Isthmin-1,8335,971,0.99 [0.85-1.14],0.854426803628652
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ISM2,Isthmin-2,7230,831,0.83 [0.71-0.98],0.0294881484043736
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IST1,IST1 homolog,7147,822,0.91 [0.85-0.98],0.0075850070864426
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGA11,Integrin alpha-11,8335,971,1.01 [0.85-1.19],0.9317696560233898
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGA2,Integrin alpha-2,7068,806,0.78 [0.64-0.95],0.0122386329380246
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGA5,Integrin alpha-5,8360,976,1.11 [0.88-1.39],0.3975565620389678
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGA6,Integrin alpha-6,8335,971,0.95 [0.85-1.07],0.4136903257892803
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGAL,Integrin alpha-L,7008,809,1.06 [0.91-1.24],0.4569469339580003
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGAM,Integrin alpha-M,8360,976,1.04 [0.87-1.24],0.6708226586215209
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGAV,Integrin alpha-V,8438,986,1.17 [0.83-1.65],0.3586632816215892
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGAX,Integrin alpha-X,7092,819,0.97 [0.86-1.11],0.6826626333920833
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGB1,Integrin beta-1,8357,973,0.83 [0.63-1.10],0.1943728025381152
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGB1BP1,Integrin beta-1-binding protein 1,8180,948,1.02 [0.88-1.18],0.8233803529957796
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGB1BP2,Integrin beta-1-binding protein 2,8206,953,0.96 [0.92-1.02],0.1754599002898881
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGB2,Integrin beta-2,8312,966,1.02 [0.83-1.25],0.8606104757056152
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGB5,Integrin beta-5,8384,984,0.91 [0.78-1.06],0.2368591020632466
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGB6,Integrin beta-6,8195,943,1.03 [0.85-1.24],0.7495252476974483
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGB7,Integrin beta-7,8438,986,1.07 [0.95-1.21],0.2918205499544669
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGBL1,Integrin beta-like protein 1,7230,831,0.96 [0.80-1.15],0.6403564635730457
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,7237,826,1.09 [0.76-1.57],0.6261578990560963
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,8395,979,0.98 [0.84-1.14],0.7792106671950082
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,7237,826,1.04 [0.79-1.37],0.7953621128403405
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,7208,827,1.02 [0.88-1.18],0.7830263293177576
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITM2A,Integral membrane protein 2A,8335,971,1.01 [0.92-1.10],0.8522619260581853
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITPA,Inosine triphosphate pyrophosphatase,6987,802,0.96 [0.87-1.07],0.4678354124445671
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",7030,808,0.90 [0.80-1.00],0.0484286443138506
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",7032,801,1.11 [0.96-1.29],0.1590963171410089
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",8164,946,0.96 [0.86-1.07],0.4731273273844815
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IZUMO1,Izumo sperm-egg fusion protein 1,6987,805,0.98 [0.84-1.14],0.7834426572745354
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",JAM2,Junctional adhesion molecule B,8412,980,1.12 [0.91-1.38],0.2864538992668325
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",JAM3,Junctional adhesion molecule C,7068,806,0.86 [0.74-0.99],0.0315958619543324
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",JCHAIN,Immunoglobulin J chain,8195,943,1.01 [0.92-1.11],0.7765447246353387
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,6987,805,1.04 [0.92-1.16],0.5442909814662422
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",JPT2,Jupiter microtubule associated homolog 2,7204,827,0.90 [0.83-0.97],0.0081971855459719
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",JUN,Transcription factor AP-1,8195,943,1.01 [0.90-1.14],0.8870233276337167
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,8322,985,1.09 [0.96-1.24],0.1777240420405307
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KAZN,Kazrin,7204,827,0.93 [0.88-1.00],0.0350980198621788
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KCNC4,Potassium voltage-gated channel subfamily C member 4,7032,801,0.92 [0.81-1.06],0.2385175069695581
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KCNH2,Potassium voltage-gated channel subfamily H member 2,7040,799,0.89 [0.80-0.99],0.0244355153991966
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KCNIP4,Kv channel-interacting protein 4,8164,946,0.91 [0.80-1.03],0.1415128758146238
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KCTD5,BTB/POZ domain-containing protein KCTD5,7091,815,1.01 [0.87-1.18],0.8839491843102677
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KDM3A,Lysine-specific demethylase 3A,7008,809,0.99 [0.92-1.07],0.8606816251069274
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KDR,Vascular endothelial growth factor receptor 2,8384,984,1.13 [0.91-1.42],0.276077500924199
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KEL,Kell blood group glycoprotein,8164,946,0.98 [0.84-1.15],0.8460428182347458
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KHDC3L,KH domain-containing protein 3,6987,805,1.03 [0.94-1.13],0.5728860993455809
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KHK,Ketohexokinase,7030,808,0.91 [0.82-1.02],0.1061600071821843
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIAA0319,Dyslexia-associated protein KIAA0319,7224,829,1.03 [0.83-1.28],0.7709986961715387
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIAA1549,UPF0606 protein KIAA1549,7092,819,0.96 [0.87-1.05],0.3732114474140448
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIAA1549L,UPF0606 protein KIAA1549L,7092,819,1.01 [0.80-1.29],0.9206643055262091
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIAA2013,Uncharacterized protein KIAA2013,7208,827,0.88 [0.77-1.02],0.0859927275235753
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIF1C,Kinesin-like protein KIF1C,6987,802,0.99 [0.80-1.22],0.9034475797205388
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIF20B,Kinesin-like protein KIF20B,7032,801,0.98 [0.90-1.08],0.7356060071851782
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIF22,Kinesin-like protein KIF22,6987,802,0.96 [0.91-1.02],0.1888262989374023
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIFBP,KIF-binding protein,8322,985,0.93 [0.87-0.99],0.0325936083829934
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,7208,827,0.98 [0.91-1.05],0.5886181029162026
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,8180,948,0.98 [0.91-1.05],0.5743420801495107
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,7204,827,1.00 [0.96-1.04],0.9808623005922048
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,8180,948,1.01 [0.96-1.05],0.728758479724364
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,6987,805,0.95 [0.87-1.04],0.2345325381091206
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIRREL1,Kin of IRRE-like protein 1,7032,801,0.92 [0.81-1.05],0.2313821636868161
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIRREL2,Kin of IRRE-like protein 2,8164,946,0.95 [0.82-1.10],0.4942537812600929
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIT,Mast/stem cell growth factor receptor Kit,8382,977,1.10 [0.91-1.33],0.3426638277385387
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KITLG,Kit ligand,8340,975,1.05 [0.90-1.22],0.5511396672935915
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLB,Beta-klotho,8164,946,0.99 [0.91-1.07],0.7313095255195607
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLF4,Krueppel-like factor 4,7032,801,1.04 [0.88-1.21],0.6683580390017716
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLHL41,Kelch-like protein 41,7222,826,1.03 [0.90-1.18],0.6468145959004024
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK1,Kallikrein-1,8280,968,1.00 [0.96-1.05],0.8376510358089189
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK10,Kallikrein-10,8364,982,0.98 [0.85-1.13],0.7906099809080487
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK11,Kallikrein-11,8302,975,1.29 [1.11-1.49],0.0009332024533964
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK12,Kallikrein-12,8180,948,1.01 [0.97-1.05],0.7368615926249638
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK13,Kallikrein-13,8188,971,0.96 [0.84-1.09],0.4978756049200882
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK14,Kallikrein-14,8438,986,1.10 [0.98-1.24],0.1064449068202394
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK15,Kallikrein-15,7193,826,1.31 [1.15-1.49],3.328250740622095e-05
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK3,Prostate-specific antigen,7230,831,1.93 [1.85-2.01],7.039882532473223e-201
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK4,Kallikrein-4,8438,986,1.02 [0.93-1.12],0.6463372008319235
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK6,Kallikrein-6,8368,981,1.19 [0.99-1.43],0.0582174533100755
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK7,Kallikrein-7,6883,786,0.90 [0.75-1.08],0.273534158135873
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK8,Kallikrein-8,8087,947,1.07 [0.91-1.25],0.4043294576761684
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLKB1,Plasma kallikrein,7086,814,1.06 [0.80-1.41],0.6737279153163502
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLRB1,Killer cell lectin-like receptor subfamily B member 1,8443,992,1.09 [0.94-1.26],0.246245455521323
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLRC1,NKG2-A/NKG2-B type II integral membrane protein,7032,801,0.87 [0.76-0.98],0.0282176743397357
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLRD1,Natural killer cells antigen CD94,8443,992,1.05 [0.93-1.18],0.4376568684606663
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLRF1,Killer cell lectin-like receptor subfamily F member 1,7008,809,1.08 [0.94-1.24],0.2549864016191431
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLRK1,NKG2-D type II integral membrane protein,7224,829,1.14 [0.99-1.31],0.0648609951087556
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KRT14,"Keratin, type I cytoskeletal 14",7920,927,1.01 [0.82-1.23],0.9437369117515778
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KRT17,"Keratin, type I cytoskeletal 17",6987,802,0.85 [0.70-1.02],0.0719526106537214
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KRT18,"Keratin, type I cytoskeletal 18",8322,985,1.00 [0.93-1.07],0.9729145667508516
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KRT19,"Keratin, type I cytoskeletal 19",8315,969,0.98 [0.90-1.07],0.6962339215895723
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KRT5,"Keratin, type II cytoskeletal 5",8164,946,0.94 [0.84-1.05],0.2900006818460255
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KRT6C,"Keratin, type II cytoskeletal 6C",6987,802,0.85 [0.69-1.04],0.1185938493431112
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KRT8,"Keratin, type II cytoskeletal 8",7032,801,0.99 [0.91-1.08],0.8215403151661901
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KYAT1,Kynurenine--oxoglutarate transaminase 1,8329,975,0.94 [0.85-1.04],0.2593677515577109
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KYNU,Kynureninase,8443,992,0.99 [0.87-1.13],0.9237870073547788
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",L1CAM,Neural cell adhesion molecule L1,8384,984,0.96 [0.79-1.16],0.6670307764928116
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,7231,828,0.89 [0.83-0.96],0.0037480661319712
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LACRT,Extracellular glycoprotein lacritin,7195,827,0.95 [0.82-1.10],0.5064400897812142
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LACTB2,Endoribonuclease LACTB2,8340,975,0.92 [0.84-1.01],0.0692348992182602
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAG3,Lymphocyte activation gene 3 protein,8322,985,1.07 [0.93-1.24],0.3460491549365617
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,8340,974,1.20 [1.05-1.38],0.0097106875047601
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,8266,970,1.06 [1.01-1.12],0.0278721747658823
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAMA1,Laminin subunit alpha-1,6987,802,0.87 [0.75-1.02],0.0860682423136483
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAMA4,Laminin subunit alpha-4,8377,979,0.99 [0.84-1.17],0.9498078539305328
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAMB1,Laminin subunit beta-1,7030,808,1.20 [0.96-1.50],0.1073375896003814
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAMP1,Lysosome-associated membrane glycoprotein 1,7041,807,1.01 [0.77-1.32],0.9568230765657856
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAMP2,Lysosome-associated membrane glycoprotein 2,8084,939,0.92 [0.69-1.21],0.5360207483863824
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAMP3,Lysosome-associated membrane glycoprotein 3,8430,991,0.95 [0.85-1.05],0.319515647102687
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAMTOR5,Ragulator complex protein LAMTOR5,7208,827,1.01 [0.86-1.20],0.8697506630601718
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAP3,Cytosol aminopeptidase,8195,943,0.90 [0.79-1.02],0.0954569330725686
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LARP1,La-related protein 1,7208,827,0.92 [0.83-1.03],0.1715045945443374
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAT,Linker for activation of T-cells family member 1,8443,992,0.96 [0.89-1.03],0.2342889242093919
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAT2,Linker for activation of T-cells family member 2,8322,985,0.97 [0.93-1.02],0.1960341540067145
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LATS1,Serine/threonine-protein kinase LATS1,7008,809,0.93 [0.86-1.01],0.0748237407938372
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAYN,Layilin,8254,968,1.09 [0.93-1.28],0.2726635680942532
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LBP,Lipopolysaccharide-binding protein,8395,979,0.86 [0.78-0.95],0.0020979197064029
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LBR,Delta(14)-sterol reductase LBR,8412,980,1.02 [0.94-1.10],0.655399715971373
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LCAT,Phosphatidylcholine-sterol acyltransferase,7238,823,0.98 [0.72-1.33],0.8890737930532071
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LCN15,Lipocalin-15,7222,826,1.01 [0.90-1.12],0.910261304118811
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LCN2,Neutrophil gelatinase-associated lipocalin,8112,947,1.01 [0.88-1.17],0.8512578238585511
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LCP1,Plastin-2,7230,831,1.01 [0.88-1.16],0.9152461779696928
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LDLR,Low-density lipoprotein receptor,8377,976,1.01 [0.90-1.13],0.917575250250946
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LDLRAP1,Low density lipoprotein receptor adapter protein 1,7222,826,0.93 [0.87-1.00],0.0374377558087704
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LECT2,Leukocyte cell-derived chemotaxin-2,7231,828,1.05 [0.95-1.16],0.3814426177934437
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LEFTY2,Left-right determination factor 2,8425,985,1.03 [0.92-1.15],0.5869799732960571
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LEG1,Protein LEG1 homolog,6851,784,0.95 [0.86-1.06],0.3666876274733242
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LELP1,Late cornified envelope-like proline-rich protein 1,7032,801,1.00 [0.91-1.11],0.941348152917046
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LEO1,RNA polymerase-associated protein LEO1,7222,826,0.79 [0.62-1.00],0.0503023405112513
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LEP,Leptin,8340,975,1.03 [0.94-1.12],0.5306838147710393
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LEPR,Leptin receptor,8340,975,1.01 [0.85-1.21],0.9045405749302752
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LETM1,Mitochondrial proton/calcium exchanger protein,7222,826,0.94 [0.83-1.07],0.328319449198089
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LGALS1,Galectin-1,8340,975,0.95 [0.81-1.12],0.5604663488779178
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LGALS3,Galectin-3,8384,977,1.05 [0.87-1.27],0.6117352588503042
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LGALS3BP,Galectin-3-binding protein,7237,826,1.12 [0.91-1.39],0.2774929470408345
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LGALS4,Galectin-4,8340,974,1.00 [0.91-1.11],0.9824483587172632
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LGALS7_LGALS7B,Galectin-7,8345,977,0.98 [0.86-1.12],0.7749064877834095
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LGALS8,Galectin-8,8412,980,0.93 [0.84-1.02],0.1296010352556358
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LGALS9,Galectin-9,8341,970,1.12 [0.93-1.35],0.24327660835222
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LGMN,Legumain,8377,979,1.02 [0.87-1.19],0.8066559033705107
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LHB,Lutropin subunit beta,8180,948,0.96 [0.90-1.02],0.2148298181230107
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,8348,974,1.02 [0.93-1.12],0.7003365807402897
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LIF,Leukemia inhibitory factor,8164,946,1.02 [0.91-1.14],0.7811045854928285
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LIFR,Leukemia inhibitory factor receptor,8335,971,0.99 [0.78-1.27],0.9664941893958932
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,8360,976,1.03 [0.88-1.20],0.7414295127990287
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,7230,831,1.00 [0.95-1.04],0.8424323248749648
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,6987,802,0.97 [0.84-1.11],0.6362945287769337
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,8328,973,1.35 [1.13-1.61],0.0007662798557841
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,7231,828,0.96 [0.88-1.05],0.4251528388702448
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,8458,987,1.16 [0.94-1.42],0.1645967521241664
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,8422,982,1.11 [0.94-1.31],0.2109750992964874
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,8195,943,1.04 [0.92-1.19],0.534404508450096
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,8458,987,1.01 [0.93-1.10],0.7949586356145477
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LIPF,Gastric triacylglycerol lipase,7030,808,0.96 [0.86-1.07],0.440220429665869
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LMNB1,Lamin-B1,7196,826,1.04 [0.93-1.15],0.508737157533955
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LMNB2,Lamin-B2,7224,829,1.13 [0.90-1.43],0.300820391142604
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LMOD1,Leiomodin-1,7222,826,1.11 [0.92-1.34],0.2894989586483439
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LMOD2,Leiomodin-2,7032,801,0.97 [0.87-1.09],0.6516968662495609
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LONP1,"Lon protease homolog, mitochondrial",7030,808,0.90 [0.83-0.98],0.0126360696159579
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LPA,Apolipoprotein(a),7079,809,1.03 [0.99-1.07],0.112929076933309
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LPCAT2,Lysophosphatidylcholine acyltransferase 2,8322,985,1.07 [0.95-1.21],0.2537870080821589
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LPL,Lipoprotein lipase,8340,975,0.97 [0.86-1.09],0.6162457928753009
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LPO,Lactoperoxidase,8043,947,1.01 [0.91-1.11],0.8954069830197801
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LPP,Lipoma-preferred partner,6987,802,0.90 [0.81-1.00],0.0451287334110045
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,6987,802,0.93 [0.84-1.03],0.1610156104899366
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,7040,799,1.01 [0.86-1.18],0.9194777731065468
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRG1,Leucine-rich alpha-2-glycoprotein,7237,826,1.27 [0.99-1.63],0.0622149171103263
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,8414,985,1.12 [0.96-1.32],0.1479804286510251
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,6986,807,0.95 [0.74-1.23],0.7098125626866821
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRP1,Prolow-density lipoprotein receptor-related protein 1,8322,985,0.94 [0.76-1.16],0.5422478076652631
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRP11,Low-density lipoprotein receptor-related protein 11,8340,975,1.21 [1.04-1.40],0.0146162889680261
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRP2,Low-density lipoprotein receptor-related protein 2,7040,799,0.97 [0.80-1.17],0.7187108217623428
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRP2BP,LRP2-binding protein,7040,799,0.95 [0.86-1.04],0.2411991724386862
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRPAP1,Alpha-2-macroglobulin receptor-associated protein,8412,980,0.94 [0.85-1.05],0.2764941875132158
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRRC25,Leucine-rich repeat-containing protein 25,8322,985,1.04 [0.90-1.19],0.6285931379285936
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRRC37A2,Leucine-rich repeat-containing protein 37A2,7204,827,1.03 [0.89-1.20],0.6857708838996157
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRRC38,Leucine-rich repeat-containing protein 38,7040,799,0.88 [0.76-1.02],0.09333815000732
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRRC59,Leucine-rich repeat-containing protein 59,7231,828,0.88 [0.76-1.02],0.0786916208324203
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,7208,827,0.88 [0.77-1.02],0.0882901007650081
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRRN1,Leucine-rich repeat neuronal protein 1,8195,943,0.99 [0.86-1.15],0.9242989890474456
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,7040,799,0.95 [0.80-1.12],0.5295483472502385
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,7222,826,0.83 [0.64-1.08],0.1762241700275907
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LSM1,U6 snRNA-associated Sm-like protein LSm1,8180,948,0.93 [0.83-1.04],0.2007134070497695
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LSM8,U6 snRNA-associated Sm-like protein LSm8,7092,819,1.01 [0.93-1.10],0.7813067202138646
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LSP1,Lymphocyte-specific protein 1,8335,971,1.05 [0.91-1.21],0.530850375646896
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LTA,Lymphotoxin-alpha,8335,971,1.05 [0.91-1.22],0.4761020082443677
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LTA4H,Leukotriene A-4 hydrolase,8438,986,1.13 [1.03-1.24],0.0094088552083065
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LTB,Lymphotoxin-beta,7208,827,1.11 [0.94-1.32],0.2245007828994109
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LTBP2,Latent-transforming growth factor beta-binding protein 2,8458,987,1.22 [1.02-1.47],0.0283196204484488
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LTBP3,Latent-transforming growth factor beta-binding protein 3,8180,948,1.07 [0.96-1.19],0.2388450856524792
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LTBR,Tumor necrosis factor receptor superfamily member 3,8303,968,1.39 [1.16-1.67],0.0003464909571626
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LTO1,Protein LTO1 homolog,8195,943,0.92 [0.79-1.07],0.2838680792956064
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LUZP2,Leucine zipper protein 2,7208,827,1.03 [0.89-1.19],0.7078066130782786
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LXN,Latexin,8232,967,1.03 [0.96-1.12],0.4006211279852271
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LY6D,Lymphocyte antigen 6D,8296,961,1.07 [0.93-1.24],0.3467027695827896
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LY75,Lymphocyte antigen 75,8335,971,0.97 [0.83-1.12],0.6348339783215158
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LY9,T-lymphocyte surface antigen Ly-9,8222,964,1.00 [0.82-1.22],0.991971925968682
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LY96,Lymphocyte antigen 96,8266,970,0.85 [0.73-1.00],0.0555375601125655
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LYAR,Cell growth-regulating nucleolar protein,8180,948,1.10 [1.00-1.21],0.0392098463141361
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LYN,Tyrosine-protein kinase Lyn,8322,985,0.95 [0.89-1.01],0.099516966657293
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LYPD1,Ly6/PLAUR domain-containing protein 1,8164,946,0.96 [0.87-1.06],0.4238294858624237
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LYPD3,Ly6/PLAUR domain-containing protein 3,8316,974,1.03 [0.87-1.22],0.7339868295317875
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LYPD8,Ly6/PLAUR domain-containing protein 8,8180,948,1.02 [0.91-1.14],0.7131945951811751
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LYPLA2,Acyl-protein thioesterase 2,7032,801,0.99 [0.93-1.06],0.8692985884691644
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,7040,799,1.00 [0.93-1.06],0.8910753929864262
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,7237,826,1.24 [0.88-1.75],0.2128342385093551
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LYZL2,Lysozyme-like protein 2,6987,805,0.87 [0.72-1.06],0.1701102257660063
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LZTFL1,Leucine zipper transcription factor-like protein 1,7068,806,0.91 [0.83-1.01],0.062966330029491
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",M6PR,Cation-dependent mannose-6-phosphate receptor,7030,808,0.80 [0.66-0.98],0.0326105840724732
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,8239,968,1.09 [0.98-1.21],0.1086104103536277
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAEA,E3 ubiquitin-protein transferase MAEA,8180,948,1.10 [0.94-1.27],0.2254426052745934
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAG,Myelin-associated glycoprotein,7040,799,0.88 [0.76-1.01],0.0664437637756482
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAGEA3,Melanoma-associated antigen 3,7092,819,0.95 [0.88-1.02],0.1746779350483021
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAGED1,Melanoma-associated antigen D1,8180,948,0.88 [0.78-1.00],0.0510220722263377
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAMDC2,MAM domain-containing protein 2,7231,828,1.15 [0.96-1.38],0.1353762666592386
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAMDC4,Apical endosomal glycoprotein,7208,827,0.99 [0.88-1.12],0.8842105721676158
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",7030,808,0.93 [0.71-1.21],0.5717076817437875
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAN2B2,Epididymis-specific alpha-mannosidase,7231,828,0.96 [0.86-1.08],0.5166969821583065
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",6987,805,0.97 [0.85-1.11],0.6367379203553338
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MANF,Mesencephalic astrocyte-derived neurotrophic factor,8377,979,0.97 [0.92-1.01],0.1604551912772047
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MANSC1,MANSC domain-containing protein 1,8384,984,1.20 [0.98-1.47],0.0789008258025027
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MANSC4,MANSC domain-containing protein 4,6987,802,1.03 [0.94-1.13],0.5016794244657339
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,7032,801,0.68 [0.55-0.85],0.0005294896787896
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,6987,802,0.94 [0.84-1.05],0.2687915918822488
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAP2,Microtubule-associated protein 2,7224,829,0.97 [0.84-1.13],0.7090972379170336
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,7204,827,0.90 [0.81-1.01],0.0620012625153564
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,8335,971,0.96 [0.91-1.02],0.188051270093674
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAP3K5,Mitogen-activated protein kinase kinase kinase 5,8180,948,0.99 [0.93-1.05],0.7192064863901704
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,8254,968,0.95 [0.91-1.00],0.0642527202219903
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAPK13,Mitogen-activated protein kinase 13,6987,805,1.08 [0.92-1.26],0.3417671868542785
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAPK9,Mitogen-activated protein kinase 9,8335,971,0.98 [0.85-1.12],0.7353396450803529
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAPKAPK2,MAP kinase-activated protein kinase 2,7092,819,0.92 [0.84-1.01],0.0736581904409235
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAPRE3,Microtubule-associated protein RP/EB family member 3,6987,805,0.96 [0.91-1.01],0.0856864306240811
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAPT,Microtubule-associated protein tau,8164,946,0.97 [0.86-1.08],0.5292813807778112
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MARCO,Macrophage receptor MARCO,8340,975,1.12 [0.90-1.40],0.3009893944688753
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MARS1,"Methionine--tRNA ligase, cytoplasmic",7058,806,0.93 [0.86-1.01],0.0803228407633328
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MASP1,Mannan-binding lectin serine protease 1,8254,968,1.00 [0.78-1.28],0.9904381704656556
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MATN2,Matrilin-2,8351,974,1.09 [0.90-1.33],0.3733469684245417
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MATN3,Matrilin-3,8252,970,1.05 [0.89-1.24],0.5759023136503494
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAVS,Mitochondrial antiviral-signaling protein,8180,948,0.96 [0.90-1.03],0.2696661458786553
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAX,Protein max,8164,946,0.96 [0.91-1.02],0.1536888464685911
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MB,Myoglobin,8458,987,1.13 [1.02-1.24],0.0165022706231902
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MBL2,Mannose-binding protein C,7141,818,1.02 [0.96-1.08],0.5485746486370836
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MCAM,Cell surface glycoprotein MUC18,8395,979,1.04 [0.88-1.24],0.6349278279158307
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",7222,826,0.97 [0.82-1.14],0.6923327495990879
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MCEMP1,Mast cell-expressed membrane protein 1,7008,809,0.90 [0.83-0.98],0.0114975199447459
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MCFD2,Multiple coagulation factor deficiency protein 2,8297,969,0.94 [0.83-1.07],0.3556106570947327
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MCTS1,Malignant T-cell-amplified sequence 1,7204,827,0.76 [0.58-1.00],0.0503751648238986
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,8266,970,1.02 [0.94-1.10],0.6954829434205112
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MDH1,"Malate dehydrogenase, cytoplasmic",7201,819,0.98 [0.82-1.16],0.8012516236479402
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MDK,Midkine,8355,979,0.90 [0.80-1.01],0.0607830705031374
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MDM1,Nuclear protein MDM1,7040,799,0.82 [0.66-1.03],0.0896167953234818
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",7030,808,0.90 [0.83-0.97],0.0060303467120538
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MED18,Mediator of RNA polymerase II transcription subunit 18,8180,948,0.95 [0.88-1.02],0.1770824855137169
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MED21,Mediator of RNA polymerase II transcription subunit 21,6987,802,0.78 [0.66-0.92],0.0036257971451742
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MEGF10,Multiple epidermal growth factor-like domains protein 10,8340,974,1.02 [0.88-1.17],0.8325049599643418
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MEGF11,Multiple epidermal growth factor-like domains protein 11,6987,802,0.82 [0.65-1.03],0.0830899242389038
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MEGF9,Multiple epidermal growth factor-like domains protein 9,8434,983,1.36 [1.01-1.84],0.0411976649668096
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MELTF,Melanotransferrin,7231,828,1.15 [0.92-1.42],0.2150291273018126
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MENT,Protein MENT,7068,806,0.75 [0.57-1.00],0.0516516875083569
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MEP1A,Meprin A subunit alpha,7204,827,0.95 [0.87-1.05],0.3198104887942403
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MEP1B,Meprin A subunit beta,8340,975,0.96 [0.91-1.01],0.0843415960324342
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MEPE,Matrix extracellular phosphoglycoprotein,8340,974,1.07 [0.84-1.36],0.5690158328530704
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MERTK,Tyrosine-protein kinase Mer,8443,992,1.16 [0.93-1.46],0.1923731150142034
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MESD,LRP chaperone MESD,8360,976,0.95 [0.91-1.00],0.0370304616372334
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MET,Hepatocyte growth factor receptor,8372,970,1.13 [0.84-1.50],0.4253749359213612
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",METAP1,Methionine aminopeptidase 1,8164,946,0.84 [0.68-1.03],0.086064570800168
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",METAP1D,"Methionine aminopeptidase 1D, mitochondrial",8335,971,0.92 [0.86-0.99],0.019020512133654
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",METAP2,Methionine aminopeptidase 2,8425,985,0.92 [0.83-1.01],0.0904569705931905
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MFAP3,Microfibril-associated glycoprotein 3,8206,953,0.99 [0.88-1.12],0.8997193818169994
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MFAP3L,Microfibrillar-associated protein 3-like,7040,799,1.01 [0.91-1.12],0.821626302991249
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MFAP4,Microfibril-associated glycoprotein 4,7068,806,0.86 [0.70-1.06],0.1612356827888601
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MFAP5,Microfibrillar-associated protein 5,8458,987,1.04 [0.90-1.19],0.5899679132705815
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MFGE8,Lactadherin,8360,976,0.86 [0.75-0.98],0.0253439653095633
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MGLL,Monoglyceride lipase,8365,974,0.95 [0.89-1.01],0.0925604546574513
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MGMT,Methylated-DNA--protein-cysteine methyltransferase,8335,971,0.99 [0.94-1.04],0.6629843454631497
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MIA,Melanoma-derived growth regulatory protein,8384,984,1.16 [0.99-1.34],0.0597923274368105
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MICALL2,MICAL-like protein 2,7040,799,0.97 [0.87-1.07],0.5193029767339401
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,8335,971,1.00 [0.96-1.04],0.957077235474966
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MIF,Macrophage migration inhibitory factor,8345,974,0.93 [0.85-1.01],0.0924508630468769
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MILR1,Allergin-1,8195,943,0.98 [0.87-1.09],0.6833754175003666
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,7208,827,0.94 [0.88-1.00],0.0407602200795285
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MINK1,Misshapen-like kinase 1,7224,829,0.92 [0.85-0.98],0.0151429058188866
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MITD1,MIT domain-containing protein 1,8266,970,0.95 [0.90-1.01],0.1222065963039898
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MKI67,Proliferation marker protein Ki-67,7008,809,1.11 [0.94-1.31],0.2144794534999851
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MLLT1,Protein ENL,6987,805,0.86 [0.77-0.96],0.0090469062637277
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MLN,Promotilin,8335,971,0.97 [0.91-1.04],0.4413800766517038
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MME,Neprilysin,8322,985,1.02 [0.95-1.10],0.6313421311700643
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MMP1,Interstitial collagenase,8059,943,0.99 [0.93-1.05],0.6679102044129857
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MMP10,Stromelysin-2,8323,968,0.97 [0.88-1.08],0.603002891268003
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MMP12,Macrophage metalloelastase,8374,978,0.99 [0.89-1.10],0.8696188718186736
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MMP13,Collagenase 3,8164,946,1.16 [0.97-1.39],0.097670239918951
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MMP15,Matrix metalloproteinase-15,7231,828,0.91 [0.78-1.07],0.2528994320566859
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MMP3,Stromelysin-1,8360,976,1.03 [0.92-1.15],0.6553123845034523
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MMP7,Matrilysin,8191,949,1.19 [1.05-1.34],0.0047913171260945
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MMP8,Neutrophil collagenase,8400,980,0.99 [0.92-1.07],0.8617337429991447
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MMP9,Matrix metalloproteinase-9,8349,973,0.98 [0.89-1.07],0.6311431572760116
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MMUT,"Methylmalonyl-CoA mutase, mitochondrial",6987,802,0.93 [0.81-1.07],0.3369355816383886
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MN1,Transcriptional activator MN1,7040,799,0.86 [0.75-0.98],0.0197712845973865
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MNAT1,CDK-activating kinase assembly factor MAT1,7092,819,1.01 [0.87-1.18],0.8527705795789065
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MNDA,Myeloid cell nuclear differentiation antigen,8327,974,1.06 [1.00-1.11],0.0453597854908329
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MOCS2,Molybdopterin synthase catalytic subunit,7068,806,0.88 [0.79-0.98],0.0203992432638853
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MOG,Myelin-oligodendrocyte glycoprotein,8438,986,1.12 [0.95-1.32],0.1824019505811442
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MORC3,MORC family CW-type zinc finger protein 3,7224,829,1.02 [0.80-1.31],0.8551237106572136
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MORF4L1,Mortality factor 4-like protein 1,7092,819,0.97 [0.82-1.16],0.7757495743671012
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MORF4L2,Mortality factor 4-like protein 2,6987,805,0.86 [0.71-1.04],0.1129559271464206
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MORN4,MORN repeat-containing protein 4,6987,805,0.98 [0.90-1.07],0.7036429211631965
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MPHOSPH8,M-phase phosphoprotein 8,8206,953,0.96 [0.88-1.03],0.2601594972905011
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MPI,Mannose-6-phosphate isomerase,8322,985,0.96 [0.89-1.02],0.2035444326528541
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,8365,974,0.94 [0.88-1.01],0.1188249517144847
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MPO,Myeloperoxidase,8360,976,1.01 [0.89-1.14],0.9148056405886392
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MPRIP,Myosin phosphatase Rho-interacting protein,7194,827,1.05 [0.90-1.23],0.5042245970145433
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MRC1,Macrophage mannose receptor 1,7238,823,0.91 [0.72-1.16],0.4490530759609064
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MRI1,Methylthioribose-1-phosphate isomerase,7040,799,1.00 [0.90-1.10],0.9493720292008032
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MRPL24,"39S ribosomal protein L24, mitochondrial",6987,802,0.90 [0.74-1.09],0.2854045456824748
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MRPL28,"39S ribosomal protein L28, mitochondrial",7222,826,1.01 [0.85-1.20],0.9317966043407424
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MRPL46,"39S ribosomal protein L46, mitochondrial",8164,946,0.88 [0.71-1.10],0.2595796825806186
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MRPL52,"39S ribosomal protein L52, mitochondrial",6970,804,0.71 [0.54-0.94],0.015552960723306
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",7222,826,0.96 [0.88-1.06],0.4591849088527961
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MRPS16,"28S ribosomal protein S16, mitochondrial",7008,809,0.91 [0.71-1.17],0.4514818166394241
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MSLN,Mesothelin,8307,983,1.03 [0.94-1.13],0.5280572172239499
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MSLNL,Mesothelin-like protein,7040,799,1.05 [0.88-1.25],0.5870870276346651
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MSMB,Beta-microseminoprotein,8357,975,1.09 [1.00-1.18],0.0378327102486945
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MSR1,Macrophage scavenger receptor types I and II,8412,980,0.99 [0.87-1.11],0.8288839980677921
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MSRA,Mitochondrial peptide methionine sulfoxide reductase,8384,984,0.94 [0.87-1.02],0.1604363417976202
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MST1,Hepatocyte growth factor-like protein,7127,813,0.98 [0.89-1.07],0.6240768649972268
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MSTN,Growth/differentiation factor 8,8206,953,1.03 [0.93-1.15],0.5972201530040937
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MTDH,Protein LYRIC,7008,809,0.93 [0.87-1.00],0.0608014580130024
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",7224,829,0.61 [0.45-0.81],0.0007969845685415
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,7092,819,0.95 [0.90-1.01],0.1321949375735533
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MTIF3,"Translation initiation factor IF-3, mitochondrial",7204,827,0.87 [0.80-0.94],0.00043829002872
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MTPN,Myotrophin,8206,953,1.03 [0.87-1.22],0.7298350514450543
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MTR,Methionine synthase,6987,802,0.90 [0.81-1.01],0.0665421723489074
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MTSS1,Protein MTSS 1,7204,827,0.95 [0.89-1.00],0.069905603935737
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MTSS2,Protein MTSS 2,7208,827,0.93 [0.87-0.99],0.0330888410774436
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MTUS1,Microtubule-associated tumor suppressor 1,7092,819,1.02 [0.90-1.15],0.7923803470747995
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MUC13,Mucin-13,8164,946,0.91 [0.81-1.02],0.1139772126110656
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MUC16,Mucin-16,8322,985,1.03 [0.99-1.06],0.110750755951522
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MUC2,Mucin-2,7230,831,0.90 [0.84-0.97],0.0042137229026058
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MUCL3,Mucin-like protein 3,6987,805,0.93 [0.79-1.10],0.4232474000362729
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MVK,Mevalonate kinase,8195,943,0.96 [0.89-1.03],0.2748077735797711
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MXRA8,Matrix remodeling-associated protein 8,7068,806,1.02 [0.82-1.28],0.8346968324182567
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYBPC1,"Myosin-binding protein C, slow-type",7231,828,1.13 [1.04-1.23],0.0040034230607274
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYBPC2,"Myosin-binding protein C, fast-type",7030,808,1.05 [0.97-1.13],0.2132043034450375
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYCBP2,E3 ubiquitin-protein ligase MYCBP2,7222,826,0.93 [0.83-1.03],0.1569484354203707
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYDGF,Myeloid-derived growth factor,7231,828,0.92 [0.86-0.99],0.0235404909113564
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYH4,Myosin-4,6987,802,0.81 [0.68-0.95],0.0125018778191378
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYH7B,Myosin-7B,6987,805,1.02 [0.87-1.19],0.84331764577333
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYH9,Myosin-9,7230,831,0.91 [0.86-0.96],0.001385285112163
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYL1,"Myosin light chain 1/3, skeletal muscle isoform",6987,802,1.08 [0.90-1.29],0.4070331251652501
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYL3,Myosin light chain 3,7030,808,1.12 [1.03-1.23],0.0114713773805766
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYL4,Myosin light chain 4,7030,808,1.05 [0.93-1.19],0.4277657437993573
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYL6B,Myosin light chain 6B,7040,799,0.96 [0.89-1.04],0.2799991263011487
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",7040,799,0.98 [0.86-1.11],0.7336272895287637
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYO6,Unconventional myosin-VI,7222,826,0.85 [0.70-1.04],0.1087732857187807
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYO9B,Unconventional myosin-IXb,8195,943,0.99 [0.90-1.08],0.7381357876415294
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYOC,Myocilin,8360,976,1.04 [0.91-1.18],0.578012574555513
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYOM1,Myomesin-1,7032,801,1.06 [0.92-1.22],0.4244479471993557
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYOM2,Myomesin-2,6987,802,1.02 [0.90-1.16],0.7122959706047014
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYOM3,Myomesin-3,7068,806,1.05 [0.97-1.12],0.2326115297346527
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MZB1,Marginal zone B- and B1-cell-specific protein,8363,979,0.84 [0.75-0.94],0.0028733896691934
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MZT1,Mitotic-spindle organizing protein 1,8180,948,0.98 [0.88-1.10],0.7403222857459322
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NAA10,N-alpha-acetyltransferase 10,6987,802,0.93 [0.81-1.06],0.2687839124769524
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NAA80,N-alpha-acetyltransferase 80,7040,799,0.92 [0.87-0.97],0.0045147043085286
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NAAA,N-acylethanolamine-hydrolyzing acid amidase,8231,967,1.03 [0.93-1.13],0.5985811940704622
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NACC1,Nucleus accumbens-associated protein 1,7208,827,0.94 [0.83-1.06],0.3013696037599215
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NADK,NAD kinase,8340,975,1.06 [0.96-1.17],0.2470345740977625
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NAGA,Alpha-N-acetylgalactosaminidase,6995,809,0.97 [0.86-1.10],0.6443456479767937
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NAGK,N-acetyl-D-glucosamine kinase,7015,807,0.99 [0.88-1.12],0.8843972724025118
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,7068,806,0.91 [0.66-1.25],0.5602203337625449
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NAMPT,Nicotinamide phosphoribosyltransferase,8180,948,1.08 [0.97-1.19],0.152847009073243
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NAP1L4,Nucleosome assembly protein 1-like 4,7187,826,0.89 [0.76-1.04],0.1444262443870512
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NAPRT,Nicotinate phosphoribosyltransferase,7224,829,0.93 [0.76-1.14],0.4792854494669207
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NARS1,"Asparagine--tRNA ligase, cytoplasmic",7222,826,0.84 [0.73-0.97],0.0167032276097645
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NBL1,Neuroblastoma suppressor of tumorigenicity 1,8384,984,1.17 [0.95-1.44],0.131619192491858
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NBN,Nibrin,8195,943,1.13 [1.03-1.24],0.0121007534495636
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NCAM1,Neural cell adhesion molecule 1,8395,979,0.93 [0.78-1.10],0.38785781359522
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NCAM2,Neural cell adhesion molecule 2,8360,976,0.97 [0.79-1.19],0.7746351554289129
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NCAN,Neurocan core protein,8412,980,1.01 [0.87-1.18],0.8558498352226027
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NCF2,Neutrophil cytosol factor 2,8321,971,1.03 [0.97-1.10],0.3101230745682946
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NCK2,Cytoplasmic protein NCK2,8377,979,0.97 [0.92-1.02],0.2357806219269149
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NCLN,Nicalin,8195,943,0.97 [0.86-1.09],0.5945863266211275
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NCR1,Natural cytotoxicity triggering receptor 1,8322,970,1.09 [0.94-1.27],0.2469198238205224
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,7204,827,1.07 [0.88-1.29],0.5002000311305455
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NCS1,Neuronal calcium sensor 1,8438,986,1.05 [0.86-1.28],0.6441654944188707
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NDRG1,Protein NDRG1,8164,946,0.98 [0.89-1.08],0.7071670000251605
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,7208,827,1.02 [0.91-1.13],0.7715828518398666
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,7001,809,0.92 [0.76-1.12],0.4153395279146473
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,7204,827,0.89 [0.82-0.96],0.0027813561310683
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",8180,948,0.96 [0.89-1.04],0.2753997016871811
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NEB,Nebulin,6987,802,1.09 [0.92-1.30],0.3232438137448163
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NECAP2,Adaptin ear-binding coat-associated protein 2,6987,802,0.88 [0.79-0.99],0.0265366037805378
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NECTIN1,Nectin-1,7008,809,1.00 [0.81-1.23],0.97008932499307
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NECTIN2,Nectin-2,8328,973,1.18 [0.99-1.42],0.0655243838198227
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NECTIN4,Nectin-4,8384,984,1.22 [1.04-1.45],0.0166274002067542
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,7008,809,0.94 [0.82-1.08],0.359824881100015
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NEDD9,Enhancer of filamentation 1,7008,809,1.11 [0.92-1.34],0.2653220711982217
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NEFL,Neurofilament light polypeptide,8143,944,1.11 [0.99-1.26],0.0809741401897061
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NEK7,Serine/threonine-protein kinase Nek7,7092,819,0.93 [0.84-1.02],0.1314809885850578
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NELL1,Protein kinase C-binding protein NELL1,8384,984,1.01 [0.88-1.16],0.8928702935485389
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NELL2,Protein kinase C-binding protein NELL2,8377,979,0.86 [0.71-1.04],0.1269838239059659
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NENF,Neudesin,7208,827,0.90 [0.84-0.96],0.0019952892128814
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NEO1,Neogenin,7222,826,1.04 [0.78-1.38],0.8051731484072986
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NEXN,Nexilin,7238,823,0.94 [0.85-1.04],0.2434545453643377
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NFASC,Neurofascin,8443,992,0.94 [0.77-1.14],0.5333480014062635
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NFAT5,Nuclear factor of activated T-cells 5,7008,809,0.96 [0.88-1.04],0.3475197392329415
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",8335,971,0.96 [0.91-1.02],0.2261596225374822
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",8195,943,0.98 [0.89-1.07],0.6150704053380838
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NFE2,Transcription factor NF-E2 45 kDa subunit,7030,808,0.93 [0.84-1.02],0.1131510207181319
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NFIC,Nuclear factor 1 C-type,7222,826,0.84 [0.71-1.00],0.0509712935493533
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NFKB1,Nuclear factor NF-kappa-B p105 subunit,6987,802,0.93 [0.85-1.03],0.1595621669259556
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NFKB2,Nuclear factor NF-kappa-B p100 subunit,7092,819,1.03 [0.92-1.16],0.5952923452110563
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NFKBIE,NF-kappa-B inhibitor epsilon,8180,948,1.04 [0.92-1.17],0.5653878021354314
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",7204,827,0.89 [0.84-0.95],0.0008340453898648
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NFX1,Transcriptional repressor NF-X1,6987,802,0.91 [0.82-1.01],0.0764249524005329
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NFYA,Nuclear transcription factor Y subunit alpha,6987,802,0.95 [0.79-1.13],0.5675057024868804
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NGF,Beta-nerve growth factor,8266,970,0.97 [0.62-1.53],0.8915626933365302
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NGFR,Tumor necrosis factor receptor superfamily member 16,7231,828,1.07 [0.86-1.33],0.5421579207475116
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NGRN,Neugrin,7224,829,0.90 [0.66-1.21],0.4750112631901639
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NHLRC3,NHL repeat-containing protein 3,6875,785,0.80 [0.64-1.00],0.0489128975285917
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NID1,Nidogen-1,8370,976,0.94 [0.80-1.10],0.4140840901476442
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NID2,Nidogen-2,8360,976,0.93 [0.86-1.01],0.0826585706948503
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NINJ1,Ninjurin-1,8180,948,1.04 [0.94-1.16],0.4133087282134383
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NIT1,Deaminated glutathione amidase,7030,808,0.93 [0.80-1.08],0.3687608424871945
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NIT2,Omega-amidase NIT2,7208,823,0.88 [0.80-0.97],0.009862575749853
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NLGN1,Neuroligin-1,7040,799,0.89 [0.79-1.00],0.0493982636565748
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NLGN2,Neuroligin-2,7032,801,0.93 [0.80-1.09],0.3922823227960549
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NME1,Nucleoside diphosphate kinase A,7008,809,0.84 [0.61-1.16],0.2912103310872748
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NME3,Nucleoside diphosphate kinase 3,8351,974,0.85 [0.66-1.09],0.2002745304587813
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NMI,N-myc-interactor,7186,826,0.98 [0.89-1.08],0.6727395277225832
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,8266,970,1.07 [0.99-1.15],0.0714166245473671
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NMRK2,Nicotinamide riboside kinase 2,6987,805,0.95 [0.79-1.14],0.573474621645276
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NMT1,Glycylpeptide N-tetradecanoyltransferase 1,7222,826,0.83 [0.74-0.93],0.0011242580109733
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NOMO1,Nodal modulator 1,8360,976,0.94 [0.73-1.20],0.6098097756890957
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NOP56,Nucleolar protein 56,6987,802,1.01 [0.96-1.08],0.6363634163803247
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NOS1,"Nitric oxide synthase, brain",8164,946,1.09 [0.99-1.20],0.0921285050534576
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NOS2,"Nitric oxide synthase, inducible",6987,802,0.92 [0.77-1.09],0.3264769249180844
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NOS3,"Nitric oxide synthase, endothelial",8164,946,1.07 [0.96-1.19],0.250150676191047
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NOTCH1,Neurogenic locus notch homolog protein 1,8458,987,1.35 [0.95-1.92],0.0916378804808182
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NOTCH2,Neurogenic locus notch homolog protein 2,7230,831,0.94 [0.69-1.28],0.683821105914621
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NOTCH3,Neurogenic locus notch homolog protein 3,8458,987,1.03 [0.87-1.22],0.7455426395282129
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPC2,NPC intracellular cholesterol transporter 2,7118,817,1.15 [0.94-1.42],0.1816517092097796
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPDC1,Neural proliferation differentiation and control protein 1,8340,975,1.18 [1.00-1.40],0.0504146427721344
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPHS1,Nephrin,7008,809,0.83 [0.67-1.02],0.0756579884164328
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPHS2,Podocin,7008,809,1.04 [0.98-1.11],0.2175335523216692
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPL,N-acetylneuraminate lyase,7231,828,1.01 [0.88-1.17],0.855781439814012
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPPB,Natriuretic peptides B,8206,953,0.99 [0.96-1.03],0.7543883569400839
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPPC,C-type natriuretic peptide,8335,971,0.98 [0.88-1.10],0.7206597209631158
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPR1,Atrial natriuretic peptide receptor 1,6987,802,0.87 [0.73-1.05],0.1436649522444767
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPTN,Neuroplastin,8180,948,1.00 [0.93-1.08],0.9988596259112636
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPTX1,Neuronal pentraxin-1,8360,976,0.94 [0.82-1.08],0.3851556164252278
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPTX2,Neuronal pentraxin-2,7230,831,0.99 [0.81-1.22],0.959242649269549
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPTXR,Neuronal pentraxin receptor,8340,975,1.09 [0.93-1.29],0.2897786662423608
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPY,Pro-neuropeptide Y,8438,986,0.97 [0.89-1.06],0.461243178756521
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NRCAM,Neuronal cell adhesion molecule,8340,975,1.07 [0.87-1.30],0.5346604133322281
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NRGN,Neurogranin,7238,823,0.89 [0.83-0.96],0.0025319067131398
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NRN1,Neuritin,7222,826,0.95 [0.79-1.16],0.6343920549864512
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NRP1,Neuropilin-1,8404,979,0.97 [0.79-1.20],0.7768537370229784
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NRP2,Neuropilin-2,8360,976,1.05 [0.86-1.28],0.6245733048767251
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NRTN,Neurturin,8195,943,0.92 [0.82-1.04],0.1839944935002641
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NRXN3,Neurexin-3,7040,799,0.89 [0.73-1.10],0.2755770043199651
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NSFL1C,NSFL1 cofactor p47,8412,980,0.97 [0.89-1.06],0.5036869389132841
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",7231,828,0.88 [0.81-0.97],0.0090505520253367
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NT5C1A,Cytosolic 5'-nucleotidase 1A,7224,829,1.13 [0.93-1.38],0.2284971154866281
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NT5C3A,Cytosolic 5'-nucleotidase 3A,8322,971,0.96 [0.90-1.03],0.2523558791322266
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NT5E,5'-nucleotidase,8384,984,1.08 [0.97-1.20],0.1558040627336823
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NTF3,Neurotrophin-3,8335,971,0.95 [0.80-1.11],0.5106964223213522
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NTF4,Neurotrophin-4,8180,948,1.01 [0.85-1.19],0.9494851581229926
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NTRK2,BDNF/NT-3 growth factors receptor,8340,975,1.10 [0.88-1.38],0.3794258684787566
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NTRK3,NT-3 growth factor receptor,8412,980,1.32 [1.01-1.72],0.0386414875838728
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NTproBNP,N-terminal prohormone of brain natriuretic peptide,8340,975,1.01 [0.96-1.06],0.7836203817894067
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NUB1,NEDD8 ultimate buster 1,8335,971,0.99 [0.92-1.06],0.7071612010656025
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,7208,827,0.93 [0.87-1.00],0.0614475133662262
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NUCB2,Nucleobindin-2,8418,984,0.91 [0.78-1.06],0.2369927573714289
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NUDC,Nuclear migration protein nudC,8443,992,0.97 [0.89-1.06],0.5410098343046843
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,7030,808,0.79 [0.58-1.06],0.116401763540919
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NUDT15,Nucleotide triphosphate diphosphatase NUDT15,6987,802,0.85 [0.73-0.99],0.0334961391310986
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NUDT16,U8 snoRNA-decapping enzyme,7189,824,0.90 [0.83-0.97],0.007437199089804
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],8322,985,0.92 [0.83-1.02],0.0989684725101893
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NUDT5,ADP-sugar pyrophosphatase,8360,976,0.92 [0.82-1.03],0.1587121293261434
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NUMB,Protein numb homolog,7008,809,0.90 [0.83-0.98],0.0173859873873293
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NUP50,Nuclear pore complex protein Nup50,6987,802,0.81 [0.64-1.02],0.0690205283616796
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NXPE4,NXPE family member 4,6987,802,0.98 [0.78-1.22],0.8443211722092958
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NXPH1,Neurexophilin-1,8164,946,1.07 [0.93-1.24],0.3277312103790902
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NXPH3,Neurexophilin-3,7008,809,1.04 [0.83-1.30],0.7500489348811633
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OBP2B,Odorant-binding protein 2b,8244,969,1.05 [0.95-1.16],0.3716063456958683
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OCLN,Occludin,7222,826,1.12 [0.96-1.31],0.1432560342539751
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ODAM,Odontogenic ameloblast-associated protein,8150,944,1.01 [0.91-1.12],0.8944750519061299
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OFD1,Oral-facial-digital syndrome 1 protein,7092,819,1.04 [0.93-1.15],0.5036096193730746
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OGA,Protein O-GlcNAcase,7204,827,0.86 [0.78-0.95],0.0025664859154131
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OGFR,Opioid growth factor receptor,8322,985,1.03 [0.86-1.23],0.7301005120937161
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OGN,Mimecan,8360,976,1.11 [0.98-1.27],0.1123277239649438
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,7092,819,0.95 [0.85-1.06],0.3666105189652799
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OLFM4,Olfactomedin-4,6794,782,1.00 [0.94-1.06],0.9820113298449338
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OLR1,Oxidized low-density lipoprotein receptor 1,8255,968,1.03 [0.94-1.13],0.5513713872384477
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OMD,Osteomodulin,8377,979,1.10 [0.95-1.26],0.1918514949793536
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OMG,Oligodendrocyte-myelin glycoprotein,8322,985,1.03 [0.95-1.12],0.4143685646056385
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OMP,Olfactory marker protein,7032,801,0.95 [0.82-1.10],0.523208656556041
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OPHN1,Oligophrenin-1,7224,829,0.93 [0.87-0.99],0.0214022058589216
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OPLAH,5-oxoprolinase,7030,808,0.85 [0.77-0.94],0.0017885843589243
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OPTC,Opticin,8322,985,0.94 [0.83-1.07],0.3611925296803858
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ORM1,Alpha-1-acid glycoprotein 1,7205,821,1.17 [0.84-1.64],0.3568388000318477
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OSBPL2,Oxysterol-binding protein-related protein 2,7224,829,0.95 [0.80-1.14],0.6158764753126761
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OSCAR,Osteoclast-associated immunoglobulin-like receptor,8351,974,1.10 [0.93-1.29],0.274168314243747
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OSM,Oncostatin-M,8297,968,0.98 [0.90-1.06],0.5994992267544339
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OSMR,Oncostatin-M-specific receptor subunit beta,8404,979,1.01 [0.76-1.35],0.945020603397136
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OSTN,Osteocrin,7040,799,1.03 [0.88-1.22],0.6834968907864891
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OTOA,Otoancorin,7032,801,0.99 [0.86-1.12],0.8287843087136599
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OTUD6B,Deubiquitinase OTUD6B,7204,827,0.84 [0.75-0.95],0.0050630017376108
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OTUD7B,OTU domain-containing protein 7B,7222,826,0.89 [0.80-0.99],0.0327970888261296
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",7030,808,0.91 [0.83-1.01],0.0737366841952244
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OXT,Oxytocin-neurophysin 1,8412,980,0.98 [0.95-1.02],0.437442469277469
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",P4HB,Protein disulfide-isomerase,8313,970,0.90 [0.78-1.05],0.1735789235752167
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PACS2,Phosphofurin acidic cluster sorting protein 2,6987,802,0.88 [0.79-0.99],0.0332234663511808
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PADI2,Protein-arginine deiminase type-2,8195,943,0.95 [0.85-1.06],0.3431083029125416
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PADI4,Protein-arginine deiminase type-4,8150,944,1.09 [1.02-1.17],0.0132977175764986
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PAEP,Glycodelin,8266,970,1.03 [0.97-1.08],0.3530003739423591
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,7222,826,0.95 [0.90-1.01],0.1147553957608309
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",7092,819,0.89 [0.77-1.02],0.0968624987609994
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,8206,953,1.02 [0.92-1.14],0.6677549028866785
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PAGR1,PAXIP1-associated glutamate-rich protein 1,7030,808,0.93 [0.79-1.10],0.3995286417476336
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PAIP2B,Polyadenylate-binding protein-interacting protein 2B,6979,804,0.93 [0.82-1.07],0.310723780732362
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PAK4,Serine/threonine-protein kinase PAK 4,8164,946,0.92 [0.83-1.02],0.097721175336233
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PALLD,Palladin,7008,809,0.94 [0.78-1.13],0.4999764598899592
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PALM,Paralemmin-1,7160,822,1.08 [0.87-1.34],0.4721142828068163
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PALM2,Paralemmin-2,7224,829,1.14 [0.96-1.36],0.1389310536488178
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PALM3,Paralemmin-3,6987,802,0.91 [0.82-1.00],0.0594030509124462
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PAM,Peptidyl-glycine alpha-amidating monooxygenase,8421,981,1.23 [1.00-1.51],0.0455277978577853
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PAMR1,Inactive serine protease PAMR1,8360,976,0.92 [0.74-1.14],0.4208793572227007
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PAPPA,Pappalysin-1,8195,943,0.88 [0.78-1.00],0.0450085583378763
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PARD3,Partitioning defective 3 homolog,7092,819,0.92 [0.84-1.01],0.0867462127914654
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PARK7,Parkinson disease protein 7,8360,976,0.92 [0.82-1.03],0.1492157221995474
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PARP1,Poly [ADP-ribose] polymerase 1,8335,971,1.11 [1.01-1.21],0.0281790311583373
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PAXX,Protein PAXX,7068,806,0.97 [0.83-1.13],0.700367328094199
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PBK,Lymphokine-activated killer T-cell-originated protein kinase,6987,805,1.00 [0.81-1.25],0.9688519950927276
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PBLD,Phenazine biosynthesis-like domain-containing protein,8164,946,1.02 [0.91-1.15],0.68109737968951
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,7204,827,0.90 [0.71-1.12],0.3403781970381404
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCARE,Photoreceptor cilium actin regulator,7032,801,0.96 [0.88-1.04],0.3055661637774609
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCBD1,Pterin-4-alpha-carbinolamine dehydratase,7054,806,0.98 [0.84-1.14],0.8126981843193354
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCBP2,Poly(rC)-binding protein 2,7222,826,0.87 [0.79-0.95],0.003328506553121
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCDH1,Protocadherin-1,8414,987,1.11 [0.84-1.45],0.4586694398748439
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCDH12,Protocadherin-12,7222,826,0.84 [0.65-1.10],0.2011250857393112
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCDH17,Protocadherin-17,8340,975,1.05 [0.90-1.23],0.5215293401160915
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCDH7,Protocadherin-7,7204,827,0.95 [0.78-1.15],0.5793486982167071
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCDH9,Protocadherin-9,7204,827,1.00 [0.82-1.22],0.9865667668987652
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCDHB15,Protocadherin beta-15,7208,827,0.95 [0.80-1.12],0.52808780750027
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCNA,Proliferating cell nuclear antigen,6987,805,0.91 [0.81-1.02],0.1108492516551523
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCSK7,Proprotein convertase subtilisin/kexin type 7,7208,827,1.03 [0.89-1.18],0.7060219959633754
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCSK9,Proprotein convertase subtilisin/kexin type 9,8458,987,0.96 [0.83-1.10],0.5480632393874042
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCYT2,Ethanolamine-phosphate cytidylyltransferase,7204,827,0.91 [0.83-0.99],0.0372124956942983
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDAP1,28 kDa heat- and acid-stable phosphoprotein,7231,828,0.90 [0.84-0.96],0.0029642259193671
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDCD1,Programmed cell death protein 1,8421,983,1.13 [0.98-1.29],0.0868901663800128
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDCD1LG2,Programmed cell death 1 ligand 2,8322,985,1.03 [0.87-1.24],0.7134128927619419
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDCD5,Programmed cell death protein 5,8412,980,0.95 [0.86-1.05],0.2832850559588771
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDCD6,Programmed cell death protein 6,8340,975,0.98 [0.90-1.06],0.5553515190962159
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDCL2,Phosducin-like protein 2,6987,805,0.96 [0.84-1.10],0.5664084722401947
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",6987,805,1.06 [0.94-1.20],0.33790509489461
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",6987,802,0.94 [0.83-1.07],0.3395248692934495
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",7068,806,0.93 [0.88-1.00],0.0377267484346839
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDGFA,Platelet-derived growth factor subunit A,8458,987,0.97 [0.90-1.05],0.4538198334821839
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDGFB,Platelet-derived growth factor subunit B,8377,979,0.99 [0.92-1.05],0.6731778923615521
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDGFC,Platelet-derived growth factor C,8180,948,1.03 [0.83-1.28],0.7673266887016795
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDGFRA,Platelet-derived growth factor receptor alpha,8340,975,1.23 [1.01-1.50],0.0431432080324119
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDGFRB,Platelet-derived growth factor receptor beta,8458,987,1.05 [0.89-1.24],0.5325934379134865
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDIA2,Protein disulfide-isomerase A2,6987,805,0.82 [0.68-0.98],0.032300973301249
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDIA3,Protein disulfide-isomerase A3,7068,806,0.83 [0.62-1.10],0.1861138783483203
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDIA4,Protein disulfide-isomerase A4,7230,831,0.89 [0.79-1.00],0.0409072433022666
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDIA5,Protein disulfide-isomerase A5,6987,805,0.98 [0.87-1.10],0.6837873227139029
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDLIM5,PDZ and LIM domain protein 5,7222,826,0.95 [0.89-1.00],0.0526845990942532
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDLIM7,PDZ and LIM domain protein 7,8377,979,0.97 [0.93-1.02],0.2505180372303285
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",8180,948,0.89 [0.79-1.01],0.0824004135203542
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDRG1,p53 and DNA damage-regulated protein 1,7040,799,0.82 [0.71-0.95],0.0091170069610052
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,6987,805,1.03 [0.92-1.16],0.5777271444766354
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDZD2,PDZ domain-containing protein 2,6987,802,0.94 [0.83-1.06],0.3083064362515079
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,7008,809,1.14 [0.98-1.33],0.0863136305160916
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PEAR1,Platelet endothelial aggregation receptor 1,8458,987,1.02 [0.80-1.30],0.9000451069137466
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PEBP1,Phosphatidylethanolamine-binding protein 1,8360,976,0.94 [0.85-1.04],0.207898324217258
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PECAM1,Platelet endothelial cell adhesion molecule,8360,976,0.90 [0.74-1.09],0.2693196761169556
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PECR,Peroxisomal trans-2-enoyl-CoA reductase,7030,808,0.83 [0.63-1.09],0.1733861237221607
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PENK,Proenkephalin-A,7068,806,0.93 [0.74-1.16],0.4975196032895145
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PEPD,Xaa-Pro dipeptidase,7238,823,1.01 [0.78-1.31],0.9230654271058464
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PER3,Period circadian protein homolog 3,7008,809,0.99 [0.94-1.05],0.8176508132754522
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PF4,Platelet factor 4,7179,818,0.97 [0.91-1.04],0.4491415107605103
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PFDN2,Prefoldin subunit 2,8164,946,0.98 [0.88-1.08],0.6473361632851977
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PFDN4,Prefoldin subunit 4,6987,805,0.81 [0.70-0.93],0.0037499760590238
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PFDN6,Prefoldin subunit 6,7040,799,0.91 [0.81-1.02],0.1064165609127337
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",8311,985,0.97 [0.90-1.04],0.4000105791222446
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PGA4,Pepsin A-4,7238,823,1.00 [0.92-1.09],0.9553992091744988
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PGD,"6-phosphogluconate dehydrogenase, decarboxylating",7231,828,0.95 [0.84-1.08],0.4551056048434605
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PGF,Placenta growth factor,8443,992,1.12 [0.91-1.39],0.2841443624009392
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PGLYRP1,Peptidoglycan recognition protein 1,8422,982,1.12 [0.98-1.27],0.0872302108108119
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PGLYRP2,N-acetylmuramoyl-L-alanine amidase,7153,820,0.74 [0.59-0.93],0.0103856283864295
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PGLYRP4,Peptidoglycan recognition protein 4,6987,802,1.07 [0.95-1.19],0.2493451205295321
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PGM2,Phosphoglucomutase-2,7040,799,0.95 [0.84-1.07],0.3813921594173781
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PGR,Progesterone receptor,7008,809,0.98 [0.92-1.05],0.6055113207186862
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PHACTR2,Phosphatase and actin regulator 2,7222,826,0.92 [0.87-0.98],0.0072183809889459
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PHLDB1,Pleckstrin homology-like domain family B member 1,7204,827,1.03 [0.91-1.18],0.623093907089129
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PHLDB2,Pleckstrin homology-like domain family B member 2,6987,805,0.96 [0.89-1.04],0.2776966135020342
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,8266,970,1.13 [0.93-1.37],0.2304142972345166
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,7068,806,0.85 [0.72-1.00],0.0472055137023346
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PI16,Peptidase inhibitor 16,7238,823,0.96 [0.73-1.26],0.7505004430368891
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PI3,Elafin,8254,960,0.92 [0.83-1.03],0.1356171151731371
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",7222,826,0.90 [0.83-0.99],0.021913442901709
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PIGR,Polymeric immunoglobulin receptor,8253,962,1.06 [0.90-1.25],0.4848232977213221
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,8335,971,1.00 [0.91-1.10],0.982763892919032
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,8360,976,1.23 [1.02-1.49],0.030133217538311
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,7008,809,1.04 [0.92-1.17],0.5777715556392744
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PILRA,Paired immunoglobulin-like type 2 receptor alpha,8360,976,1.17 [1.03-1.34],0.0200823353284743
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PILRB,Paired immunoglobulin-like type 2 receptor beta,8340,975,1.12 [1.01-1.24],0.0255818985079018
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,7068,806,0.96 [0.88-1.06],0.4608640242745493
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PITHD1,PITH domain-containing protein 1,6979,804,1.02 [0.94-1.12],0.6268728209476508
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PKD1,Polycystin-1,7231,828,0.98 [0.77-1.26],0.901088976720563
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PKD2,Polycystin-2,6987,802,0.93 [0.83-1.06],0.2836792891426968
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PKLR,Pyruvate kinase PKLR,8352,972,1.05 [0.96-1.14],0.2829262082810759
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PKN3,Serine/threonine-protein kinase N3,7092,819,0.93 [0.85-1.03],0.1545908603286406
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLA2G10,Group 10 secretory phospholipase A2,8266,970,0.93 [0.84-1.03],0.1709793713358232
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLA2G15,Phospholipase A2 group XV,8384,984,1.03 [0.83-1.27],0.8108978481290576
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLA2G1B,Phospholipase A2,8450,987,1.06 [0.94-1.20],0.3507374600468462
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLA2G2A,"Phospholipase A2, membrane associated",8359,977,1.08 [0.97-1.20],0.1854895051241094
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLA2G4A,Cytosolic phospholipase A2,8377,979,0.94 [0.88-1.00],0.0591386179110279
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLA2G7,Platelet-activating factor acetylhydrolase,8360,976,1.00 [0.85-1.19],0.9543854970704452
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLAT,Tissue-type plasminogen activator,8434,983,0.96 [0.86-1.08],0.5027907024143693
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLAU,Urokinase-type plasminogen activator,8360,976,1.03 [0.85-1.24],0.7604012659627288
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLAUR,Urokinase plasminogen activator surface receptor,8294,967,1.08 [0.88-1.33],0.4800561680682386
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLB1,"Phospholipase B1, membrane-associated",7224,829,0.98 [0.88-1.10],0.7206245096530305
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",7008,809,1.03 [0.88-1.21],0.72415568417113
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",7224,829,0.91 [0.85-0.98],0.0075247861203657
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLEKHO1,Pleckstrin homology domain-containing family O member 1,7224,829,0.90 [0.82-0.99],0.0383868398579775
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLG,Plasminogen,7059,807,0.79 [0.58-1.09],0.1574830389787543
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLIN1,Perilipin-1,8164,946,1.11 [0.94-1.30],0.2125852107517027
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLIN3,Perilipin-3,8340,975,1.01 [0.88-1.16],0.8840746428957071
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLPBP,Pyridoxal phosphate homeostasis protein,8340,975,0.94 [0.86-1.03],0.1741447564603083
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLSCR3,Phospholipid scramblase 3,7208,823,0.93 [0.83-1.05],0.2556929468117607
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLTP,Phospholipid transfer protein,8434,984,1.04 [0.89-1.21],0.6371601078569893
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLXDC1,Plexin domain-containing protein 1,8180,948,0.95 [0.79-1.15],0.5967050285184039
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLXDC2,Plexin domain-containing protein 2,7224,829,0.74 [0.57-0.95],0.0207177916443755
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLXNA4,Plexin-A4,8335,971,0.93 [0.87-1.00],0.0569805038504054
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLXNB2,Plexin-B2,8419,978,1.11 [0.88-1.39],0.396120933246629
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLXNB3,Plexin-B3,8314,972,0.94 [0.83-1.06],0.3011020697330594
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,8297,971,0.98 [0.95-1.01],0.2405313976366916
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PMCH,Pro-MCH,6987,802,1.03 [0.95-1.12],0.419191261166975
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PMM2,Phosphomannomutase 2,6987,802,0.83 [0.74-0.93],0.0019585565298906
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PMS1,PMS1 protein homolog 1,7040,799,0.91 [0.79-1.05],0.178040997796953
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PMVK,Phosphomevalonate kinase,8150,943,0.95 [0.90-1.00],0.0566490183147171
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PNLIP,Pancreatic triacylglycerol lipase,7238,823,1.00 [0.90-1.11],0.9855111084531112
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PNLIPRP1,Inactive pancreatic lipase-related protein 1,7224,829,1.03 [0.95-1.12],0.4157070071429932
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PNLIPRP2,Pancreatic lipase-related protein 2,8340,974,1.02 [1.00-1.04],0.1042921990603291
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PNMA1,Paraneoplastic antigen Ma1,7030,808,0.79 [0.70-0.90],0.0004174407062983
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PNMA2,Paraneoplastic antigen Ma2,7032,801,1.06 [0.91-1.22],0.451628978121525
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",8195,943,1.00 [0.95-1.05],0.9550730746902542
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PODXL,Podocalyxin,8322,985,1.12 [0.77-1.62],0.5569934108810677
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PODXL2,Podocalyxin-like protein 2,8384,984,1.13 [0.93-1.38],0.2191052187621817
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",POF1B,Protein POF1B,7008,809,0.99 [0.85-1.15],0.8789912639832208
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",POLR2A,DNA-directed RNA polymerase II subunit RPB1,7008,809,0.91 [0.72-1.15],0.422311570376118
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",8322,985,1.13 [0.97-1.32],0.112048562069925
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",POMC,Pro-opiomelanocortin,7030,808,0.90 [0.82-1.00],0.0400680390164445
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PON1,Serum paraoxonase/arylesterase 1,7238,823,1.42 [1.10-1.82],0.0065331854210521
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PON2,Serum paraoxonase/arylesterase 2,8206,953,0.94 [0.80-1.10],0.4308469973918019
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PON3,Serum paraoxonase/lactonase 3,8377,979,0.91 [0.76-1.10],0.3341830633920232
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",POSTN,Periostin,7230,831,1.03 [0.86-1.23],0.7315047962967074
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPBP,Platelet basic protein,7182,820,0.93 [0.85-1.00],0.0554018421385046
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPCDC,Phosphopantothenoylcysteine decarboxylase,8412,980,0.94 [0.83-1.06],0.2982643132196079
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPIB,Peptidyl-prolyl cis-trans isomerase B,8368,976,0.95 [0.89-1.00],0.0673137076148039
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPIE,Peptidyl-prolyl cis-trans isomerase E,7092,819,0.89 [0.79-1.01],0.0657013872741949
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",7230,831,0.85 [0.76-0.95],0.005430140175114
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPL,Periplakin,7008,809,1.02 [0.82-1.26],0.8871068213242538
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPM1A,Protein phosphatase 1A,8180,948,0.96 [0.80-1.15],0.6633714406660527
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPM1B,Protein phosphatase 1B,7008,809,0.95 [0.85-1.07],0.4195049283750659
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPM1F,Protein phosphatase 1F,7231,828,0.86 [0.75-0.97],0.0175124976196278
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPME1,Protein phosphatase methylesterase 1,8322,985,0.97 [0.89-1.07],0.5877836275809465
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,7208,827,0.90 [0.83-0.98],0.0140896730716231
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,8384,984,0.96 [0.90-1.02],0.1457842035045231
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,7092,819,0.94 [0.85-1.04],0.2323063638328288
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,7222,826,0.90 [0.82-0.98],0.0156944538085194
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,7222,826,0.95 [0.80-1.13],0.5801992095708507
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPP1R2,Protein phosphatase inhibitor 2,8340,975,0.95 [0.88-1.02],0.1550585918704433
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPP1R9B,Neurabin-2,8443,992,0.98 [0.92-1.04],0.4138254336353394
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,7204,827,0.97 [0.91-1.02],0.215784255557273
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPP3R1,Calcineurin subunit B type 1,8266,970,0.95 [0.82-1.09],0.4641073866234482
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPT1,Palmitoyl-protein thioesterase 1,7040,799,1.03 [0.95-1.13],0.4806302166336506
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPY,Pancreatic prohormone,8340,978,1.00 [0.94-1.05],0.8712424031445007
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PQBP1,Polyglutamine-binding protein 1,8180,948,1.07 [0.98-1.18],0.1418977824657699
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRAME,Melanoma antigen preferentially expressed in tumors,6987,805,0.90 [0.69-1.19],0.4663830700205663
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRAP1,Proline-rich acidic protein 1,7230,831,0.90 [0.76-1.07],0.2348420098733048
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRC1,Protein regulator of cytokinesis 1,7208,827,0.99 [0.86-1.15],0.9469403963579625
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRCP,Lysosomal Pro-X carboxypeptidase,8407,979,1.07 [0.90-1.28],0.4594029764059041
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRDX1,Peroxiredoxin-1,8096,951,0.98 [0.92-1.05],0.5871354050877404
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRDX2,Peroxiredoxin-2,7108,810,1.08 [0.97-1.20],0.1768693729354883
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",8195,943,0.91 [0.84-0.99],0.0327113324828542
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRDX5,"Peroxiredoxin-5, mitochondrial",8443,992,0.96 [0.88-1.04],0.3061354797275471
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRDX6,Peroxiredoxin-6,8438,986,1.00 [0.91-1.09],0.9745643951110544
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PREB,Prolactin regulatory element-binding protein,8195,943,1.07 [0.88-1.31],0.497697852945801
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRELP,Prolargin,8340,974,1.10 [0.86-1.40],0.4553257063986171
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRG2,Bone marrow proteoglycan,7230,831,1.04 [0.92-1.19],0.524237492062644
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRG3,Proteoglycan 3,7230,831,0.94 [0.82-1.08],0.4005584375979691
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRKAB1,5'-AMP-activated protein kinase subunit beta-1,8195,943,0.99 [0.89-1.10],0.8322452379756633
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,7040,799,0.67 [0.53-0.85],0.0009891800569455
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,8340,975,0.91 [0.85-0.97],0.0061765944632249
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,7209,828,0.93 [0.86-1.02],0.1120574115292498
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRKCQ,Protein kinase C theta type,8195,943,0.97 [0.84-1.11],0.6140363435931226
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRKD2,Serine/threonine-protein kinase D2,6987,802,0.86 [0.72-1.03],0.094009204604148
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRKG1,cGMP-dependent protein kinase 1,7068,806,0.95 [0.90-1.00],0.0668787364947646
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,8180,948,0.97 [0.89-1.06],0.5376745594621877
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRL,Prolactin,8412,980,1.02 [0.95-1.10],0.6087363196809756
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRND,Prion-like protein doppel,7224,829,1.03 [0.90-1.19],0.6501733166597017
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PROC,Vitamin K-dependent protein C,8382,977,0.98 [0.78-1.22],0.8297316401301078
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PROCR,Endothelial protein C receptor,6987,802,0.87 [0.69-1.09],0.2235073704251734
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PROK1,Prokineticin-1,8335,971,0.95 [0.85-1.06],0.3829015584101762
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PROS1,Vitamin K-dependent protein S,7237,826,1.05 [0.81-1.36],0.6918867914861841
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRR4,Proline-rich protein 4,7021,801,0.98 [0.89-1.08],0.739433238455613
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRR5,Proline-rich protein 5,7008,809,1.08 [0.93-1.24],0.308062414927265
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRRT3,Proline-rich transmembrane protein 3,7030,808,1.11 [0.93-1.33],0.2350068481556355
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRSS2,Trypsin-2,8395,979,1.09 [0.99-1.21],0.0710870429289367
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRSS22,Brain-specific serine protease 4,7008,809,1.06 [0.87-1.29],0.5456403660074319
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRSS27,Serine protease 27,8317,972,1.05 [0.91-1.21],0.5191395098365061
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRSS53,Serine protease 53,7224,829,0.93 [0.78-1.11],0.4054018397921676
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRSS8,Prostasin,8313,967,1.07 [0.93-1.23],0.3597414564136967
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,8164,946,0.96 [0.91-1.01],0.0969027333263216
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRTG,Protogenin,8438,986,0.96 [0.76-1.20],0.6975854211079074
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRTN3,Myeloblastin,8138,947,1.08 [0.97-1.21],0.1689987845013742
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRUNE2,Protein prune homolog 2,7092,819,0.80 [0.63-1.02],0.0776794274620363
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSAP,Prosaposin,7168,823,0.98 [0.76-1.26],0.8748111139750682
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSAPL1,Proactivator polypeptide-like 1,7204,827,0.96 [0.84-1.10],0.583060433670686
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSCA,Prostate stem cell antigen,7204,827,1.02 [0.99-1.05],0.1587997778527237
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSG1,Pregnancy-specific beta-1-glycoprotein 1,8266,970,1.01 [0.97-1.07],0.5723554958765907
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSIP1,PC4 and SFRS1-interacting protein,8335,971,1.05 [0.97-1.15],0.2337284276010683
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSMA1,Proteasome subunit alpha type-1,8180,948,0.97 [0.85-1.11],0.6588659680727768
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSMC3,26S proteasome regulatory subunit 6A,6987,805,0.92 [0.74-1.15],0.490304391931644
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSMD1,26S proteasome non-ATPase regulatory subunit 1,7222,826,0.92 [0.80-1.06],0.2503834655448008
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSMD5,26S proteasome non-ATPase regulatory subunit 5,7040,799,0.94 [0.82-1.07],0.3463253115892394
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSMD9,26S proteasome non-ATPase regulatory subunit 9,8322,985,1.04 [0.94-1.15],0.4055985546475874
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSME1,Proteasome activator complex subunit 1,8242,967,1.00 [0.85-1.16],0.9728592376939708
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSME2,Proteasome activator complex subunit 2,8228,960,1.10 [0.94-1.29],0.2406709949500192
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSMG3,Proteasome assembly chaperone 3,8335,971,1.01 [0.90-1.13],0.8909422151040325
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSMG4,Proteasome assembly chaperone 4,7008,809,1.03 [0.92-1.16],0.6360478377248096
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSPN,Persephin,8335,971,0.97 [0.91-1.03],0.3619495387763397
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSRC1,Proline/serine-rich coiled-coil protein 1,8180,948,0.99 [0.90-1.10],0.9088719333352692
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,6826,782,0.92 [0.86-0.98],0.0081559822339441
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",8164,946,0.90 [0.74-1.09],0.2621911788160309
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTGDS,Prostaglandin-H2 D-isomerase,8307,968,1.05 [0.88-1.26],0.5777038818235807
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTGES2,Prostaglandin E synthase 2,6961,807,0.91 [0.80-1.04],0.1522264022033084
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTGR1,Prostaglandin reductase 1,7231,828,1.00 [0.92-1.08],0.928174198615555
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTH,Parathyroid hormone,7040,799,0.99 [0.91-1.07],0.7677364287143521
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,8335,971,0.99 [0.86-1.16],0.9369408278479772
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTK7,Inactive tyrosine-protein kinase 7,8164,946,1.01 [0.87-1.18],0.8758717060945462
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTN,Pleiotrophin,8206,953,0.98 [0.87-1.10],0.7353240414530098
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTP4A3,Protein tyrosine phosphatase type IVA 3,7008,809,0.97 [0.85-1.11],0.6734766029066226
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPN1,Tyrosine-protein phosphatase non-receptor type 1,8266,970,0.99 [0.92-1.06],0.7504165727257813
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPN6,Tyrosine-protein phosphatase non-receptor type 6,8365,974,0.95 [0.90-1.02],0.1400472364405345
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPN9,Tyrosine-protein phosphatase non-receptor type 9,6997,807,1.00 [0.84-1.19],0.9553426249581196
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPRB,Receptor-type tyrosine-protein phosphatase beta,7231,828,1.08 [0.86-1.35],0.5149036952606048
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPRC,Receptor-type tyrosine-protein phosphatase C,7230,831,0.99 [0.74-1.33],0.966559270185103
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPRF,Receptor-type tyrosine-protein phosphatase F,8458,987,1.14 [0.94-1.38],0.1985911477294761
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPRH,Receptor-type tyrosine-protein phosphatase H,7204,827,0.94 [0.82-1.08],0.3628365242799721
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPRK,Receptor-type tyrosine-protein phosphatase kappa,7204,827,0.87 [0.63-1.20],0.3891163216706029
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPRM,Receptor-type tyrosine-protein phosphatase mu,8321,969,0.85 [0.67-1.08],0.1855724599163278
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,8241,968,1.22 [1.03-1.44],0.0233423152503974
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPRR,Receptor-type tyrosine-protein phosphatase R,7224,829,1.00 [0.84-1.20],0.95744153528265
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPRS,Receptor-type tyrosine-protein phosphatase S,8458,987,1.39 [1.11-1.73],0.0037177672906677
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,7231,828,0.94 [0.76-1.16],0.5461783317001925
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,7068,806,0.92 [0.82-1.03],0.1434450490316535
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTS,6-pyruvoyl tetrahydrobiopterin synthase,8119,941,1.08 [0.97-1.20],0.1698682274583263
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTTG1,Securin,7092,819,0.94 [0.79-1.11],0.447078954847212
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTX3,Pentraxin-related protein PTX3,8335,971,0.98 [0.88-1.10],0.74761576896395
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PVALB,Parvalbumin alpha,8399,984,0.97 [0.92-1.02],0.1906639983144483
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PVR,Poliovirus receptor,8412,980,1.04 [0.89-1.22],0.582439569531013
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PXDNL,Peroxidasin-like protein,7208,827,0.96 [0.85-1.09],0.5484067779329073
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PXN,Paxillin,8164,946,1.10 [0.99-1.22],0.077490820043216
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PYDC1,Pyrin domain-containing protein 1,7030,808,0.98 [0.83-1.16],0.8246964169614099
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PYY,Peptide YY,6987,802,0.94 [0.88-1.01],0.0905540720589358
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PZP,Pregnancy zone protein,7237,826,0.99 [0.82-1.20],0.920555001323402
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",QDPR,Dihydropteridine reductase,8302,968,0.95 [0.83-1.09],0.4732506089311755
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",QPCT,Glutaminyl-peptide cyclotransferase,8369,973,1.09 [0.88-1.35],0.4242226141353824
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",QSOX1,Sulfhydryl oxidase 1,7095,811,1.06 [0.90-1.25],0.4595133024971197
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAB10,Ras-related protein Rab-10,7231,828,0.79 [0.70-0.90],0.0004465763860496
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAB11FIP3,Rab11 family-interacting protein 3,7231,828,0.94 [0.88-1.00],0.0453674020205753
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAB27B,Ras-related protein Rab-27B,7231,828,0.90 [0.83-0.97],0.0092209034262175
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAB2B,Ras-related protein Rab-2B,7208,827,0.87 [0.78-0.97],0.0140530262183801
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAB33A,Ras-related protein Rab-33A,6987,802,0.91 [0.82-1.01],0.0870269813213714
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAB37,Ras-related protein Rab-37,8195,943,1.02 [0.95-1.10],0.5926975367157268
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAB39B,Ras-related protein Rab-39B,6987,802,1.01 [0.94-1.09],0.7977162634645281
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,7032,801,0.84 [0.74-0.97],0.0153076259228904
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAB44,Ras-related protein Rab-44,7208,827,1.08 [0.94-1.24],0.2688094986938263
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAB6A,Ras-related protein Rab-6A,8335,971,1.05 [0.93-1.20],0.4359444121210796
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAB6B,Ras-related protein Rab-6B,8164,946,1.02 [0.90-1.15],0.7871826406182892
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RABEP1,Rab GTPase-binding effector protein 1,7068,806,0.91 [0.83-1.00],0.0544177691909412
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RABEPK,Rab9 effector protein with kelch motifs,8180,948,1.03 [0.93-1.14],0.5438053252176774
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RABGAP1L,Rab GTPase-activating protein 1-like,8195,943,0.96 [0.87-1.06],0.4589224414355648
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAC3,Ras-related C3 botulinum toxin substrate 3,7040,799,0.95 [0.86-1.06],0.395482158192152
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAD23B,UV excision repair protein RAD23 homolog B,8180,948,0.89 [0.78-1.02],0.0838573692197751
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAD51,DNA repair protein RAD51 homolog 1,7092,819,0.97 [0.85-1.10],0.6390919683919438
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RALB,Ras-related protein Ral-B,7008,809,1.03 [0.82-1.30],0.772016616032245
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RALY,RNA-binding protein Raly,7208,827,1.06 [0.93-1.21],0.3847315098578512
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RANBP1,Ran-specific GTPase-activating protein,7030,808,0.93 [0.82-1.06],0.2944955039868593
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RANBP2,E3 SUMO-protein ligase RanBP2,7032,801,0.77 [0.62-0.95],0.015856277265541
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RANGAP1,Ran GTPase-activating protein 1,8180,948,0.99 [0.87-1.12],0.8785981671517136
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAP1A,Ras-related protein Rap-1A,7008,809,0.93 [0.83-1.03],0.1772453782826783
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAPGEF2,Rap guanine nucleotide exchange factor 2,7092,819,0.84 [0.73-0.96],0.0121303331449723
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RARRES1,Retinoic acid receptor responder protein 1,8180,948,1.06 [0.89-1.27],0.4847419360361672
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RARRES2,Retinoic acid receptor responder protein 2,8404,979,0.97 [0.86-1.09],0.587611181071561
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RASA1,Ras GTPase-activating protein 1,8164,946,0.88 [0.74-1.06],0.1828497546204892
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,6987,805,0.87 [0.74-1.03],0.0983858006077095
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RASSF2,Ras association domain-containing protein 2,8180,948,1.08 [0.99-1.19],0.0992791705092418
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RBFOX3,RNA binding protein fox-1 homolog 3,7222,826,1.17 [0.99-1.38],0.0673572455031175
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RBKS,Ribokinase,8146,960,1.07 [0.96-1.20],0.2309487583775294
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RBM17,Splicing factor 45,7222,826,0.88 [0.81-0.97],0.0063643108386726
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RBM19,Probable RNA-binding protein 19,6987,802,1.01 [0.87-1.18],0.8700827702384691
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RBM25,RNA-binding protein 25,6987,805,0.98 [0.85-1.14],0.8227653006359179
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RBP1,Retinol-binding protein 1,7040,799,0.90 [0.81-1.01],0.0680994850185693
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RBP2,Retinol-binding protein 2,8322,985,0.99 [0.92-1.07],0.8864302151741844
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RBP5,Retinol-binding protein 5,8322,985,1.11 [1.00-1.23],0.046199535219843
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RBP7,Retinoid-binding protein 7,7204,827,1.10 [0.99-1.22],0.0757963241061701
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RBPMS,RNA-binding protein with multiple splicing,7008,809,1.02 [0.92-1.13],0.7091816457157183
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RBPMS2,RNA-binding protein with multiple splicing 2,7030,808,0.95 [0.89-1.02],0.1456046494826446
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RCC1,Regulator of chromosome condensation,7208,827,0.99 [0.87-1.14],0.9418810434852144
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RCOR1,REST corepressor 1,8206,953,1.05 [0.92-1.20],0.4838545542675423
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,7030,808,0.85 [0.62-1.16],0.2989864234279227
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",REEP4,Receptor expression-enhancing protein 4,7222,826,0.90 [0.81-1.01],0.0682678886423365
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",REG1A,Lithostathine-1-alpha,8312,969,0.95 [0.85-1.07],0.4096406557326353
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",REG1B,Lithostathine-1-beta,8458,987,0.98 [0.89-1.08],0.6863764220143916
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",REG3A,Regenerating islet-derived protein 3-alpha,8458,987,1.03 [0.95-1.13],0.4710005346626944
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",REG3G,Regenerating islet-derived protein 3-gamma,7208,827,1.07 [0.91-1.26],0.4330918831985604
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",REG4,Regenerating islet-derived protein 4,8351,974,1.09 [0.98-1.22],0.1132473207115662
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RELB,Transcription factor RelB,7008,809,0.93 [0.80-1.08],0.3194508708313561
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RELT,Tumor necrosis factor receptor superfamily member 19L,8360,976,1.13 [0.93-1.36],0.2182811300492828
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",REN,Renin,8340,975,0.90 [0.84-0.96],0.0021638375150851
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",REPS1,RalBP1-associated Eps domain-containing protein 1,7008,809,1.13 [0.96-1.33],0.1563130523815403
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",REST,RE1-silencing transcription factor,6987,805,0.95 [0.78-1.16],0.6058170664600224
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,8322,985,0.97 [0.83-1.13],0.6764831418188162
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RETN,Resistin,8334,971,1.18 [1.03-1.34],0.0128452523975026
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",REXO2,"Oligoribonuclease, mitochondrial",6987,802,0.85 [0.73-0.99],0.0429180425501179
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RFC4,Replication factor C subunit 4,7208,827,0.81 [0.59-1.12],0.2099805241991879
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RGCC,Regulator of cell cycle RGCC,7222,826,0.88 [0.81-0.97],0.0061503907521679
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RGL2,Ral guanine nucleotide dissociation stimulator-like 2,7092,819,0.97 [0.87-1.08],0.5382937414355706
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RGMA,Repulsive guidance molecule A,8412,980,1.02 [0.86-1.22],0.8201389576883702
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RGMB,RGM domain family member B,8412,980,1.09 [0.90-1.33],0.3735047648075164
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RGS10,Regulator of G-protein signaling 10,7222,826,0.84 [0.75-0.94],0.0035770377870723
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RGS8,Regulator of G-protein signaling 8,8195,943,1.04 [0.96-1.14],0.305956601333392
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RHOC,Rho-related GTP-binding protein RhoC,8219,964,0.96 [0.92-1.01],0.1104212818394525
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RICTOR,Rapamycin-insensitive companion of mTOR,7008,809,1.00 [0.87-1.16],0.9677244722245272
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,7068,806,1.02 [0.89-1.17],0.7815912898992744
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RILP,Rab-interacting lysosomal protein,8414,985,0.98 [0.89-1.08],0.6530268125281881
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RILPL2,RILP-like protein 2,7231,828,0.93 [0.87-1.00],0.0482330360360696
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RIPK4,Receptor-interacting serine/threonine-protein kinase 4,6987,802,0.95 [0.86-1.06],0.385540251442129
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RLN1,Prorelaxin H1,7222,826,0.97 [0.83-1.14],0.7267800198972287
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RLN2,Prorelaxin H2,7057,803,1.14 [1.01-1.28],0.0355779557165928
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNASE1,Ribonuclease pancreatic,7238,823,1.11 [0.86-1.44],0.4173696370191599
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNASE10,Inactive ribonuclease-like protein 10,7030,808,0.93 [0.81-1.08],0.3393457920883039
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNASE3,Eosinophil cationic protein,8304,971,1.03 [0.98-1.09],0.1782113460128672
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNASE4,Ribonuclease 4,6996,794,1.11 [0.87-1.42],0.4108613777492237
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNASE6,Ribonuclease K6,7187,817,1.10 [0.90-1.34],0.3716845602316241
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNASEH2A,Ribonuclease H2 subunit A,7222,826,0.82 [0.71-0.96],0.0118651158708316
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNASET2,Ribonuclease T2,8419,981,1.25 [1.02-1.54],0.0353784082629758
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNF149,E3 ubiquitin-protein ligase RNF149,7030,808,1.10 [0.89-1.37],0.3900696647352898
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNF168,E3 ubiquitin-protein ligase RNF168,7008,809,1.10 [0.94-1.29],0.2390038072440591
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNF31,E3 ubiquitin-protein ligase RNF31,7008,809,1.04 [0.87-1.24],0.6411216029210074
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNF4,E3 ubiquitin-protein ligase RNF4,7092,819,1.00 [0.90-1.10],0.938327616496092
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNF41,E3 ubiquitin-protein ligase NRDP1,8180,948,0.97 [0.89-1.06],0.5370145439901793
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNF43,E3 ubiquitin-protein ligase RNF43,7092,819,0.96 [0.85-1.09],0.5151956765625443
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNF5,E3 ubiquitin-protein ligase RNF5,7030,808,0.88 [0.80-0.96],0.0050361049072969
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ROBO1,Roundabout homolog 1,8351,974,0.91 [0.71-1.15],0.4264144251252242
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ROBO2,Roundabout homolog 2,8412,980,0.93 [0.73-1.20],0.5814434969445867
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ROBO4,Roundabout homolog 4,7030,808,1.08 [0.74-1.58],0.6859099134953863
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,8340,975,1.24 [1.04-1.48],0.0158527650516799
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RP2,Protein XRP2,8322,985,0.91 [0.79-1.04],0.1522223121108287
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RPA2,Replication protein A 32 kDa subunit,7008,809,0.89 [0.71-1.12],0.3332834209704289
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RPE,Ribulose-phosphate 3-epimerase,7092,819,0.86 [0.78-0.95],0.0028651410565664
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RPGR,X-linked retinitis pigmentosa GTPase regulator,7040,799,0.94 [0.79-1.12],0.4829429822852416
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RPL14,60S ribosomal protein L14,7030,808,1.03 [0.86-1.23],0.7673209001320499
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RPS10,40S ribosomal protein S10,6987,802,0.88 [0.73-1.05],0.1630775909771853
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RRAS,Ras-related protein R-Ras,7040,799,0.93 [0.88-0.98],0.0113167897607218
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RRM2,Ribonucleoside-diphosphate reductase subunit M2,8180,948,1.03 [0.91-1.16],0.6776184100603223
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,8180,948,0.95 [0.87-1.04],0.2682584745435821
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RRP15,RRP15-like protein,7032,801,0.94 [0.87-1.01],0.0939705587491182
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RSPO1,R-spondin-1,8266,970,0.85 [0.72-1.01],0.065824117894174
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RSPO3,R-spondin-3,8438,986,0.89 [0.73-1.10],0.2812114639857446
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RTBDN,Retbindin,8322,985,0.94 [0.77-1.14],0.5235029451099933
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RTKN2,Rhotekin-2,6987,802,1.06 [0.92-1.21],0.4287437277092372
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",7222,826,0.90 [0.83-0.97],0.0037490631017731
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RTN4R,Reticulon-4 receptor,8438,986,1.12 [0.95-1.33],0.1868015075678271
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RUVBL1,RuvB-like 1,8180,948,1.00 [0.94-1.06],0.990047620389684
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RWDD1,RWD domain-containing protein 1,8412,980,0.95 [0.87-1.04],0.2741634803615062
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RYR1,Ryanodine receptor 1,6987,802,0.76 [0.61-0.95],0.0151133124869117
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",S100A11,Protein S100-A11,8284,967,1.14 [1.02-1.27],0.0186661301629779
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",S100A12,Protein S100-A12,8249,974,1.07 [0.99-1.15],0.0940375079294033
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",S100A13,Protein S100-A13,7008,809,1.01 [0.83-1.23],0.9361327474301462
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",S100A14,Protein S100-A14,7222,826,1.14 [1.01-1.29],0.0393427825231769
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",S100A16,Protein S100-A16,8150,944,1.08 [0.98-1.18],0.1203188632312758
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",S100A3,Protein S100-A3,7208,827,1.04 [0.90-1.20],0.5752855832520954
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",S100A4,Protein S100-A4,8384,984,0.93 [0.84-1.03],0.1409981191970433
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",S100G,Protein S100-G,7222,826,1.03 [0.91-1.18],0.6343569445154038
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",S100P,Protein S100-P,8206,953,1.01 [0.91-1.12],0.8935052118801827
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SAA4,Serum amyloid A-4 protein,7237,826,1.15 [0.95-1.39],0.1562871096966086
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SAFB2,Scaffold attachment factor B2,7222,826,0.88 [0.68-1.13],0.3182987085538085
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SAG,S-arrestin,7032,801,0.85 [0.74-0.98],0.0254315527780505
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SAMD9L,Sterile alpha motif domain-containing protein 9-like,8335,971,0.99 [0.91-1.07],0.822263460591506
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SAP18,Histone deacetylase complex subunit SAP18,7092,819,0.98 [0.89-1.08],0.6675480032813588
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SARG,Specifically androgen-regulated gene protein,7202,821,0.93 [0.87-0.98],0.0127681637307079
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SART1,U4/U6.U5 tri-snRNP-associated protein 1,6987,802,1.10 [0.92-1.31],0.2873449533430786
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SAT1,Diamine acetyltransferase 1,6987,802,0.93 [0.81-1.08],0.3498589523821344
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SAT2,Thialysine N-epsilon-acetyltransferase,7092,819,0.98 [0.88-1.08],0.6354738272291065
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SATB1,DNA-binding protein SATB1,7222,826,0.97 [0.78-1.22],0.8056900093432033
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SBSN,Suprabasin,7213,830,0.97 [0.80-1.17],0.7247044055118508
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCAMP3,Secretory carrier-associated membrane protein 3,8322,985,0.94 [0.87-1.00],0.0571824126087854
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCARA5,Scavenger receptor class A member 5,8412,980,1.13 [0.94-1.36],0.2051304772334622
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCARB1,Scavenger receptor class B member 1,8164,946,0.97 [0.87-1.08],0.5346141703659926
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCARB2,Lysosome membrane protein 2,8114,954,1.22 [1.02-1.45],0.0272440507605369
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCARF1,Scavenger receptor class F member 1,8458,987,0.92 [0.80-1.05],0.2119594714419762
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCARF2,Scavenger receptor class F member 2,8412,980,1.18 [0.97-1.43],0.1045186825223842
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCG2,Secretogranin-2,8394,983,1.00 [0.85-1.19],0.9604506219829666
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCG3,Secretogranin-3,8351,974,1.11 [0.94-1.31],0.2308674951505043
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCGB1A1,Uteroglobin,8349,973,0.98 [0.89-1.09],0.7715285698058731
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCGB2A2,Mammaglobin-A,6987,802,0.91 [0.72-1.16],0.4617876891146686
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCGB3A1,Secretoglobin family 3A member 1,7068,806,0.89 [0.69-1.16],0.4002452534677095
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCGB3A2,Secretoglobin family 3A member 2,8365,974,0.99 [0.92-1.06],0.7465450055989038
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCGN,Secretagogin,8195,943,0.98 [0.86-1.12],0.7994615034670828
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCIN,Adseverin,7032,801,0.97 [0.88-1.06],0.4603238572712956
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCLY,Selenocysteine lyase,8414,985,1.02 [0.90-1.16],0.7211845272778186
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCN2A,Sodium channel protein type 2 subunit alpha,7032,801,1.00 [0.87-1.15],0.9491690899374218
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCN2B,Sodium channel subunit beta-2,7040,799,0.88 [0.68-1.14],0.3473765400853927
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCN3A,Sodium channel protein type 3 subunit alpha,7040,799,0.99 [0.82-1.20],0.9480655554431764
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCN3B,Sodium channel subunit beta-3,7032,801,0.97 [0.84-1.12],0.6727982628115248
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCN4B,Sodium channel subunit beta-4,7030,808,1.04 [0.89-1.22],0.6030867278587493
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCP2,Non-specific lipid-transfer protein,8180,948,1.03 [0.95-1.11],0.5119755132166919
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCPEP1,Retinoid-inducible serine carboxypeptidase,7007,806,0.87 [0.75-1.00],0.0487660967191366
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCRG1,Scrapie-responsive protein 1,7231,828,1.10 [0.87-1.40],0.4297034943950946
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCRIB,Protein scribble homolog,7030,808,0.97 [0.90-1.05],0.4398690831786349
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCRN1,Secernin-1,8335,971,0.95 [0.86-1.06],0.376286357086749
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCT,Secretin,7040,799,0.97 [0.84-1.11],0.6320065149215033
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SDC1,Syndecan-1,8340,975,0.99 [0.85-1.14],0.8719925972873123
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SDC4,Syndecan-4,8340,975,1.04 [0.92-1.17],0.5447309303775385
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SDCCAG8,Serologically defined colon cancer antigen 8,7208,827,0.95 [0.90-1.01],0.1171246233379663
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SDHB,Succinate dehydrogenase,7204,827,1.02 [0.92-1.14],0.6711976080622343
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SDK2,Protein sidekick-2,7068,806,1.00 [0.84-1.20],0.9700338992226548
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEC31A,Protein transport protein Sec31A,7030,808,0.92 [0.84-1.00],0.0478212174488436
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEL1L,Protein sel-1 homolog 1,7030,808,1.03 [0.82-1.30],0.8108652145396057
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SELE,E-selectin,8458,987,1.02 [0.91-1.14],0.7281146158621024
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SELENOP,Selenoprotein P,7237,826,1.02 [0.76-1.37],0.8910566413858858
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SELL,L-selectin,7237,826,1.05 [0.78-1.42],0.7589826155295867
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SELP,P-selectin,8395,979,0.86 [0.78-0.95],0.0044603324693144
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SELPLG,P-selectin glycoprotein ligand 1,8335,971,0.95 [0.77-1.17],0.6323981197628357
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEMA3F,Semaphorin-3F,8340,975,1.17 [0.94-1.44],0.1583838702950779
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEMA3G,Semaphorin-3G,7068,806,1.00 [0.86-1.16],0.9957933276824296
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEMA4C,Semaphorin-4C,8322,985,1.11 [0.92-1.35],0.2687790451808948
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEMA4D,Semaphorin-4D,8412,980,0.94 [0.78-1.14],0.541738739432905
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEMA6C,Semaphorin-6C,7008,809,0.98 [0.75-1.28],0.8617376246698073
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEMA7A,Semaphorin-7A,8434,983,1.03 [0.84-1.26],0.7990342811486053
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEPTIN3,Neuronal-specific septin-3,7222,826,0.95 [0.87-1.04],0.2339093208249964
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEPTIN7,Septin-7,7092,819,0.89 [0.77-1.02],0.0912514652465538
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEPTIN8,Septin-8,7211,828,1.00 [0.81-1.24],0.979224491722836
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEPTIN9,Septin-9,8322,985,1.03 [0.85-1.26],0.7294415147569107
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINA1,Alpha-1-antitrypsin,7087,811,1.34 [0.61-2.93],0.4651613993430711
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINA11,Serpin A11,8458,987,1.01 [0.88-1.16],0.8789949996499702
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINA12,Serpin A12,8102,942,1.02 [0.96-1.08],0.5529103722886033
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINA3,Alpha-1-antichymotrypsin,7216,823,1.55 [1.04-2.30],0.0314942720212023
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINA4,Kallistatin,7092,811,0.95 [0.72-1.27],0.7401647208106021
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINA5,Plasma serine protease inhibitor,7120,817,1.17 [0.94-1.46],0.1542015607968835
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINA6,Corticosteroid-binding globulin,7237,826,1.13 [0.74-1.74],0.5732033197070951
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINA7,Thyroxine-binding globulin,7237,826,0.95 [0.66-1.36],0.7611636174552521
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINA9,Serpin A9,8283,982,1.07 [0.99-1.16],0.0911596614805406
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINB1,Leukocyte elastase inhibitor,8334,971,0.97 [0.91-1.03],0.3619587098541614
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINB5,Serpin B5,8206,953,0.95 [0.85-1.08],0.4415671797298032
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINB6,Serpin B6,8381,976,0.96 [0.87-1.06],0.4181500368862211
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINB8,Serpin B8,8443,992,1.13 [1.04-1.23],0.0041491720593032
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINB9,Serpin B9,8266,970,0.87 [0.73-1.03],0.1018414079455138
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINC1,Antithrombin-III,7227,826,1.05 [0.67-1.64],0.8401963573471776
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPIND1,Heparin cofactor 2,7227,826,1.10 [0.87-1.38],0.4443664396672563
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINE1,Plasminogen activator inhibitor 1,8458,987,0.96 [0.88-1.05],0.3603934084208212
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINE2,Glia-derived nexin,7231,828,0.90 [0.81-1.00],0.0428342683153022
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINF1,Pigment epithelium-derived factor,7125,817,1.03 [0.80-1.33],0.8063147466049341
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINF2,Alpha-2-antiplasmin,7094,819,1.09 [0.66-1.80],0.7450361756459016
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPING1,Plasma protease C1 inhibitor,7227,826,1.18 [0.82-1.70],0.3624102891780293
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINH1,Serpin H1,7092,819,0.95 [0.90-1.00],0.0598629755292472
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINI1,Neuroserpin,7058,806,1.08 [0.85-1.36],0.5478117631629024
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINI2,Serpin I2,7204,827,1.02 [0.90-1.15],0.7767065987297558
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SESTD1,SEC14 domain and spectrin repeat-containing protein 1,8164,946,0.93 [0.85-1.02],0.1129935678207387
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SETMAR,Histone-lysine N-methyltransferase SETMAR,8237,967,1.17 [0.97-1.40],0.1071828755051718
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEZ6,Seizure protein 6 homolog,7040,799,0.94 [0.75-1.18],0.6215295598385591
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEZ6L,Seizure 6-like protein,8384,984,1.15 [0.94-1.40],0.1881394620638895
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEZ6L2,Seizure 6-like protein 2,8322,985,1.29 [1.02-1.63],0.0320116236576339
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SF3B4,Splicing factor 3B subunit 4,8322,985,1.00 [0.92-1.08],0.947711041003328
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SFRP1,Secreted frizzled-related protein 1,8239,970,1.03 [0.90-1.18],0.6656713495608031
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SFRP4,Secreted frizzled-related protein 4,7068,806,1.04 [0.87-1.24],0.6572169516291865
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SFTPA1,Pulmonary surfactant-associated protein A1,8180,948,1.00 [0.89-1.11],0.9311968714010777
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SFTPA2,Pulmonary surfactant-associated protein A2,8180,948,0.96 [0.86-1.08],0.5293090737745625
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SFTPD,Pulmonary surfactant-associated protein D,8340,975,0.96 [0.89-1.05],0.3805638761721821
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SGSH,N-sulphoglucosamine sulphohydrolase,7116,816,1.03 [0.91-1.16],0.6738811200980703
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SH2B3,SH2B adapter protein 3,8180,948,0.93 [0.88-0.99],0.0162076211354569
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SH2D1A,SH2 domain-containing protein 1A,8335,971,1.06 [0.97-1.17],0.1951252801235249
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,7032,801,0.85 [0.75-0.97],0.0156865121133623
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SH3BP1,SH3 domain-binding protein 1,7204,827,0.85 [0.74-0.99],0.0340574391485159
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SH3GL3,Endophilin-A3,7061,816,0.93 [0.86-1.00],0.056864272621866
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SH3GLB2,Endophilin-B2,7224,829,0.94 [0.85-1.04],0.2417184509158426
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SHBG,Sex hormone-binding globulin,7238,823,0.89 [0.77-1.03],0.1275944158435585
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SHC1,SHC-transforming protein 1,6987,805,0.99 [0.93-1.05],0.6323953444484336
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SHD,SH2 domain-containing adapter protein D,6974,802,0.98 [0.91-1.07],0.6981407853152288
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SHH,Sonic hedgehog protein,7008,809,1.01 [0.86-1.18],0.9393172274356254
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SHISA5,Protein shisa-5,7230,831,1.25 [0.97-1.62],0.0833637482262198
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SHMT1,"Serine hydroxymethyltransferase, cytosolic",8365,974,0.96 [0.89-1.03],0.2148029573666166
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SHPK,Sedoheptulokinase,7092,819,0.85 [0.71-1.02],0.07345426163867
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIAE,Sialate O-acetylesterase,8374,983,0.89 [0.78-1.00],0.0593002534517541
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIGLEC1,Sialoadhesin,8377,979,1.00 [0.87-1.15],0.9835451237568
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIGLEC10,Sialic acid-binding Ig-like lectin 10,8335,971,1.06 [0.90-1.26],0.4902493240287361
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIGLEC15,Sialic acid-binding Ig-like lectin 15,8164,946,1.00 [0.92-1.08],0.9464717604895508
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIGLEC5,Sialic acid-binding Ig-like lectin 5,8360,976,0.99 [0.94-1.04],0.6921364526040621
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIGLEC6,Sialic acid-binding Ig-like lectin 6,8438,986,0.98 [0.83-1.16],0.8206669467882147
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIGLEC7,Sialic acid-binding Ig-like lectin 7,8340,975,1.14 [0.93-1.40],0.1943068992264235
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIGLEC8,Sialic acid-binding Ig-like lectin 8,7030,808,1.05 [0.91-1.23],0.5003263617275586
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIGLEC9,Sialic acid-binding Ig-like lectin 9,8427,986,1.11 [0.92-1.35],0.2613298117042977
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIL1,Nucleotide exchange factor SIL1,7030,808,0.92 [0.74-1.15],0.4599601256059764
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,8377,975,1.05 [0.95-1.16],0.3295418195090471
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIRPB1,Signal-regulatory protein beta-1,8327,972,1.05 [0.94-1.19],0.3877002088031732
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIRT1,NAD-dependent protein deacetylase sirtuin-1,7008,809,0.97 [0.90-1.06],0.53260012895493
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIRT2,NAD-dependent protein deacetylase sirtuin-2,8322,985,0.95 [0.89-1.02],0.1475952170748504
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",8164,946,0.93 [0.83-1.04],0.2025062199591416
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIT1,Signaling threshold-regulating transmembrane adapter 1,8195,943,1.03 [0.92-1.14],0.6029473524882134
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SKAP1,Src kinase-associated phosphoprotein 1,8254,968,1.06 [0.98-1.14],0.1811595239667312
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SKAP2,Src kinase-associated phosphoprotein 2,8377,979,0.96 [0.91-1.01],0.1233328741667827
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SKIV2L,Helicase SKI2W,6987,802,0.92 [0.77-1.12],0.4105635535650772
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLA2,Src-like-adapter 2,7222,826,0.92 [0.87-0.98],0.0140811993338826
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLAMF1,Signaling lymphocytic activation molecule,8195,943,1.01 [0.92-1.12],0.7816652823275675
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLAMF6,SLAM family member 6,8180,948,1.02 [0.87-1.19],0.8093998351461891
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLAMF7,SLAM family member 7,8335,971,0.96 [0.87-1.05],0.3614547234393446
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLAMF8,SLAM family member 8,8180,948,1.05 [0.94-1.17],0.3730851457431667
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC12A2,Solute carrier family 12 member 2,6987,802,0.78 [0.60-1.02],0.0745265597278697
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC13A1,Solute carrier family 13 member 1,7208,827,1.00 [0.90-1.12],0.9834964725759232
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC16A1,Monocarboxylate transporter 1,8164,946,0.94 [0.85-1.05],0.3085958142806094
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC1A4,Neutral amino acid transporter A,7040,799,1.04 [0.91-1.18],0.6049457947335142
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC27A4,Long-chain fatty acid transport protein 4,8164,946,1.01 [0.93-1.10],0.8205883880059199
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC28A1,Sodium/nucleoside cotransporter 1,6987,805,0.95 [0.85-1.07],0.4401923051869911
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC34A3,Sodium-dependent phosphate transport protein 2C,6987,805,1.08 [0.95-1.24],0.2434109524309371
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC39A14,Zinc transporter ZIP14,8164,946,1.12 [0.95-1.32],0.1867649993137515
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC39A5,Zinc transporter ZIP5,8335,971,1.07 [0.96-1.19],0.2482517298320017
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC44A4,Choline transporter-like protein 4,7040,799,1.01 [0.91-1.11],0.9201493519771234
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC4A1,Band 3 anion transport protein,7230,831,0.96 [0.84-1.10],0.5742563639814617
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC51B,Organic solute transporter subunit beta,6987,802,1.06 [0.97-1.16],0.2191091242440543
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,7068,806,0.92 [0.85-0.99],0.0370000610239172
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,7204,827,0.97 [0.85-1.11],0.6666441471510514
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",6987,805,0.96 [0.84-1.08],0.4822553711343519
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLIT2,Slit homolog 2 protein,8164,946,0.94 [0.84-1.05],0.3043160647313134
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLITRK1,SLIT and NTRK-like protein 1,7008,809,0.90 [0.73-1.12],0.3473687270227552
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLITRK2,SLIT and NTRK-like protein 2,8438,986,1.04 [0.91-1.20],0.5499352513914375
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLITRK6,SLIT and NTRK-like protein 6,8206,953,1.03 [0.87-1.21],0.7601881379885254
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLK,STE20-like serine/threonine-protein kinase,7092,819,0.98 [0.90-1.07],0.6955340067782112
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLMAP,Sarcolemmal membrane-associated protein,7204,827,0.91 [0.84-0.99],0.0342940494725297
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLURP1,Secreted Ly-6/uPAR-related protein 1,7172,824,1.02 [0.85-1.23],0.8416883022881074
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMAD1,Mothers against decapentaplegic homolog 1,8180,948,0.93 [0.87-1.00],0.0563487474462521
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMAD2,Mothers against decapentaplegic homolog 2,7208,827,0.93 [0.84-1.02],0.1249826611813473
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMAD3,Mothers against decapentaplegic homolog 3,7208,827,0.89 [0.78-1.02],0.0891479907610341
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMAD5,Mothers against decapentaplegic homolog 5,8322,985,0.88 [0.66-1.18],0.3884742820156199
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMARCA2,Probable global transcription activator SNF2L2,8164,946,1.01 [0.94-1.10],0.7373484470844767
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMC3,Structural maintenance of chromosomes protein 3,6987,805,0.88 [0.76-1.01],0.0790111037102186
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMNDC1,Survival of motor neuron-related-splicing factor 30,7204,827,1.11 [1.00-1.23],0.0411707891245166
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMOC1,SPARC-related modular calcium-binding protein 1,8438,986,1.06 [0.89-1.26],0.5381756711362359
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMOC2,SPARC-related modular calcium-binding protein 2,8377,979,1.04 [0.90-1.20],0.5857887334429919
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMPD1,Sphingomyelin phosphodiesterase,8367,975,0.97 [0.87-1.09],0.6397557336205004
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMPD3,Sphingomyelin phosphodiesterase 3,7008,809,1.01 [0.90-1.14],0.8820941021264662
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,8364,977,1.04 [0.96-1.14],0.3256333113848518
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,7208,827,0.88 [0.80-0.98],0.0170507296400402
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMS,Spermine synthase,7032,801,0.87 [0.77-0.98],0.0190427279556531
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMTN,Smoothelin,7212,828,0.98 [0.91-1.06],0.6315207389643784
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNAP23,Synaptosomal-associated protein 23,8340,975,0.94 [0.88-1.00],0.0413152487591452
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNAP25,Synaptosomal-associated protein 25,7032,801,0.82 [0.71-0.95],0.0073130541859388
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNAP29,Synaptosomal-associated protein 29,8384,984,0.95 [0.89-1.01],0.0940820247278371
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNAPIN,SNARE-associated protein Snapin,7222,826,0.96 [0.86-1.08],0.5099495050404379
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNCA,Alpha-synuclein,7068,806,0.96 [0.91-1.02],0.2057014415787726
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNCG,Gamma-synuclein,8266,970,1.05 [0.96-1.14],0.3056240156871348
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",7030,808,0.84 [0.67-1.05],0.124277890369057
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNRPB2,U2 small nuclear ribonucleoprotein B'',7224,829,1.06 [0.93-1.21],0.3731603227718136
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNU13,NHP2-like protein 1,6987,802,1.09 [0.98-1.20],0.114704708580891
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNX15,Sorting nexin-15,7068,806,0.97 [0.85-1.10],0.6269464916284255
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNX18,Sorting nexin-18,7204,827,0.98 [0.84-1.15],0.8375908577045144
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNX2,Sorting nexin-2,7208,827,0.92 [0.85-1.00],0.0479408003087258
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNX5,Sorting nexin-5,7030,808,0.75 [0.59-0.97],0.0254373127774554
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNX9,Sorting nexin-9,8340,975,0.91 [0.83-0.99],0.0362331902779392
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SOD1,Superoxide dismutase [Cu-Zn],8202,955,0.97 [0.86-1.09],0.584563350542862
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SOD2,"Superoxide dismutase [Mn], mitochondrial",8360,976,0.92 [0.79-1.08],0.2954543912297579
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SOD3,Extracellular superoxide dismutase,7238,823,0.96 [0.86-1.08],0.5222359276060016
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SORBS1,Sorbin and SH3 domain-containing protein 1,7222,826,1.09 [0.93-1.27],0.2965980166236769
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SORCS2,VPS10 domain-containing receptor SorCS2,8180,948,1.14 [0.97-1.35],0.1075278788918824
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SORD,Sorbitol dehydrogenase,8399,983,0.98 [0.90-1.06],0.6066925350245367
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SORT1,Sortilin,8328,973,0.89 [0.76-1.04],0.1350758572509368
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SOST,Sclerostin,8328,973,1.06 [0.91-1.22],0.4644503217679435
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,7040,799,0.95 [0.82-1.09],0.4425176296294366
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SOX2,Transcription factor SOX-2,7205,825,0.73 [0.55-0.97],0.0318788921764255
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SOX9,Transcription factor SOX-9,7040,799,0.90 [0.69-1.16],0.3953794741508023
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPACA5_SPACA5B,Sperm acrosome-associated protein 5,7222,826,1.04 [0.84-1.30],0.7181396034286959
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPAG1,Sperm-associated antigen 1,7222,826,0.94 [0.83-1.06],0.3168130796051686
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPARC,SPARC,8384,984,0.96 [0.89-1.04],0.3554691972469989
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPARCL1,SPARC-like protein 1,8369,978,0.90 [0.73-1.10],0.293187587307491
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPART,Spartin,7068,806,0.91 [0.83-1.00],0.0444255199604154
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPESP1,Sperm equatorial segment protein 1,7231,828,1.06 [0.88-1.28],0.549448584211971
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPINK1,Serine protease inhibitor Kazal-type 1,8360,976,0.99 [0.87-1.14],0.9376284155705076
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPINK2,Serine protease inhibitor Kazal-type 2,7068,806,1.04 [0.86-1.26],0.6648761369769971
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPINK4,Serine protease inhibitor Kazal-type 4,8335,971,1.00 [0.92-1.09],0.9925400442149872
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPINK5,Serine protease inhibitor Kazal-type 5,8360,976,1.10 [0.94-1.29],0.2520798761192127
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPINK6,Serine protease inhibitor Kazal-type 6,8438,986,1.02 [0.92-1.14],0.712089732463691
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPINK8,Serine protease inhibitor Kazal-type 8,6987,802,0.80 [0.65-1.00],0.0453133250626897
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPINT1,Kunitz-type protease inhibitor 1,8334,973,1.07 [0.85-1.34],0.5781256179011786
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPINT2,Kunitz-type protease inhibitor 2,8377,979,0.94 [0.81-1.09],0.4070417645715474
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPINT3,Kunitz-type protease inhibitor 3,7204,827,0.98 [0.94-1.02],0.2553414848980728
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPOCK1,Testican-1,8266,970,1.02 [0.82-1.27],0.844238759964665
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPON1,Spondin-1,8351,974,1.02 [0.85-1.21],0.8609616276685382
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPON2,Spondin-2,8305,969,1.09 [0.92-1.29],0.302131394851222
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPP1,Osteopontin,8446,986,1.15 [1.01-1.31],0.0316276398034104
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",7008,809,0.94 [0.80-1.11],0.4703242862270625
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPRING1,SREBP regulating gene protein,6987,805,0.86 [0.75-0.97],0.0170694343452016
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPRR1B,Cornifin-B,7092,819,1.02 [0.94-1.10],0.6084175902404116
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPRR3,Small proline-rich protein 3,7224,829,1.00 [0.90-1.11],0.9459403182650488
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPRY2,Protein sprouty homolog 2,8195,943,0.96 [0.90-1.03],0.2765460050752757
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPTBN2,"Spectrin beta chain, non-erythrocytic 2",7032,801,0.87 [0.70-1.09],0.2347305179624466
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPTLC1,Serine palmitoyltransferase 1,7224,829,0.83 [0.69-1.01],0.059863693065855
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SRC,Proto-oncogene tyrosine-protein kinase Src,8371,983,0.97 [0.92-1.01],0.1394770424445948
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SRP14,Signal recognition particle 14 kDa protein,8322,985,1.07 [0.98-1.18],0.1491680708681882
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SRPK2,SRSF protein kinase 2,8335,971,0.99 [0.93-1.06],0.8311478072058978
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SRPX,Sushi repeat-containing protein SRPX,7231,828,0.87 [0.74-1.03],0.1089911043918261
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SSB,Lupus La protein,8164,946,0.96 [0.86-1.06],0.3794226676082746
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SSBP1,"Single-stranded DNA-binding protein, mitochondrial",7008,809,0.97 [0.79-1.19],0.759543873510379
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,8328,973,1.01 [0.96-1.05],0.7675728734346703
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,8395,979,1.05 [0.92-1.19],0.5070265760064263
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SSH3,Protein phosphatase Slingshot homolog 3,6987,805,0.95 [0.75-1.21],0.6789814514725827
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SSNA1,Sjoegren syndrome nuclear autoantigen 1,7204,827,0.88 [0.77-1.01],0.0695669512509074
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ST13,Hsc70-interacting protein,7068,806,0.95 [0.84-1.08],0.4203330543714848
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",8322,985,1.07 [0.94-1.21],0.3338287291239278
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",8458,987,0.96 [0.80-1.16],0.6778334104864254
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",7008,809,0.96 [0.84-1.11],0.598608548272265
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STAB2,Stabilin-2,7230,831,0.95 [0.75-1.22],0.7048005504188943
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STAM,Signal transducing adapter molecule 1,7208,827,0.85 [0.70-1.03],0.0890337494242352
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STAMBP,STAM-binding protein,8254,968,0.94 [0.86-1.03],0.1724350031778005
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STAT2,Signal transducer and activator of transcription 2,7008,809,0.92 [0.84-1.01],0.0929637351522421
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STAT5B,Signal transducer and activator of transcription 5B,8322,985,0.97 [0.93-1.01],0.1617039078298524
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STAU1,Double-stranded RNA-binding protein Staufen homolog 1,6987,805,0.82 [0.73-0.93],0.0013063721118677
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STC1,Stanniocalcin-1,8412,980,1.09 [0.96-1.23],0.1827186386815119
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STC2,Stanniocalcin-2,8351,974,1.22 [0.96-1.56],0.0993688181601104
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STEAP4,Metalloreductase STEAP4,7032,801,0.96 [0.86-1.06],0.3781230596969207
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STIP1,Stress-induced-phosphoprotein 1,8345,974,0.94 [0.86-1.03],0.1989965853192872
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STK11,Serine/threonine-protein kinase STK11,8206,953,0.94 [0.87-1.02],0.1328209624621595
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STK24,Serine/threonine-protein kinase 24,8164,946,0.96 [0.87-1.06],0.4211719736043413
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STK4,Serine/threonine-protein kinase 4,8340,975,0.94 [0.88-1.00],0.0476085633209283
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STOML2,"Stomatin-like protein 2, mitochondrial",6987,805,0.92 [0.85-0.99],0.0342358979780759
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STX16,Syntaxin-16,8180,948,0.95 [0.86-1.06],0.3757478419746713
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STX1B,Syntaxin-1B,7040,799,0.95 [0.79-1.13],0.5327345779285075
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STX3,Syntaxin-3,7224,829,0.87 [0.72-1.05],0.1388341692973588
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STX4,Syntaxin-4,8322,985,0.99 [0.90-1.09],0.8918529772711983
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STX5,Syntaxin-5,7008,809,0.91 [0.76-1.09],0.3024261421303788
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STX6,Syntaxin-6,8180,948,0.96 [0.87-1.05],0.3451377525069853
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STX7,Syntaxin-7,7008,809,0.90 [0.78-1.04],0.141884310449765
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STX8,Syntaxin-8,8335,971,1.00 [0.88-1.12],0.9385897796553156
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STXBP1,Syntaxin-binding protein 1,7222,826,0.88 [0.80-0.95],0.0023016707992769
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STXBP3,Syntaxin-binding protein 3,8180,948,0.96 [0.84-1.11],0.5977540315421628
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SUGP1,SURP and G-patch domain-containing protein 1,7204,827,0.98 [0.83-1.16],0.8116016567559029
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SUGT1,Protein SGT1 homolog,8180,948,0.95 [0.88-1.02],0.1498134132839808
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SULT1A1,Sulfotransferase 1A1,8412,980,0.95 [0.91-1.00],0.0350551402573393
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SULT2A1,Bile salt sulfotransferase,8335,971,0.96 [0.87-1.07],0.4828001826032547
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SUMF1,Formylglycine-generating enzyme,7008,809,1.03 [0.93-1.15],0.5630627826546869
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,8412,980,0.95 [0.85-1.06],0.3603418599579859
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SUOX,"Sulfite oxidase, mitochondrial",7222,826,0.94 [0.84-1.05],0.2911357573190324
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SUSD1,Sushi domain-containing protein 1,8206,953,0.87 [0.78-0.98],0.0242373887670508
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SUSD2,Sushi domain-containing protein 2,8360,976,0.95 [0.78-1.17],0.6524954131195753
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SUSD4,Sushi domain-containing protein 4,7208,827,1.05 [0.89-1.24],0.570785328609178
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SUSD5,Sushi domain-containing protein 5,7034,801,1.12 [0.92-1.37],0.2710618712666927
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SV2A,Synaptic vesicle glycoprotein 2A,7040,799,0.82 [0.73-0.93],0.0016563742883384
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SWAP70,Switch-associated protein 70,7204,827,0.87 [0.72-1.06],0.1772909271074544
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SYAP1,Synapse-associated protein 1,7068,806,0.93 [0.82-1.05],0.2187902217705745
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,7032,801,0.89 [0.79-1.02],0.0922871839278827
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SYT1,Synaptotagmin-1,7224,829,1.06 [0.91-1.23],0.4511421034708143
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SYTL4,Synaptotagmin-like protein 4,7231,828,0.86 [0.78-0.95],0.0026041132342208
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,7092,819,0.94 [0.88-1.00],0.0561763586537008
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TACC3,Transforming acidic coiled-coil-containing protein 3,8322,985,0.96 [0.91-1.01],0.0878204889994406
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TACSTD2,Tumor-associated calcium signal transducer 2,7367,852,1.38 [1.11-1.71],0.003057506163175
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TADA3,Transcriptional adapter 3,7208,827,0.82 [0.69-0.97],0.0216828873057483
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TAFA5,Chemokine-like protein TAFA-5,8322,985,1.03 [0.88-1.20],0.719011238717
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TAGLN3,Transgelin-3,6987,805,0.95 [0.85-1.07],0.413127737880502
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TALDO1,Transaldolase,7207,827,0.93 [0.79-1.09],0.3537206114631174
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TANK,TRAF family member-associated NF-kappa-B activator,8195,943,1.00 [0.92-1.09],0.979937913818116
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TAP1,Antigen peptide transporter 1,7092,819,0.98 [0.87-1.11],0.7359973184428009
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TARBP2,RISC-loading complex subunit TARBP2,8164,946,0.96 [0.89-1.03],0.2292734766868684
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",7040,799,1.07 [0.98-1.16],0.1164792786219562
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TARS1,"Threonine--tRNA ligase 1, cytoplasmic",7208,827,0.69 [0.57-0.83],7.885994819417622e-05
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TAX1BP1,Tax1-binding protein 1,7224,829,0.92 [0.82-1.03],0.1451722790491056
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TBC1D17,TBC1 domain family member 17,8164,946,0.97 [0.85-1.11],0.6654374560259716
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TBC1D23,TBC1 domain family member 23,8322,985,0.96 [0.90-1.03],0.2380230067779617
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TBC1D5,TBC1 domain family member 5,8335,971,1.00 [0.93-1.07],0.9626913610813654
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TBCA,Tubulin-specific chaperone A,7068,806,0.92 [0.85-1.00],0.0596685709409892
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TBCB,Tubulin-folding cofactor B,8266,970,0.96 [0.91-1.01],0.1391954316745752
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TBCC,Tubulin-specific chaperone C,8266,970,0.94 [0.87-1.00],0.0648735496455468
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TBL1X,F-box-like/WD repeat-containing protein TBL1X,8180,948,0.96 [0.90-1.03],0.2775588614499242
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TBR1,T-box brain protein 1,7040,799,1.02 [0.89-1.17],0.7718125544957379
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TCL1A,T-cell leukemia/lymphoma protein 1A,8261,970,1.01 [0.95-1.07],0.7597204198645354
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TCL1B,T-cell leukemia/lymphoma protein 1B,8206,953,0.98 [0.91-1.05],0.521104096343026
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TCN1,Transcobalamin-1,7095,812,0.99 [0.81-1.21],0.9271220368671712
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TCN2,Transcobalamin-2,8446,986,0.87 [0.73-1.05],0.1555700939301757
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TCOF1,Treacle protein,7231,828,1.21 [0.99-1.48],0.0595850060111294
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TCP11,T-complex protein 11 homolog,7092,819,0.96 [0.85-1.09],0.5424467532230031
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TCTN3,Tectonic-3,7231,828,1.09 [0.87-1.36],0.4415373230250837
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TDGF1,Teratocarcinoma-derived growth factor 1,8164,946,1.01 [0.97-1.05],0.7079962693437463
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TDO2,"Tryptophan 2,3-dioxygenase",7040,799,1.02 [0.85-1.22],0.8421440788967302
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TDP1,Tyrosyl-DNA phosphodiesterase 1,7208,827,0.99 [0.90-1.08],0.7842828690459971
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TDRKH,Tudor and KH domain-containing protein,8164,946,0.97 [0.91-1.04],0.4112715627612003
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TEF,Thyrotroph embryonic factor,6987,802,0.98 [0.83-1.15],0.7887735833082352
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TEK,Angiopoietin-1 receptor,8384,984,1.08 [0.84-1.39],0.5479767167965539
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TERF1,Telomeric repeat-binding factor 1,7008,809,1.04 [0.82-1.32],0.761334938145406
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TET2,Methylcytosine dioxygenase TET2,7075,818,1.03 [0.97-1.10],0.3531226785101891
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TEX101,Testis-expressed protein 101,7040,799,1.00 [0.90-1.12],0.9510197268714126
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TEX33,Testis-expressed protein 33,7092,819,0.93 [0.77-1.13],0.4802937827049274
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TF,Serotransferrin,7237,826,0.83 [0.61-1.12],0.2175213567607861
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TFAP2A,Transcription factor AP-2-alpha,7032,801,0.89 [0.79-1.00],0.0603058153179826
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TFF1,Trefoil factor 1,8321,969,0.98 [0.91-1.05],0.6163354620295078
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TFF2,Trefoil factor 2,8365,974,0.96 [0.87-1.06],0.446932698004917
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TFF3,Trefoil factor 3,8353,975,1.04 [0.89-1.22],0.6099033170034097
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TFPI,Tissue factor pathway inhibitor,8346,972,0.88 [0.73-1.06],0.1916155441031699
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TFPI2,Tissue factor pathway inhibitor 2,8362,983,1.04 [0.90-1.20],0.6161690211742854
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TFRC,Transferrin receptor protein 1,8387,976,1.09 [0.94-1.26],0.2650268821736847
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TG,Thyroglobulin,7208,827,1.05 [0.99-1.12],0.1333070623641546
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TGFA,Protransforming growth factor alpha,8335,971,0.96 [0.84-1.09],0.4990898682560266
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TGFB1,Transforming growth factor beta-1 proprotein,8430,991,0.95 [0.82-1.10],0.4951377729816919
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TGFB2,Transforming growth factor beta-2 proprotein,7208,827,0.93 [0.82-1.06],0.2896638874685253
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TGFBI,Transforming growth factor-beta-induced protein ig-h3,8324,969,1.05 [0.85-1.30],0.6398385672445601
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TGFBR1,TGF-beta receptor type-1,7008,809,0.98 [0.71-1.34],0.8854312660655432
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TGFBR2,TGF-beta receptor type-2,8384,984,1.24 [1.06-1.45],0.007758792850547
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TGFBR3,Transforming growth factor beta receptor type 3,8458,987,1.15 [0.95-1.38],0.1493871195029704
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TGM2,Protein-glutamine gamma-glutamyltransferase 2,8327,972,1.05 [0.97-1.13],0.198676035567631
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TGOLN2,Trans-Golgi network integral membrane protein 2,7238,823,1.15 [0.90-1.47],0.2782554933233611
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",THAP12,52 kDa repressor of the inhibitor of the protein kinase,6979,804,1.03 [0.95-1.11],0.5253701998866467
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",THBD,Thrombomodulin,8340,975,1.36 [1.14-1.62],0.0006193044423687
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",THBS2,Thrombospondin-2,8360,976,0.98 [0.84-1.14],0.8127891574453021
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",THBS4,Thrombospondin-4,8370,976,1.00 [0.88-1.13],0.9632345635518104
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",THOP1,Thimet oligopeptidase,8302,971,1.13 [0.94-1.35],0.1912136619419042
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",THPO,Thrombopoietin,8206,953,0.96 [0.83-1.11],0.6017053888170942
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",THRAP3,Thyroid hormone receptor-associated protein 3,6987,802,0.97 [0.91-1.04],0.38037061867197
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",THSD1,Thrombospondin type-1 domain-containing protein 1,6956,807,0.83 [0.68-1.02],0.0789273247455933
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",THTPA,Thiamine-triphosphatase,7194,827,0.91 [0.84-0.98],0.0154455787277699
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",THY1,Thy-1 membrane glycoprotein,8412,980,1.25 [1.03-1.51],0.0227665088241814
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TIA1,Nucleolysin TIA-1 isoform p40,8116,942,0.97 [0.92-1.01],0.1618193724556139
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TIE1,Tyrosine-protein kinase receptor Tie-1,8458,987,1.02 [0.89-1.17],0.77200324367833
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",8152,944,0.93 [0.82-1.06],0.2910411528886868
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,7092,819,0.91 [0.76-1.10],0.3349829608287848
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,8395,979,1.20 [1.05-1.37],0.0072973132548254
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,7231,828,0.78 [0.66-0.93],0.0062476178432543
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,7224,829,0.93 [0.86-1.01],0.079590986073285
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TIMP1,Metalloproteinase inhibitor 1,8279,966,0.93 [0.76-1.15],0.5150881686739069
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TIMP2,Metalloproteinase inhibitor 2,7231,828,0.95 [0.75-1.20],0.6696995682013266
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TIMP3,Metalloproteinase inhibitor 3,8377,979,0.98 [0.94-1.02],0.3343443173482096
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TIMP4,Metalloproteinase inhibitor 4,8360,976,0.87 [0.76-1.01],0.0724013768292484
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TINAGL1,Tubulointerstitial nephritis antigen-like,8316,971,1.18 [0.91-1.53],0.2243159314854907
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TJAP1,Tight junction-associated protein 1,8384,984,0.95 [0.89-1.02],0.1518603493991654
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TJP3,Tight junction protein ZO-3,7032,801,0.85 [0.72-1.01],0.0679326188121643
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TK1,"Thymidine kinase, cytosolic",7092,819,1.04 [0.89-1.20],0.6348926676758975
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TLR1,Toll-like receptor 1,7008,809,1.19 [0.93-1.53],0.1716426225391959
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TLR2,Toll-like receptor 2,7092,819,0.98 [0.74-1.30],0.8943596549217618
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TLR3,Toll-like receptor 3,8443,992,0.94 [0.86-1.03],0.2181150319360292
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TLR4,Toll-like receptor 4,7008,809,1.10 [0.87-1.39],0.4406109343174277
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,7040,799,0.82 [0.71-0.94],0.0038027129635854
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMED1,Transmembrane emp24 domain-containing protein 1,7092,819,0.86 [0.75-0.98],0.0264875235344585
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMED10,Transmembrane emp24 domain-containing protein 10,6987,802,0.92 [0.78-1.08],0.2965829460542373
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMED4,Transmembrane emp24 domain-containing protein 4,6987,802,1.07 [0.95-1.20],0.2448466769835979
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMED8,Protein TMED8,7204,827,0.91 [0.85-0.97],0.0039976606550544
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMEM106A,Transmembrane protein 106A,7208,827,0.92 [0.83-1.01],0.0762271144928874
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMEM132A,Transmembrane protein 132A,7030,808,1.01 [0.91-1.13],0.7985726519858828
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMEM25,Transmembrane protein 25,7222,826,1.11 [0.97-1.27],0.1360409113064959
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMOD4,Tropomodulin-4,6987,805,0.86 [0.72-1.02],0.0913507762895837
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMPRSS11B,Transmembrane protease serine 11B,7032,801,1.04 [0.95-1.13],0.4138063059786994
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMPRSS11D,Transmembrane protease serine 11D,7211,828,0.99 [0.84-1.18],0.951566165026982
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMPRSS15,Enteropeptidase,8322,985,0.97 [0.91-1.04],0.4102312500619317
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMPRSS5,Transmembrane protease serine 5,8232,968,1.03 [0.89-1.20],0.6709088380872938
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMSB10,Thymosin beta-10,8360,976,0.96 [0.89-1.04],0.3161213462357871
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNC,Tenascin,8395,979,0.90 [0.80-1.01],0.0806070812615684
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNF,Tumor necrosis factor,8202,953,0.99 [0.84-1.17],0.8821209355747596
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFAIP2,Tumor necrosis factor alpha-induced protein 2,7204,827,0.96 [0.83-1.11],0.5744689357277615
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFAIP8,Tumor necrosis factor alpha-induced protein 8,8195,943,0.91 [0.78-1.07],0.25518712521841
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,7068,806,0.88 [0.78-0.98],0.0212572436741848
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,8266,970,1.09 [0.93-1.29],0.2966147056016462
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,8266,970,1.06 [0.93-1.20],0.4021053552210425
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,8377,980,1.01 [0.90-1.13],0.8810366125530267
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,8443,992,1.11 [0.97-1.28],0.139090026620054
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,8340,974,1.09 [0.90-1.33],0.3654358732993714
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,8384,984,1.10 [0.94-1.28],0.2473610172065221
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,8351,974,1.14 [0.96-1.35],0.1284584162075693
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,8195,943,1.22 [1.05-1.40],0.0075717286922122
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,8351,974,1.13 [0.94-1.36],0.179214754915588
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,7068,806,0.82 [0.70-0.96],0.0157298659873083
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,8438,986,1.26 [1.07-1.48],0.0057866109429361
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,8360,976,1.16 [0.96-1.38],0.1172518735273181
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,8360,976,1.13 [0.97-1.31],0.1209159393177895
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,8412,980,1.25 [1.03-1.53],0.0256145248885114
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,8430,991,1.07 [0.92-1.24],0.3863539177246389
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,8266,970,1.07 [0.96-1.18],0.2108556775727086
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,8412,980,0.96 [0.84-1.09],0.5474729290483197
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,8266,970,1.24 [1.08-1.42],0.0022678559308825
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFSF10,Tumor necrosis factor ligand superfamily member 10,8443,992,1.15 [0.92-1.44],0.2130450689699215
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFSF11,Tumor necrosis factor ligand superfamily member 11,8335,971,0.99 [0.90-1.09],0.8448948971374002
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFSF12,Tumor necrosis factor ligand superfamily member 12,8443,992,0.91 [0.74-1.11],0.350747001485282
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFSF13,Tumor necrosis factor ligand superfamily member 13,8377,979,0.98 [0.80-1.22],0.887163099359162
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,8447,987,0.91 [0.73-1.12],0.357021366805915
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFSF14,Tumor necrosis factor ligand superfamily member 14,8266,970,0.95 [0.86-1.05],0.3063654459358048
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFSF8,Tumor necrosis factor ligand superfamily member 8,7230,831,0.94 [0.78-1.13],0.5241463274293292
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNIP1,TNFAIP3-interacting protein 1,7224,829,0.94 [0.87-1.01],0.1001415400505178
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNN,Tenascin-N,7230,831,1.05 [0.90-1.22],0.5382990693570153
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNNI3,"Troponin I, cardiac muscle",8206,953,1.00 [0.93-1.07],0.9540804024619418
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNPO1,Transportin-1,7092,819,1.07 [0.88-1.30],0.4850108400062142
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNR,Tenascin-R,8266,970,1.12 [0.98-1.28],0.1019353613992005
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNXB,Tenascin-X,8360,976,1.02 [0.82-1.27],0.8842908382704602
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TOMM20,Mitochondrial import receptor subunit TOM20 homolog,7231,828,0.87 [0.79-0.95],0.0022076142503743
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TOP1,DNA topoisomerase 1,7204,827,0.96 [0.91-1.01],0.1478472570443725
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TOP1MT,"DNA topoisomerase I, mitochondrial",6987,805,0.87 [0.74-1.01],0.0672483880659178
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TOP2B,DNA topoisomerase 2-beta,7008,809,0.97 [0.88-1.06],0.4447957114734863
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TOR1AIP1,Torsin-1A-interacting protein 1,7030,808,1.04 [0.92-1.18],0.5609218162614151
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TP53,Cellular tumor antigen p53,8180,948,0.91 [0.80-1.04],0.1832336887875773
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TP53BP1,TP53-binding protein 1,7008,809,1.00 [0.93-1.09],0.9279092617728124
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TP53I3,Quinone oxidoreductase PIG3,6906,787,0.91 [0.79-1.04],0.1591468416572037
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TP53INP1,Tumor protein p53-inducible nuclear protein 1,8206,953,0.91 [0.73-1.12],0.368890043839114
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TP73,Tumor protein p73,7040,799,0.95 [0.78-1.17],0.6421427758883953
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPBGL,Trophoblast glycoprotein-like,7040,799,1.00 [0.85-1.17],0.9987137543011316
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPD52L2,Tumor protein D54,7068,806,0.92 [0.86-0.98],0.0077826490687094
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPK1,Thiamin pyrophosphokinase 1,7231,828,1.00 [0.78-1.27],0.9727733625070608
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPM3,Tropomyosin alpha-3 chain,6987,802,1.03 [0.89-1.19],0.6916782246384836
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPMT,Thiopurine S-methyltransferase,8180,948,0.95 [0.88-1.04],0.2698094475726494
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPP1,Tripeptidyl-peptidase 1,8288,967,1.03 [0.91-1.17],0.6320463051090528
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPPP2,Tubulin polymerization-promoting protein family member 2,7092,819,0.91 [0.83-1.00],0.0484218930738316
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPPP3,Tubulin polymerization-promoting protein family member 3,8164,946,0.98 [0.84-1.14],0.782973975001991
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPR,Nucleoprotein TPR,6987,802,1.02 [0.89-1.17],0.7634895586096802
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPRKB,EKC/KEOPS complex subunit TPRKB,6987,805,0.91 [0.81-1.01],0.0845607995977822
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPSAB1,Tryptase alpha/beta-1,8432,991,1.01 [0.91-1.12],0.8503321198037144
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPSD1,Tryptase delta,7222,826,0.88 [0.73-1.06],0.1909742783512242
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPSG1,Tryptase gamma,7008,809,0.86 [0.66-1.13],0.2836343182219534
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPT1,Translationally-controlled tumor protein,8195,943,0.95 [0.86-1.04],0.2693655661275237
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRAF2,TNF receptor-associated factor 2,8335,971,1.02 [0.93-1.10],0.7119896735702068
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRAF3,"TNF receptor-associated factor 3, Isoform 2",7008,809,1.13 [0.96-1.33],0.1472062960130516
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,6987,802,0.94 [0.81-1.09],0.4214934276999365
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,7092,819,0.94 [0.87-1.02],0.1506293908523976
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TREH,Trehalase,7230,831,1.00 [0.91-1.09],0.9423008880443008
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TREM2,Triggering receptor expressed on myeloid cells 2,8340,974,1.04 [0.93-1.15],0.5186898463398248
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TREML1,Trem-like transcript 1 protein,7238,823,0.84 [0.74-0.96],0.0081195899813347
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TREML2,Trem-like transcript 2 protein,8360,976,1.17 [0.99-1.38],0.0589356192799323
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRIAP1,TP53-regulated inhibitor of apoptosis 1,8438,986,0.94 [0.85-1.03],0.161828204988446
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRIM21,E3 ubiquitin-protein ligase TRIM21,8335,971,0.96 [0.89-1.04],0.2792147572989231
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRIM24,Transcription intermediary factor 1-alpha,7084,818,0.92 [0.83-1.03],0.1413620988195624
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,7204,827,0.95 [0.89-1.01],0.0899087689915519
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRIM26,Tripartite motif-containing protein 26,6987,805,0.98 [0.86-1.11],0.714805601147502
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRIM40,E3 ubiquitin ligase TRIM40,7040,799,0.89 [0.81-0.98],0.0228294480311646
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRIM5,Tripartite motif-containing protein 5,8335,971,1.00 [0.93-1.07],0.974349125524416
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRIM58,E3 ubiquitin-protein ligase TRIM58,7208,827,0.91 [0.84-0.99],0.0209666790733935
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRPV3,Transient receptor potential cation channel subfamily V member 3,6987,802,0.98 [0.86-1.13],0.8275996224350123
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TSC1,Hamartin,7008,809,0.97 [0.88-1.07],0.5203490398412884
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TSC22D1,TSC22 domain family protein 1,7222,826,0.88 [0.79-0.98],0.0177617656617435
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TSHB,Thyrotropin subunit beta,8340,975,0.99 [0.91-1.07],0.7579407462325678
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TSLP,Thymic stromal lymphopoietin,8206,953,0.97 [0.87-1.07],0.5035167327576611
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TSNAX,Translin-associated protein X,6987,802,0.77 [0.64-0.92],0.0042389180834186
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TSPAN1,Tetraspanin-1,8206,953,1.14 [1.08-1.20],4.305421546889905e-06
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TSPAN15,Tetraspanin-15,6987,802,0.97 [0.85-1.11],0.6613968025678931
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TSPAN7,Tetraspanin-7,7032,801,0.90 [0.83-0.97],0.0070454592173371
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TSPAN8,Tetraspanin-8,7204,827,1.07 [0.99-1.15],0.0698551517664416
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TSPYL1,Testis-specific Y-encoded-like protein 1,7008,809,0.89 [0.74-1.06],0.1949802966922975
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TST,Thiosulfate sulfurtransferase,8150,946,0.94 [0.87-1.02],0.1201560233424429
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TTF2,Transcription termination factor 2,7040,799,0.92 [0.80-1.07],0.2788758582451095
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TTN,Titin,6987,802,0.94 [0.84-1.04],0.2423507532619785
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TTR,Transthyretin,7162,817,0.94 [0.71-1.23],0.6459964374882103
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TUBB3,Tubulin beta-3 chain,7032,801,0.74 [0.58-0.94],0.0147612118481102
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TWF2,Twinfilin-2,7230,831,0.90 [0.83-0.98],0.0142307889975162
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TXK,Tyrosine-protein kinase TXK,7092,819,0.90 [0.81-0.99],0.0322231684485795
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TXLNA,Alpha-taxilin,8266,970,0.96 [0.90-1.02],0.1811104404382018
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TXN,Thioredoxin,7111,807,0.96 [0.82-1.13],0.6266425206649935
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TXNDC15,Thioredoxin domain-containing protein 15,8384,984,0.86 [0.70-1.06],0.147484919967622
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TXNDC5,Thioredoxin domain-containing protein 5,8412,980,0.94 [0.87-1.03],0.176497413535649
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TXNDC9,Thioredoxin domain-containing protein 9,7224,829,0.83 [0.72-0.95],0.0064000393550423
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TXNL1,Thioredoxin-like protein 1,7018,798,0.96 [0.89-1.03],0.2351605260098002
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TXNRD1,"Thioredoxin reductase 1, cytoplasmic",8360,976,0.91 [0.80-1.03],0.1313117878156685
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TYMP,Thymidine phosphorylase,8291,968,0.92 [0.84-1.00],0.0643252446327693
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TYRO3,Tyrosine-protein kinase receptor TYRO3,8340,975,1.17 [0.95-1.42],0.1320208376164425
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",7008,809,1.01 [0.91-1.12],0.8837541911123753
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UBAC1,Ubiquitin-associated domain-containing protein 1,8322,985,1.10 [0.93-1.30],0.2649821157086223
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UBE2B,Ubiquitin-conjugating enzyme E2 B,7208,827,0.79 [0.62-1.00],0.0480263029210215
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,7231,828,0.96 [0.86-1.07],0.4419798428311816
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UBE2Z,Ubiquitin-conjugating enzyme E2 Z,7008,809,0.92 [0.81-1.04],0.176672710293424
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UBQLN3,Ubiquilin-3,6987,802,0.91 [0.81-1.03],0.1524200586114502
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UBXN1,UBX domain-containing protein 1,7068,806,0.92 [0.83-1.02],0.1125891361861753
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,7204,827,0.93 [0.89-0.98],0.0035401710151083
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UGDH,UDP-glucose 6-dehydrogenase,6987,802,0.96 [0.89-1.03],0.2482059612762264
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UHRF2,E3 ubiquitin-protein ligase UHRF2,6987,802,0.89 [0.72-1.10],0.2685159903983715
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ULBP2,UL16-binding protein 2,8266,970,1.08 [0.93-1.24],0.3226252750387498
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UMOD,Uromodulin,8433,982,1.01 [0.90-1.12],0.9010390768033294
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UNC5D,Netrin receptor UNC5D,7008,809,0.88 [0.68-1.16],0.3680921881202942
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UNC79,Protein unc-79 homolog,6987,805,0.89 [0.78-1.02],0.0871379846127841
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UNG,Uracil-DNA glycosylase,7208,827,0.82 [0.68-1.01],0.0589065215192246
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UPB1,Beta-ureidopropionase,7231,828,0.97 [0.90-1.05],0.4869501132731519
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UPK3A,Uroplakin-3a,7032,801,1.10 [0.97-1.26],0.1459197181640933
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UPK3BL1,Uroplakin-3b-like protein 1,7075,818,0.96 [0.84-1.09],0.5173152629009204
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UROD,Uroporphyrinogen decarboxylase,7068,806,0.88 [0.79-0.98],0.0150010135121004
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UROS,Uroporphyrinogen-III synthase,7040,799,1.05 [0.95-1.16],0.3450901152923392
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",USO1,General vesicular transport factor p115,8322,985,0.94 [0.89-1.01],0.0783582866187027
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",USP25,Ubiquitin carboxyl-terminal hydrolase 25,7208,827,0.90 [0.81-0.99],0.0244150033688327
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",USP28,Ubiquitin carboxyl-terminal hydrolase 28,7224,829,1.06 [0.89-1.27],0.4926502712950363
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",USP47,Ubiquitin carboxyl-terminal hydrolase 47,6987,802,0.88 [0.80-0.96],0.0036915406233686
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",USP8,Ubiquitin carboxyl-terminal hydrolase 8,8206,953,0.95 [0.89-1.02],0.1413444758826341
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UXS1,UDP-glucuronic acid decarboxylase 1,8180,948,0.89 [0.79-1.00],0.053152080961773
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VAMP5,Vesicle-associated membrane protein 5,8206,953,0.95 [0.85-1.07],0.4054713210074204
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VAMP8,Vesicle-associated membrane protein 8,7008,809,0.94 [0.87-1.01],0.1105816121527479
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VASH1,Tubulinyl-Tyr carboxypeptidase 1,8335,971,0.93 [0.87-1.00],0.0553246447209953
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VASN,Vasorin,8225,960,1.06 [0.86-1.32],0.5604714764129612
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VASP,Vasodilator-stimulated phosphoprotein,7238,823,0.90 [0.82-0.99],0.0238312270167347
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VAT1,Synaptic vesicle membrane protein VAT-1 homolog,8322,985,1.21 [0.90-1.61],0.2081781546820399
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VAV3,Guanine nucleotide exchange factor VAV3,7032,801,0.92 [0.85-0.98],0.0151209314557316
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VCAM1,Vascular cell adhesion protein 1,8382,977,1.07 [0.87-1.32],0.5303612000987303
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VCAN,Versican core protein,8412,980,1.15 [0.96-1.39],0.1375440348682002
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VCPKMT,Protein-lysine methyltransferase METTL21D,6987,805,1.00 [0.93-1.08],0.9801297203450184
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VEGFA,Vascular endothelial growth factor A,8420,986,0.96 [0.87-1.06],0.3908073701196226
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VEGFB,Vascular endothelial growth factor B,7008,809,0.87 [0.69-1.10],0.2445769161379481
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VEGFC,Vascular endothelial growth factor C,8384,984,0.97 [0.88-1.08],0.6138078722745488
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VEGFD,Vascular endothelial growth factor D,8433,990,1.14 [0.99-1.32],0.0759364561688414
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VGF,Neurosecretory protein VGF,7222,826,1.01 [0.82-1.26],0.90553419615221
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VIM,Vimentin,8206,953,1.01 [0.96-1.06],0.6845605141572804
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VIPR1,Vasoactive intestinal polypeptide receptor 1,7030,808,0.96 [0.72-1.30],0.8033676517461358
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VIT,Vitrin,7231,828,1.13 [0.95-1.35],0.1720217220531819
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VMO1,Vitelline membrane outer layer protein 1 homolog,8322,985,1.03 [0.94-1.12],0.5374383075188573
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VNN1,Pantetheinase,7238,823,0.96 [0.87-1.05],0.3500430813868757
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VNN2,Vascular non-inflammatory molecule 2,8322,985,0.91 [0.81-1.03],0.1209813838718086
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VPS28,Vacuolar protein sorting-associated protein 28 homolog,7092,819,0.88 [0.79-0.98],0.0201018940674838
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VPS37A,Vacuolar protein sorting-associated protein 37A,8322,985,0.97 [0.91-1.04],0.4362432621384151
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VPS4B,Vacuolar protein sorting-associated protein 4B,7208,827,0.93 [0.86-1.00],0.045773129189496
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VPS53,Vacuolar protein sorting-associated protein 53 homolog,8322,985,0.95 [0.88-1.02],0.1870172065391076
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VSIG10,V-set and immunoglobulin domain-containing protein 10,7208,827,0.95 [0.77-1.17],0.6263830713660781
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,6987,802,0.80 [0.65-1.00],0.0490922522705889
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VSIG2,V-set and immunoglobulin domain-containing protein 2,7208,827,0.99 [0.90-1.10],0.876247895039666
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VSIG4,V-set and immunoglobulin domain-containing protein 4,8351,974,1.05 [0.92-1.20],0.4376863902686608
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,8327,974,0.92 [0.83-1.01],0.073431928940264
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VSNL1,Visinin-like protein 1,7224,829,0.94 [0.78-1.12],0.4814122111379822
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VSTM1,V-set and transmembrane domain-containing protein 1,8164,946,1.01 [0.90-1.13],0.8814857400686389
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VSTM2B,V-set and transmembrane domain-containing protein 2B,7092,819,0.71 [0.58-0.86],0.000524811726665
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,8206,953,0.96 [0.87-1.06],0.3818290009157449
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,8412,980,0.93 [0.85-1.00],0.0592760952317762
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VTCN1,V-set domain-containing T-cell activation inhibitor 1,8180,948,1.01 [0.84-1.23],0.8802603011913368
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,7068,806,0.84 [0.74-0.96],0.0078555748870231
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VWA1,von Willebrand factor A domain-containing protein 1,8425,985,1.06 [0.93-1.22],0.3967490492442321
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VWA5A,von Willebrand factor A domain-containing protein 5A,6987,805,0.88 [0.79-0.97],0.0119361153964195
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VWC2,Brorin,8240,968,1.04 [0.90-1.19],0.6317419731616909
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VWC2L,von Willebrand factor C domain-containing protein 2-like,7222,826,0.90 [0.77-1.06],0.2115554139394324
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VWF,von Willebrand factor,8458,987,1.04 [0.96-1.12],0.3504126899944488
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WARS,"Tryptophan--tRNA ligase, cytoplasmic",8360,976,0.97 [0.83-1.13],0.6985594074489578
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WAS,Wiskott-Aldrich syndrome protein,8195,943,0.98 [0.89-1.07],0.6432616814999519
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WASF1,Wiskott-Aldrich syndrome protein family member 1,8206,953,0.95 [0.89-1.01],0.0842042884191973
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WASF3,Wiskott-Aldrich syndrome protein family member 3,8164,946,1.01 [0.94-1.08],0.8515708337305299
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WASHC3,WASH complex subunit 3,7224,829,0.91 [0.83-1.00],0.0455077168021032
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WASL,Neural Wiskott-Aldrich syndrome protein,7008,809,0.99 [0.88-1.11],0.8707905004214469
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WDR46,WD repeat-containing protein 46,7208,827,1.13 [0.95-1.36],0.1783545941024385
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WFDC1,WAP four-disulfide core domain protein 1,7054,805,0.93 [0.82-1.06],0.2821627403796656
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WFDC12,WAP four-disulfide core domain protein 12,8425,985,0.99 [0.90-1.08],0.7592959485822685
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WFDC2,WAP four-disulfide core domain protein 2,7937,926,1.08 [0.94-1.25],0.2808820365098955
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",8237,967,0.97 [0.84-1.11],0.6307338061083216
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",8351,974,1.03 [0.87-1.23],0.6908902034278025
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WIF1,Wnt inhibitory factor 1,8438,986,0.96 [0.82-1.14],0.6764754815071268
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WNT9A,Protein Wnt-9a,8195,943,0.90 [0.74-1.10],0.3104193919062345
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,8266,970,0.97 [0.87-1.08],0.6173317375659109
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",XCL1,Lymphotactin,8438,986,1.07 [0.96-1.18],0.2033892531707863
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",XG,Glycoprotein Xg,8426,987,1.18 [1.00-1.39],0.05109557524895
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",XIAP,E3 ubiquitin-protein ligase XIAP,7008,809,0.90 [0.80-1.02],0.0977309271007445
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",XPNPEP2,Xaa-Pro aminopeptidase 2,8384,984,1.01 [0.96-1.07],0.642655871724662
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",XRCC4,DNA repair protein XRCC4,8164,946,0.85 [0.72-1.00],0.0447389029406537
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",YAP1,Transcriptional coactivator YAP1,7224,829,1.09 [0.86-1.39],0.4778515875345599
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",YARS1,"Tyrosine--tRNA ligase, cytoplasmic",7204,827,0.93 [0.89-0.98],0.002900077597946
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",YES1,Tyrosine-protein kinase Yes,8322,985,0.96 [0.91-1.01],0.0951351167978606
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",YJU2,Splicing factor YJU2,7208,827,0.85 [0.69-1.06],0.1449222540098194
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",YOD1,Ubiquitin thioesterase OTU1,6987,802,0.99 [0.89-1.11],0.9170825190070868
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",YTHDF3,YTH domain-containing family protein 3,8195,943,0.95 [0.89-1.02],0.1371616502593819
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",YWHAQ,14-3-3 protein theta,7068,806,0.91 [0.83-1.00],0.0601580100879515
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",YY1,Transcriptional repressor protein YY1,7008,809,1.10 [0.86-1.40],0.4404502674837183
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZBP1,Z-DNA-binding protein 1,7008,809,1.15 [0.98-1.36],0.0942601681132187
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZBTB16,Zinc finger and BTB domain-containing protein 16,8180,948,0.96 [0.89-1.04],0.3306011532508243
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZBTB17,Zinc finger and BTB domain-containing protein 17,8206,953,1.13 [1.00-1.29],0.0583024809416538
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZCCHC8,Zinc finger CCHC domain-containing protein 8,6987,802,1.00 [0.89-1.12],0.9981659805832104
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZFYVE19,Abscission/NoCut checkpoint regulator,7204,827,0.89 [0.82-0.96],0.0020515056763899
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZHX2,Zinc fingers and homeoboxes protein 2,7224,829,1.19 [1.00-1.41],0.046040178987809
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZNF174,Zinc finger protein 174,7008,809,0.94 [0.77-1.14],0.5405236750751798
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZNF75D,Zinc finger protein 75D,7092,819,1.01 [0.90-1.12],0.9083239814667022
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZNF830,Zinc finger protein 830,7208,827,1.06 [0.97-1.15],0.1818396581906494
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZNRD2,Protein ZNRD2,7204,827,0.92 [0.83-1.01],0.0893487388977218
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZNRF4,E3 ubiquitin-protein ligase ZNRF4,7208,827,0.87 [0.77-0.99],0.0361452168348026
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZP3,Zona pellucida sperm-binding protein 3,7030,808,0.99 [0.97-1.02],0.4453349716415662
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZP4,Zona pellucida sperm-binding protein 4,6987,805,0.79 [0.62-1.00],0.0539518156857714
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZPR1,Zinc finger protein ZPR1,7032,801,0.94 [0.87-1.01],0.090994819161361
